US20030055445A1 - Expansible shearing catheters for thrombus and occlusive material removal - Google Patents
Expansible shearing catheters for thrombus and occlusive material removal Download PDFInfo
- Publication number
- US20030055445A1 US20030055445A1 US10/285,843 US28584302A US2003055445A1 US 20030055445 A1 US20030055445 A1 US 20030055445A1 US 28584302 A US28584302 A US 28584302A US 2003055445 A1 US2003055445 A1 US 2003055445A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- occlusion
- struts
- shearing
- guidewire
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320725—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with radially expandable cutting or abrading elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320758—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with a rotating cutting instrument, e.g. motor driven
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320783—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions through side-hole, e.g. sliding or rotating cutter inside catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00681—Aspects not otherwise provided for
- A61B2017/00685—Archimedes screw
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22094—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for for crossing total occlusions, i.e. piercing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
- A61B2017/2212—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions having a closed distal end, e.g. a loop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/08—Accessories or related features not otherwise provided for
- A61B2090/0801—Prevention of accidental cutting or pricking
- A61B2090/08021—Prevention of accidental cutting or pricking of the patient or his organs
Definitions
- the present invention relates generally to medical devices and methods.
- the present invention relates to devices and methods for disrupting, collecting, and removing thrombus and/or other occlusive material from blood vessels and other body lumens.
- the present invention relates to devices and methods for placement of guidewires, often for subsequent removal of unwanted tissue, thrombus, atheroma, fluid, polyps, cysts or other obstructive matter from natural and artificial body lumens such as blood vessels, grafts, implanted stenosed stents, ureters, bile ducts or fallopian tubes.
- Thrombosis and atherosclerosis are common ailments which occur in humans and which result from the deposition of thrombus and clot on the walls of blood vessels. When hardened, such deposits are commonly referred to as plaque. Such deposits are most common in the peripheral blood vessels that feed the limbs of the human body and the coronary arteries which feed the heart. Stasis, incompetent valves, and trauma in the venous circulation cause thrombosis, particularly occurring as a deep vein thrombosis in the peripheral vasculature. When such deposits build-up in localized regions of the blood vessel, they can restrict blood flow and cause a serious health risk.
- thrombosis is a serious problem in “artificial” blood vessels, particularly in peripheral femoral-popliteal and coronary bypass grafts and dialysis access grafts and fistulas.
- the creation of such artificial blood vessels generally involves anastomotic attachment at at least one, and usually at at least two, locations in the vasculature.
- Such sites of an anastomotic attachment are particularly susceptible to thrombus formation due to narrowing caused by intimal hyperplasia, and thrombus formation at these sites is a frequent cause of failure of the implanted graft or fistula.
- arteriovenous grafts and fistulas which are used for dialysis access are significantly compromised by thrombosis at the sites of anastomotic attachment and elsewhere. Thrombosis often occurs to such an extent that the graft needs to be replaced within a few years or, in the worst cases, a few months.
- thrombosis and atherosclerosis have been developed for treating thrombosis and atherosclerosis in the coronary and peripheral vasculature as well as in implanted grafts and fistulas.
- Such techniques include surgical procedures, such as coronary artery bypass grafting, and minimally invasive procedures, such as angioplasty, atherectomy, transmyocardial revasculaturization, and the like.
- the treatment site is accessed directly through a surgical incision.
- thrombectomy a variety of techniques generally described as “thrombectomy” have been developed.
- Thrombectomy generally refers to procedures for the removal of relatively soft thrombus and clot from the vasculature. Removal is usually achieved by mechanically disrupting the clot, optionally with the introduction of thrombolytic agents. The disrupted thrombus or clot is then withdrawn through a catheter, typically with a vacuum or mechanical transport device.
- Thrombectomy generally differs from angioplasty and atherectomy in the type of occlusive material which is being treated and in the desire to avoid damage to the blood vessel wall.
- the material removed in most thrombectomy procedures is relatively soft, such as the clot formed in deep vein thrombosis, and is usually not hardened plaque of the type treated by angioplasty in the coronary vasculature.
- Atherectomy has been proposed for treatment of the hardened plaque of atherosclerosis. Atherectomy may also remove occlusive tissues proliferating from the vessel wall. While a variety of atherectomy structures and devices have been proposed, and although a variety of atherectomy structures have been made commercially available on the market, the efficacy and use of atherectomy has remained somewhat limited, particularly when compared to alternative treatments for stenotic disease.
- vascular catheter devices recently developed for fragmentation and removal of plaque and/or thrombus, and for other intraluminal and intravascular procedures, are inserted percutaneously through a puncture in the skin.
- a catheter device may be inserted into a blood vessel at some distance away from the intended treatment site, and can then be advanced through the vessel lumen until the selected location is reached. In most instances this approach is performed “over the wire,” a technique in which the physician first places a guidewire device into the vessel lumen, so that the larger treatment catheter device can be tracked over the guidewire.
- the vessel to be treated is effectively blocked by an occlusive lesion (sometimes referred to as a “total occlusion,” the occlusive lesion usually comprising, thrombus, soft plaque, and/or calcified plaque) so that advancing a guidewire to and/or beyond the lesion is challenging and/or impossible.
- an occlusive lesion sometimes referred to as a “total occlusion”
- the occlusive lesion usually comprising, thrombus, soft plaque, and/or calcified plaque
- these improved devices and methods might be used to treat a total occlusion as the treatment device is being advanced through the occlusion, facilitating placement of a wire across the occlusion so that further treatment can be easily commenced.
- Device and methods which allow creation of a channel through a total occlusion for placement of a guidewire would also be advantageous, as would improved debulking of stenotic tissues.
- a cutting stent with a flexible tissue extractor is described in U.S. Pat. No. 6,036,708.
- a compressible/expandable atherectomy cutter is described in U.S. Pat. No. 5,224,945. Unitary removal of plaque is described in U.S. Pat. No. 5,665,098.
- a method for performing a partial atherectomy is described in U.S. Pat. No. 5,282,484, while an atherectomy device having a helical blade and a blade guide is described in U.S. Pat. No. 5,569,277.
- a catheter arthrotome is described in U.S. Pat. No. 5,178,625.
- a surgical apparatus for transurethral resection is described in U.S. Pat. No. 3,320,957.
- a vessel deposit sharing apparatus is described in U.S. Pat. No. 5,527,326.
- a coiled stent with locking ends is described in U.S. Pat. No. 5,725,549.
- a medical instrument with a slotted memory metal tube is described in U.S. Pat. No. 5,885,258.
- a method for manufacturing a tubular medical device is described in U.S. Pat. No. 6,027,863.
- the following U.S. Pat. Nos. may also be relevant: 6,010,449; 5,968,064; 5,741,270; 5,766,191; 5,569,275; 5,501,694; 5,795,322; 5,904,968; 5,224,945; 5,312,425; 5,330,484; and 6,022,336.
- the present invention provides improved devices, methods, kits, methods for fabrication, and the like, for removing thrombus and/or other obstructive material from the vasculature and other body lumens.
- the invention generally makes use of cooperating radially expansible shearing members, each shearing members often being in the form of an expansible basket.
- the exemplary baskets comprise helically oriented struts, with the struts of each shearing member extending with a uniform circumferential direction.
- the struts will often be independently flexible between proximal and distal portions of the shearing members, which can allow the shearing the members to flex axially to follow axially curving body lumens.
- the inner basket may be rotatably driven within the outer basket, and may optionally be coupled to an axial pump extending proximally from the shearing members.
- the outer basket may be coupled to a catheter body to avoid excessive tissue trauma to the body lumen, and the helical struts of the shearing members can by helically counterwound, so that the inner struts may slide substantially continuously across the outer struts.
- the inner and outer baskets may both radially expand selectively, independently and/or with a single actuator. The resulting shearing action is sufficiently aggressive for highly effective thrombectomy, while use of a rotationally static and axially flexible outer basket may provide a safe, limited, and controllable atherectomy treatment.
- Improved methods and apparatus are also provided for treating total occlusions in natural and artificial lumens of the body such as the vasculature (including the coronary, peripheral, neurovascular circulation, grafts, and implanted stents).
- the present invention provides methods and devices for positioning a catheter or guidewire at the proximal side of a total occlusion and crossing that occlusion with a guidewire, and often with another catheter to enable further treatment.
- the present invention further provides a treatment device that enables crossing of the lesion, and optionally isolating the treatment site (for purposes of embolic protection or for infusing a therapeutic agent to assist in debulking the occlusion), flushing debris, treatment of the occlusion, and maceration and removal of the debris.
- These techniques may include flushing the vessel or treatment site with fluid (saline, for example) or pharmacologic agents to assist in breaking up the clot or tissue into a particle size that can then be aspirated through a lumen of a treatment device, or of a secondary catheter coupled with a source of vacuum/suction.
- a non-integral embolic protection device one or more balloons or expandable structures mounted to the treatment catheter, guidewire, a proximal sheath over the treatment catheter, or the like.
- the invention provides a vascular obstruction removal catheter comprising a flexible tubular body having a proximal end and a distal end.
- An outer shearing member is attached near the distal end, the outer member having a perforate inner surface.
- An inner shearing member is rotatably disposed within the outer member, the inner member having a proximal portion, a distal portion, and a circumferential series of struts extending therebetween. The struts can flex to slide across the inner surface of the outer shearing member when the inner shearing member rotates.
- the inner member may rotate about an axis, and the inner and outer shearing bodies may be sufficiently flexible to deflect the axis laterally when the outer shearing member is expanded to engage a surrounding vessel and the inner member rotates therein.
- the struts may uniformly coil helically in a first circumferential orientation so that rotation of the inner shearing member toward the first circumferential orientation consistently urges sheared occlusive material proximally.
- the inner shearing member may comprise tube material, the struts being separated by cut surfaces between adjacent tube material portions.
- the outer shearing member may comprise outer tube material having a proximal outer portion, a distal outer portion and a circumferential series of outer struts extending helically therebetween, with the struts being separated by cut outer surfaces between outer adjacent tube material portions.
- the struts may be affixed together at the proximal portion and at the distal portion, and may flex independently therebetween.
- the struts may be helically oriented with a local pitch of the struts varying axially along the struts.
- the local pitch can increase toward the proximal and distal portions sufficiently to inhibit excessive separation between adjacent struts when the outer shearing member flexes axially.
- the struts may have protrusions which inhibit sliding of obstructive material axially between cooperating edges of the inner and outer shearing bodies.
- At least one expansion actuator may extend proximally from the shearing members so that the inner and outer shearing members can be radially expanded in situ. Axial translation of an expansion actuator may selectively radially expand the inner and outer shearing members concurrently.
- a distally oriented occlusion penetrator may be disposed adjacent the distal end of the shearing members.
- the occlusion penetrator may comprise one or more end cutters that rotate with the inner shearing member and are exposed distally of the outer shearing member to help advance the shearing members distally through occlusive material and within a body lumen.
- Alternative occlusion penetrators include a shaft extendable distally of the shearing members, the shaft axially oscillating through occlusive material without penetrating through a vessel wall.
- An intravascular ultrasound sensor can be used to measure vascular obstructions for removal and/or identify partial or total occlusion that may impede access to the target region.
- a porous or non-porous coverings or coatings may extend between the struts of a shearing member or positioning cage when the shearing member or positioning cage expands, and can be made from PTFE woven material, filter material (metallic or polymeric), braid material (metallic or polymeric), mesh, polymeric coatings, and the like.
- the coatings can be applied to the outer basket through a dipping process.
- the coverings may be applied to the outer basket using cyanoacrylate or other adhesives, thread or suturing, welding or bonding, or the like.
- Such coatings may be disposed along a distal and/or proximal region of the expandable perforate shearing member or positioning cage, and may inhibit embolization of fragmented occlusive material, constrain a treatment fluid or fluid stream, and the like.
- the invention provides a vascular obstruction removal catheter comprising a flexible tubular body having a proximal end and a distal end.
- a flexible drive shaft is rotatably disposed within the tubular body.
- An outer shearing member attached near the distal end of the tubular body has a circumferential series of independently flexible outer struts with inner surfaces.
- An inner shearing member is rotationally driven by the drive shaft within the outer member, the inner member having a circumferential series of independently flexible inner struts, the inner struts having outer surfaces which slide across the inner surfaces of the outer struts when the inner shearing member rotates, at least one member of the group comprising the inner struts and the outer struts being helically oriented.
- the inner and outer shearing members can each have proximal portions and distal portions, the struts of each shearing member affixed together at the proximal and distal portions and extending independently therebetween so that the shearing members flex axially primarily along the struts.
- a proximal housing may be coupled to the tubular body, the housing having a motor drivingly engaging the drive shaft.
- the drive shaft may engage the distal portion of the inner shearing member and be axially translatable relative to the outer tubular member from adjacent the proximal housing.
- An axial bearing surfaces of the outer and inner shearing members can cooperate to effect concurrent radial expansion of the inner and outer shearing members when the drive shave translates axially.
- the invention also provides a method for forming a vascular obstruction removal catheter.
- the method comprises providing a first tube having a proximal end and a distal end with a central region therebetween, the tube comprising a tube material.
- the central region of the first tube is cut axially so as to define a circumferential series of independent deformable struts, the struts comprising the tube material.
- the first cage can be positioned coaxially with a second resiliently deformable cage, and a drive can be attached for rotating at least one of the cages within a blood vessel for shearing of obstructive material between the cages.
- the invention comprises a method for removing obstructive material from a blood vessel of a patient.
- the method comprises introducing a distal portion of a catheter into the blood vessel.
- the distal portion of the catheter is positioned adjacent the obstructive material from outside the patient by manipulating a flexible body of the catheter.
- Inner and outer shearing members of the catheter are radially expanded within the blood vessel, the inner shearing member is rotated within the outer shearing member to shear the occlusive material therebetween.
- the invention provides a component for use in a catheter device for removal of obstructive material from the lumen of a body conduit.
- the component comprises first and second end portions having a longitudinal axis there between.
- a middle portion has one or more struts around the circumference of said longitudinal axis and extending between (but not along) said first end portion and said second end portion. Said middle portion and said end portions are formed from a continuous tube.
- the struts may comprise a helix about said longitudinal axis.
- the struts may be formed in a straight configuration along said longitudinal axis and between said first and second end portions.
- the struts may have a width and a thickness, wherein said width is greater than said thickness.
- the width of the struts may vary along the length of the struts, and may form at least one serration or pocket.
- the thickness of the struts may be varied along the length of said strut, optionally so as to form a cutting edge.
- a cross section of the middle portion may be greater than cross sections of said end first and second end portions.
- the struts may be formed by laser cutting, by photoetching, by EDM, or by water jet abrasion.
- the first and second end portions can be formed in a zigzag configuration, and may have a longitudinal length that is less than that of the length of said middle portion.
- the component can comprise a shape memory alloy (such as a nickel titanium alloy, Elgiloy®, or the like), stainless steel, a formable polymer, a composite material, or the like.
- the invention may comprise a component for use in a catheter device for removal of obstructive material from the lumen of a body conduit.
- the component comprises first and second end portions having a first cross sectional diameter and a longitudinal axis therebetween.
- a middle portion extends between but does not include the end portions, and has at least one second cross sectional diameter and a plurality of struts forming a helix around the circumference of said longitudinal axis.
- the middle portion and said end portions are formed from a continuous tube.
- the struts are axially connected to the adjacent strut by an expandable connector element, with the expandable connector element optionally having a serpentine configuration, defining a zigzag, or the like.
- the invention provides a device for treating a total occlusion in a vessel having a vessel wall.
- the device comprises a catheter body having a proximal end, a distal end and a lumen.
- a radially expansible positioning cage is disposed near the distal end of the catheter body.
- a shaft is disposed in the catheter body lumen, the shaft advanceable into the total occlusion without penetrating through the vessel wall when the positioning cage is radially expanded.
- the shaft may comprises a dottering member extendable beyond the catheter body distal end.
- the dottering member by cycle axially and/or rotationally to facilitate advancing the dottering member into the total occlusion, the dottering member making a “pilot hole” into the occlusive material without penetrating through the vessel wall.
- a mechanical pump may be received within the catheter body lumen, and/or a macerator may extend at least partially along the length of said lumen, particularly adjacent the distal end. Distally exposed rotating cutters may be particularly beneficial for advancing the catheter into the total occlusion.
- the invention provides a method of removing a total occlusion from the vessel of a patient.
- the method comprises introducing a positioning cage catheter system into a vessel of a patient and advancing the catheter system to the site of the occlusion to be treated.
- a positioning cage of the catheter system is radially expanded within the vessel to position a lumen of the catheter system.
- An occlusion penetrator of the catheter system is advanced within the positioned lumen and into the occlusion along a luminal length of the occlusion.
- the catheter system is manipulated to advance a guidewire or guide catheter distally of the occlusion.
- FIG. 1 is a perspective view of inclusive material removal catheter having a rotationally driven inner basket which cooperates with a outer basket to shear occlusive material therebetween.
- FIG. 2 is a perspective view of the distal portion of the catheter of FIG. 1.
- FIG. 3A- 3 C is a perspective view showing the inner and outer baskets of the catheter of FIG. 1.
- 3 B and 3 C show how the outer basket may have a coating or covering for embolic capture.
- FIG. 4 is a perspective view of an outer basket or shearing member of the catheter of FIG. 1.
- FIG. 5 is a perspective view of a tube cut so as to form the inner or outer basket of the catheter of FIG. 1.
- FIG. 6 illustrates a flat pattern of the basket of FIG. 5, showing variable pitch of the helical struts.
- FIG. 7 is a perspective view of an alternative basket having protrusions and/or circumferential indentations to inhibit axial sliding of occlusive material during shearing.
- FIG. 8 is a perspective view of yet another alternative basket having circumferential proximal and/or distal web members between struts to inhibit severing of valves and other structures disposed axially of the shearing baskets.
- FIG. 9 is a cross-sectional view of the connection between the proximal end of the shearing baskets and the distal end of the catheter body.
- FIG. 10 is a simplified cross-sectional view of the proximal end of the shearing baskets and the distal end of the catheter.
- FIG. 11 is a cross-sectional view showing attachment of the inner shearing basket to a drive shaft.
- FIG. 12 is a perspective view of a proximal housing of the catheter of FIG. 1.
- FIG. 13 is a perspective view of the housing of FIG. 12 with a portion of the cover removed to show the drive system and other internal components.
- FIGS. 14 - 17 schematically illustrate the use of the occlusive material removal catheter of FIG. 1.
- FIGS. 18A and 18B illustrate alternative embodiments of the positioning cage catheter device of the present invention.
- FIGS. 18 C- 18 F illustrate radially expandable positioning and shearing structures having an occlusive material penetrator in the form of a distally exposed morcellator for forming a passage through a total occlusion.
- FIG. 19 illustrates the positioning cage catheter device of the present invention being used to initiate the crossing of a total occlusion.
- FIG. 20 illustrates an alternative embodiment of the present invention wherein a positioning cage and a treatment device are formed integrally and placed over a guidewire.
- FIG. 21 illustrates details of the distal end of the integral positioning cage and treatment device of FIG. 20.
- FIGS. 22, 23, and 24 A- 24 B illustrates steps in methods for use of the system of FIG. 20 for accessing a treatment site of an occlusion which is challenging and/or impossible to traverse with a standard guidewire.
- FIG. 25A- 25 C illustrates method of treating luminal occlusions in which a treatment region of the lumen is at least partially isolated.
- FIG. 26 illustrates an alternative embodiment of the present invention wherein a drive shaft is advanced to gain access through the total occlusion.
- a vascular obstruction removal catheter 10 generally includes an elongate flexible catheter body 12 having a proximal end 14 and a distal end 16 .
- Cooperating inner and outer shearing baskets 18 , 20 define shearing means 19 , and are disposed near distal end 16 of catheter body 12 , while a proximal housing 22 is disposed near proximal end 14 of the catheter body.
- outer basket 20 will typically be affixed at distal end 16 of catheter body 12 , while a drive shaft drivingly couples inner basket 18 to a drive motor of proximal housing 22 .
- inner and outer baskets 18 , 20 of shearing means 19 are illustrated with some of the adjacent structures in FIG. 2, and in a simplified format (without some of the adjacent structures) in FIG. 3A.
- Outer basket 20 is shown without inner basket 18 in FIG. 4.
- Each of the baskets 18 , 20 includes a proximal portion 24 , a distal portion 26 , and an intermediate portion 28 .
- Intermediate portion 28 includes a circumferential series of helical struts 30 .
- Struts 30 are affixed together at proximal portion 24 and distal portion 26 , but generally extend independently therebetween. This allows struts 30 to flex individually, and allows the overall axis of each basket 18 , 20 (as well as shearing means 19 ) to deflect laterally so as to accommodate axial curvature of the vasculature.
- Baskets 18 , 20 will generally be radially expansible in situ from a low profile configuration to a larger profile configuration. Baskets 18 , 20 will often comprise a resilient or superelastic material, and may be biased to expand radially when released from a radially constraining sheath. As helically wound baskets exhibit radial expansion which is coupled with a decrease in axial length, manipulation of the axial lengths of the baskets may also be used to induce or control the radial expansion, so that baskets 18 , 20 may expand resiliently when released from an axial elongation restraint.
- the baskets may also be biased toward a profile which is smaller than a fully radially expanded configuration, so that radially and/or axial restraints are used to actively expand the diameter of shearing means 19 .
- struts 30 may be pushed radially outwardly.
- inner and outer baskets 18 , 20 will expand radially when an axial actuator 34 of proximal housing 22 (see FIG. 1) is actuated from outside the patient body, as will be described hereinbelow.
- struts 30 may optionally be biased toward the radially expanded configuration, a low-profile configuration, or some configuration therebetween.
- the profile of shearing means 19 can be selected from a plurality and/or continuous range of expanded sizes, and can be varied during treatment.
- Outer basket 20 may be rotationally coupled to catheter body 12 .
- movement of the outer basket within the vasculature can be substantially limited to, for example, axial positioning and advancement of the shearing means for treatment, thereby inhibiting excessive trauma to the surrounding vessel wall.
- additional manipulation of catheter body 12 may be used to abraid the vessel wall with direct engagement between the outer basket and the endothelium.
- Struts 30 of outer basket 20 have continuous inner surfaces 36 between proximal portion 24 and distal portion 26 .
- struts 30 of inner basket 18 may have continuous outer surfaces 38 between the proximal and distal portions.
- outer surfaces 38 slide across inner surfaces 36 so as to shear occlusive material within the vasculature therebetween.
- direct engagement between the inner basket and the surrounding tissues between the struts of the outer basket may also provide some shearing and/or abrasion of occlusive mater.
- the drive shaft may be axially coupled to both the inner and outer baskets at distal portions 26 . This allows concurrent and coordinated radial expansion of the inner and outer baskets so as to maintain sufficient proximity between the inner surface 36 and the outer surface 38 to provide the desired shearing effect.
- drive shaft 32 comprises a tube having a guide wire lumen 40 and an outer helical pumping element 42 .
- rotation of such a helical pumping element within an aspiration lumen 44 of catheter body 12 can draw and/or pump severed fragments of occlusive material, debris, and fluid proximally into and/or through the catheter body.
- This actively pumped aspiration may draw fluid proximally from within proximal portions 24 of baskets 18 , 20 , and/or radially inwardly and then proximally through one or more aspiration windows 46 about catheter body 12 .
- At least one of the inner and outer baskets 18 , 20 may have struts 30 which extend, at least in part, substantially axially.
- at least one of the baskets will have struts 30 , which wind primarily toward a first circumferential orientation 50 as the struts proceed distally, as can be understood with reference to FIG. 4.
- Such a consistent winding direction can be used to consistently urge sheared materials proximally, as can be understood with reference to the arrows illustrated in FIG. 3A.
- inner and outer surfaces 36 , 38 slide against each other, material which is severed between these cooperating surfaces can be urged proximally when the inner basket is rotated relative to the outer basket in the proper direction.
- FIGS. 3B and 3C illustrate a catheter having a shearing means similar to that of FIG. 3A, and also having an expansible distal covering 31 (FIG. 3B) or an expansible proximal covering 33 (FIG. 3C).
- Coverings 31 , 33 comprise a porous or non-porous coverings or coatings carried on (and expansible with) the outer shearing member along some (but typically not all) of the expansible portion of baskets 18 , 20 .
- Coatings 31 , 33 may inhibit embolization of fragmented occlusive material, constrian a treatment fluid or fluid stream, inhibit injury to the venous valves and the like.
- Coverings 31 , 33 extend between adjacent struts of a shearing member or positioning cage and accommodate radial expansion of the shearing member or positioning cage, the covering optionally being made from a PTFE woven material, filter material (metallic or polymeric), braid material (metallic or polymeric), mesh, polymeric coatings, and the like.
- the coatings may be applied to the outer basket through a dipping, filament winding or braiding process, or the like.
- the coverings may be applied to the outer basket using cyanoacrylate or other adhesives, thread or suturing, welding or bonding, or the like.
- FIGS. 5 and 6 an alternative basket structure is illustrated in a perspective view and as a flat pattern, respectively.
- the flat pattern of FIG. 6 graphically illustrates the configuration of the struts 30 as if basket 50 were cut along one side and unrolled. Such flat patterns are useful for fabrication and understanding the strut configuration.
- a local helical wind angle defined between struts 30 and an axis 52 of basket 50 can vary along the axis.
- a helical angle 54 along a central portion of struts 30 is significantly greater than a helical angle 56 near proximal and distal portions 24 , 26 .
- a pitch of struts 30 may vary locally along the axis of basket 50 , with the pitch generally being greater adjacent the proximal and distal portions 24 , 26 .
- the pitch varies according to a sinusoidal function in which the period in the central 1 ⁇ 3 of the axial strut length is 1 ⁇ 2 the period on the proximal and distal thirds.
- such enhanced central helical winding angles help to avoid circumferential distortion of struts 30 when axis 52 is deflected laterally, so that uneven separation between the struts during axial bending is inhibited.
- At least one of inner and outer baskets 18 , 20 may include struts 30 having one or more circumferential protrusions 62 .
- Struts 30 of basket 60 can define pockets which effectively capture occlusive material against the struts of the cooperating basket. This can help avoid excessively axial sliding of material for which shearing is desired, as the material will be caught at a pocket or protrusion between the cooperating shearing struts.
- This can be understood by imagining a pencil which is to be sheared between the cooperating surfaces of a pair of scissors. The pencil may slide along straight cooperating shearing surfaces. Such sliding may be inhibited by forming a protrusion and/or pocket to capture the pencil along an edge of one or both shearing members.
- FIG. 8 A still further alternative basket 70 is illustrated in FIG. 8.
- one or more circumferential members 72 extend between adjacent struts 30 adjacent proximal and/or distal portions 24 , 26 .
- Circumferential member 72 can allow some expansion at the ends, and can help inhibit entraining structures which are disposed axially of the shearing baskets.
- circumferential member 72 may help avoid severing valves within blood vessels.
- a variety of alternative circumferential members might be used, including expandable and/or elastomeric webs, braided meshes, or the like.
- the shearing baskets may be formed of a metal, optionally comprising a superelastic metal, such as Nitinol®, Elgiloy®, or the like.
- Alternative basket materials may include stainless steel or other high strength metals, and the baskets may comprise a polymer in some embodiments.
- struts 30 may comprise wire with wire struts often being affixed at the proximal and distal portions 24 , 26 .
- the shearing baskets are formed from a continuous material extending along proximal portion 24 , along struts 30 , and along distal portion 26 .
- the struts may have a circumferential width in a range from about 0.004′′ to about 0.100′′, preferably having a width from about 0.006′′ to about 0.025′′.
- the radial thickness of the struts will typically be in a range from about 0.001′′ to 0.050′′, preferably being in a range from about 0.003′′ to about 0.025′′.
- the baskets may be formed by selectively cutting a tube so as to define the struts, often by use of photoetch processing, laser cutting, water jet abrasion, or EDM techniques.
- FIGS. 9 - 11 coupling of drive shaft 32 and catheter body 12 to inner and outer shearing baskets 18 , 20 can be understood.
- Adjacent proximal end 24 , catheter 12 is axially and rotationally affixed to outer basket 20 , as illustrated in FIGS. 9 and 10.
- Drive shaft 32 rotates within aspiration lumen 44 of catheter body 12 , and the drive shaft may have a helical pumping member 42 .
- Pumping member 42 acts as an Archimedes screw, urging fluid and debris within proximal portion 24 of inner basket 18 proximally, and/or entraining fluid radially through aspiration windows 46 .
- Inner cutter 18 is rotationally affixed to drive shaft 32 adjacent portion 26 , as illustrated in FIG. 11.
- Inner basket 18 is rotatable within proximal portion 24 of outer basket 20 , and axial movement of the inner basket within the outer basket is limited by proximal cooperating thrust bearing surfaces 80 , as seen in FIGS. 9 and 10.
- distal portion 26 of outer basket 20 is axially coupled to drive shaft 32 and inner basket 18 by distal thrust bearing surfaces 82 , as illustrated in FIG. 11.
- a nose cone 84 presents an atraumatic distal tip adjacent the distal port of guidewire lumen 40 .
- Housing 22 contains a motor drivingly engaging drive shaft 32 within catheter body 12 .
- the motor may be actuated by a drive actuator 88 , with the drive actuator optionally effecting shearing motion of the inner basket and urging the sheared debris proximally when the actuator is moved in a first direction.
- drive actuator When drive actuator is moved in a second direction, drive shaft 32 may rotate in an alternative direction, which may help free a jammed inner cutting member, or the like.
- An aspiration port 90 may be coupled to a vacuum source, such as a lockable syringe, a vacuum pump, or the like.
- a vacuum actuator 92 may provide momentary aspiration.
- Linear actuation of the drive shaft 32 may be provided by a linear actuator 34 (See FIG. 1)coupled to the drive shaft using thrust bearings and axially slidable engagement of drive splines, or the like.
- catheter 10 will generally be introduced into a blood vessel B over a guidewire GW using a conventional percutaneous or cut-down technique.
- a portion of the blood vessel encompassing the target occlusive material may be isolated from surrounding blood flow.
- Such isolation may be provided by using a balloon guidewire and/or a sheath disposed around catheter body 12 , with the sheath having an expandable member such as an annular balloon.
- isolation may be provided proximally and/or distally of an occlusive material O within a blood vessel wall W.
- Inner and outer baskets 18 , 20 may be inserted and positioned adjacent the targeted occlusive material O while the baskets are in a low profile configuration, optionally using a remote imaging modality such as fluoroscopy, ultrasound, or the like.
- drive shaft 32 may be translated proximally relative to catheter body 12 so as to radially expand inner and outer baskets 18 , 20 . Where the inner and outer baskets are biased to expand resiliently, drive shaft 32 may be released to allow the baskets to expand. Where the baskets are biased to a configuration smaller than the desired deployed configuration, the drive shaft may be urged proximally relative to catheter body 12 so as to overcome the resilience of the basket structures.
- the overall size of the cooperating shearing members may be selected by selectively axially positioning the drive shaft relative to the surrounding catheter body. This helps provide accurate control over the depth of material sheared from wall W.
- catheter 10 may advanced distally over guidewire GW within the vessel wall W during rotation of inner basket 18 .
- Outer basket 20 slides distally against the vessel wall substantially without rotating, thereby providing an incremental and controlled shearing action which can follow axial bends of the natural or artificial blood vessel B.
- the amount of occlusive material O removed form vessel wall W at a particular location may depend on the expanded size of the cooperating shearing baskets at that location, on the speed of rotation of the inner basket, on the speed of axial translation of the shearing means, and on the total time and number of rotations of the inner basket at that location.
- the proximal shearing action of the struts may, at least in part, draw the occlusive material proximally from along the vessel wall into the interior of the baskets, as can be understood with reference to FIG. 17.
- rotation of the helical struts 30 of inner basket 18 may help draw catheter 10 distally within blood vessel B.
- serrated circumferential surfaces 94 may improve shearing efficiency by limiting sliding of occlusive material O. Regardless, as the strut of inner basket 18 rotates relative to the struts of outer basket 20 , occlusive material O protruding into an interior of the baskets from wall W is both severed and/or urged proximally.
- kits may include some or all of the components of catheter 10 together with instructions for their use according to one or more of the methods described herein.
- Proximal end or distal portions 24 , 26 of the inner and/or outer baskets may comprise a serpentine circumferential member, thereby allowing that portion to be expanded radially during assembly of catheter 10 . It may be advantageous to at least slightly bias struts 30 radially outwardly so as to facilitate initial axial compression of the baskets.
- the structures and methods of the present invention may find applications for removing occlusive material from a wide variety of alternative body structures and lumens, including the fallopian tubes, genitourinary tract (for example, for treatment of benign prostatic hyperplasia, and the like), gastrointestinal tract, and the like.
- FIGS. 18A and 18B A positioning cage catheter 120 which is particularly beneficial for treatment of blood vessels having a total occlusion (when it is difficult or impossible to access the entire treatment site with a standard guidewire) is illustrated in FIGS. 18A and 18B.
- Many of known intraluminal therapies require that (or are facilitated when) the lumen has a significant open cross section, without an excessively tortuous luminal path, to allow the guide structure to be placed across the occlusion.
- total occlusion may refer to any substance or anatomic morphology that acts to severely occlude a body conduit such that it is difficult to pass a wire from proximal end of the occlusion to the distal end.
- some occlusions may be more severe than others but all are included in the scope of the present invention when there may be some difficulty passing a guidewire therethrough.
- Cage 110 may be formed of multiple straight wires or struts 111 , or multiple curved wires or struts 112 formed into a helix as depicted in FIG. 18B. It is noted that a double wire (not shown) may also be employed to form the cage structure. These cage structures are fixedly attached to a catheter body 113 , having a distal tip 114 accommodating passage of a guidewire through lumen 115 .
- catheter system 120 comprises a positioning cage such as described one of those described above, or such as those in related U.S. patent application Ser. No. 09/388,294, incorporated herein by reference.
- a guidewire such as the described in U.S. patent application Ser. No. 09/491,401 (vibrating guidewire) or U.S. patent application Ser. No.
- 09/005,217 incorporated herein by reference or in some cases such as those readily available from various manufacturers (TERUMO, CORP./BOSTON SCIENTIFIC, Natick, Mass., GUIDANT, CORP., Indianapolis, Ind., or PERCUSURGE, Sunnyvale, Calif.) may be used within catheter system 120 , as will be understood from the following description.
- the positioning cage and the treatment catheter may be employed as an integral unit to both place the guidewire, and to perform the subsequent treatment.
- a device such as those described in U.S. patent application Ser. Nos. 09/491,401 and 09/388,294 previously incorporated herein by reference, may be employed.
- the total occlusion access devices of the present invention may be inserted into a body conduit and advanced to the proximal side of the occlusion, either over a guidewire, or by just advancing the positioning cage to the treatment site, depending on the body lumen to be treated. Once at the treatment site, the positioning cage can be pushed against the occlusion.
- a guidewire or dottering device may be advanced from the cage through a lumen coaxial with the cage (and hence, substantially coaxial with the body lumen when the cage is expanded therein ) to penetrate and/or pierce the occlusion.
- the combination action of the positioning cage asserting forces against the vessel wall and the occlusive material (optionally by rotating the cage or expanding the against the vessel wall), and the guidewire or dottering device probing against the occlusion, may work to tunnel the devices through the occlusion to the distalmost portion and beyond.
- the positioning cage may help to center the action of the dottering member and inhibit perforations through the vessel wall or other vessel wall damage.
- the positioning cage may be part of a treatment catheter and therefore, once the guidewire is in place, the treatment catheter may be advanced to initiate removal of the occlusion.
- a distal protection device such as a balloon fixed to a guidewire, a filter affixed to a guidewire, or the like, may be employed distal of the occlusion and expanded to minimize any embolization of clot or other material.
- an occlusion balloon or filter may be deployed proximal of the occlusion to isolate the lesion and allow the treatment device (or a separate structure) to infuse saline, contrast, pharmacologic agents such as tPA, ReoPro, IIB3A inhibitors and the like, or chemical ablation agents or acid solutions such as those described in PCT Application No. PCT/US99/15918 (WO 00/03651).
- pharmacologic agents such as tPA, ReoPro, IIB3A inhibitors and the like
- chemical ablation agents or acid solutions such as those described in PCT Application No. PCT/US99/15918 (WO 00/03651).
- the occlusive debris can be removed by activating the shearing, macerating, and aspirating function of the device of the present invention as described above, and in U.S. patent application Ser. No. 09/388,294 and U.S. Provisional Patent Application No. 60/154,752.
- Catheter system 120 a includes inner and outer shearing members in the form of baskets 18 , 20 , as described above, and can also include some or all of the catheter structures described above for selectively expanding the inner and/or outer baskets, for irrigating and/or aspirating fluids, for urging fluids and severed fragments proximally within the outer sheath, for isolating the body lumen proximally and/or distally of the shearing members, and the like.
- a total occlusion penetrator is provided adjacent tip 114 .
- the penetrator is in the form of a distally exposed morcellator 122 .
- Morcellator 122 comprises a circumferential series of helical cutters which may be rotationally coupled to inner shearing member 18 or may rotate independently of the shearing member.
- the cutters of morcellator 122 may extend distally of the distal portion of the outer shearing member 20 and/or distally of the inner tubular body which defines the guidewire lumen 115 sufficiently to allow the rotating cutters to advance into the occlusive material of a total occlusion when the morcellator rotates. Expansion of the shearing member can maintain separation between the advancing morcellator and the vascular walls, so that the expanded shearing member acts as a positioning cage.
- use of a morcellator in the form of one or more helical structures within a lumen can act as a pump or Archimedes screw to urge the occlusive material proximally.
- the positioning catheter 120 is inserted into a vessel BV and advanced to the treatment site just proximal of total occlusion TO.
- Cage 110 may actually engage the occlusion TO and begin loosening the plaque or other material making up the occlusion.
- cage may be manually rotated to further engage the occlusion.
- guidewire GW may be optionally advanced out of the distal tip of the positioning catheter to contact and help fragment the occlusion TO, the guidewire optionally being adapted for use as an occlusion penetrator, as will be described below. As described above regarding FIGS.
- a morcellator 122 may also be used as an occlusive material penetrator by rotating the distally exposed morcellator and advancing the catheter system to engage the rotating morcellator against the total occlusion TO.
- Catheter 120 , guidewire GW, and/or morcellator 122 may be used in combination or in an alternating motions or cycles to create a pilot hole through the occlusion TO such that the guidewire GW may be placed through the occlusion and advanced distally therebeyond.
- Treatment catheter 130 comprises a proximal end having a handle 131 with an actuator knob 132 and a Y connection 133 to allow infusion and/or aspiration.
- a catheter shaft 113 extends distally from handle 131 toward a distal working end 134 .
- FIG. 21 depicts the distal working end of treatment catheter 130 , showing a positioning cage 110 attached at its proximal end to catheter shaft 113 , and on its distal end to distal tip 114 .
- Distal working end 134 further comprises a drive shaft 141 with an optional coiled mechanical pump 141 ′ and a macerator 142 coiled therearound.
- treatment catheter 130 is inserted into the lumen of a vessel BV and advanced to the proximal portion of the treatment site.
- the lesion can either be crossed mechanically (as described above regarding FIG. 19) and/or saline or other therapeutic agents may be infused (optionally via guidewire lumen 115 , as shown in FIGS. 18) to assist in dissolving, softening, and/or fragmenting the occlusive material.
- agent flow from the catheter system alone may be sufficient to allow a standard guidewire to be advanced through the occlusion.
- the remaining components of the catheter system may then be advanced over the guidewire and remove some or all of the occlusive material, as described above.
- a standard or modified guidewire may be used to help form a pilot hole or passage for placement of a guide structure.
- a dottering tool or dottering guidewire 151 can be centered within the lumen of the blood vessel BV by expanding cage 110 .
- the centered dottering tool 151 may then be used as an occlusive material penetrator by advancing the dottering tool in a linear translating and/or cycling motion to begin formation of a pilot hole or pathway through the total occlusion.
- dottering guidewire 151 may have a structure similar to a standard guidewire, the dottering tool will optionally have a more rigid construction than a standard guidewire adjacent the distal end, and the distal portion of the dottering tool may also be able to assume a straight configuration with sufficient axial column strength for advancement of an atraumatic tip distally from the guidewire lumen of the catheter system and into the occlusive material.
- dottering tool 151 Once dottering tool 151 has formed a passage 153 through the total occlusion, other devices (such as standard guidewires, a balloon guidewire or other distal protection devices to inhibit embolisms and/or release of therapeutic agents distally of the total occlusion, and the like) may be advanced through the passage, or the dottering wire may be used as a guide structure.
- other devices such as standard guidewires, a balloon guidewire or other distal protection devices to inhibit embolisms and/or release of therapeutic agents distally of the total occlusion, and the like
- the dottering wire may be used as a guide structure.
- centering cage or basket 110 can provide centering of guidewire lumen 115 . Centering of this coaxial lumen can help protect the vessel wall from mechanical injury imposed by dottering device 151 .
- Dottering device 151 may be cycled axially mechanically or using an axial drive motor, and may also be rotated manually or by drive motor.
- the centered guidewire lumen which should be substantially coaxial with the vessel, may also be used for infusion of any of a variety of fluids.
- a thrombolytic agent having an enzymatic action with breads down fibrin clot matrix (such as Alteplase, tPA, Activase, Tenecteplase, TNK, and TNKase from Genentech, Inc.; Anistrpelase a-SK, and Eminase from Roberts Pharmaceuticals; Reteplase, r-PA, and Retavase from Centocor, Inc.; Streptokinase, SK, and Streptase from AstraZeneca, Inc.; and/or Abbokinase, from Abbott, Inc.
- breads down fibrin clot matrix such as Alteplase, tPA, Activase, Tenecteplase, TNK, and TNKase from Genentech, Inc.; Anistrpelase a-SK, and Eminase from Roberts Pharmaceuticals; Reteplase, r-PA, and Retavase from Cento
- a GP IIb/IIIa inhibitor which inhibits the fibrogen binding site of platelet membrane, may be locally delivered.
- Suitable GP IIb/IIIa inhibitors may include Abciximab and ReoPro from Centocor, Inc.; Tirofiban and Aggrastat from Merck, Inc.; Eptifibatide and Integrelin from Cor Therapeutics, Inc.; Bitistatin, Kistrin, and Aspirin.
- Still further active agents might be used, including anti-thrombin agents and agents directed toward prevention of restenosis (to inhibit coagulation and/or decreasing smooth muscle proliferation and migration), such as Heparin, LMW, enoxaparine or Lovenox, dalteparin or Fragmin, ardeparin or Normoflo, Hirudin, Argatroban, PPACK, radioactive agents, nitrate, HA 1077, calcium antagonists, angiotensin converting enzyme inhibitor, anti-inflammatory agents, steroidal agents, anti-mitotic agents, HMG CoA reductase inhibitors, colchicine, angiopeptin, cytoclasin B, and the like.
- Gene therapy agents might also be locally delivered to inhibit restenosis and/or promote angiogenesis, with suitable agents optionally being delivered via plasmid vectors or by viral vectors, and suitable agents including genes relating to VEGF, C-myb, FGF, transforming growth factor b. endothelial growth factor, protooncogenes such as C-myc, C-myg, CDC-2, PCNA, and the like.
- suitable agents including genes relating to VEGF, C-myb, FGF, transforming growth factor b. endothelial growth factor, protooncogenes such as C-myc, C-myg, CDC-2, PCNA, and the like.
- Local delivery of chemotherapeutic agents (which are used to treat malignancies) may be employed, such as adriamycin or Doxorubicin.
- Imaging Media such as contrast media, radioactively labeled agents, or the like may be locally delivered, as might other agents such as plasminogen addative as an adjunct to thrombolytic therapy, immunosuppressive agents, Corazo'n material, lytics, saline, or the like.
- positioning cage 110 and dottering device 151 may be advanced simultaneously or in alternating partial steps into and through the total occlusion.
- dottering device 151 may be advanced through the total occlusion while the expanded positioning cage remains at a fixed location.
- some penetrator structure of the catheter system will preferably advance until a passage 153 is formed through the total occlusion. Once an opening, propagation plane, or pathway has been formed through the occlusion TO, a guide structure may be passed distally along passage 153 beyond the total occlusion.
- the cage may be advanced against the proximal portion of the occlusion TO as shown in FIG. 24A (in which cage 110 is shown in a partially expanded configuration 110 a ) and then expanded (to a more fully expanded configuration 110 b ) to assist in propagating a passage, plane, or pathway through the occlusion, as shown in FIG. 24B.
- expansion of cage 110 may open up or propagate a cleavage plane to facilitate passing a guidewire or dottering device 51 using a wedge effect.
- This wedge effect may, of course, be combined with axial cycling of dottering device 51 , rotation and advancement of a cutter, occlusive material agent dissolution, and any of the other mechanisms described herein.
- the various occlusion treatment methods and structures described herein will generally be compatible for use in combination.
- FIGS. 25 A- 25 B illustrate further steps in treatment of the occlusion (TO) once a guidewire has been passed distally.
- a distal protection member 155 is inserted over the guidewire (or is attached to the guidewire itself) through passage 153 and expanded distally of the occlusion.
- Distal protection member 155 inhibits distal flow beyond the occlusion and can help decrease or prevent embolization of material downstream of the treatment site.
- Distal member 155 may comprise an annular balloon fixed on a catheter or guidewire, a radially expandable filter, or any of a wide variety of flow and/or embolization inhibiting intraluminal structures.
- an intravascular ultrasound (IVUS) sensor 157 may be carried by at least one of the components of the catheter system, optionally in a component which will traverse the occlusion such as the guidewire or dottering device 151 (or other penetrator), a shaft axially coupled to distal protection member 155 , or the like.
- IVUS capabilities may be incorporated in one or more of the other catheter system components, or may be provided by a dedicated structure that can be advanced through a lumen of the catheter system or independent thereof. Such IVUS capabilities may be useful for planning an occlusion therapy, for monitoring progress of the therapy, and/or for verifying the effectiveness of the therapy.
- a proximal occluding member 159 may also be inflated or expanded to isolate the treatment site.
- Proximal occluding member may again comprise a balloon or embolic filter carried on the outer surface of shaft 113 or on an outer sheath 161 , with occlusion and fluid isolation allowing the infusion of various treatment modalities such as saline, contrast, pharmacologic agents such as tPA, ReoPro, IIB3A inhibitors and the like, or chemical ablation agents or acid solutions such as those listed above regarding FIGS. 22 and 23, and/or those described in PCT Application No. PCT/US99/15918 (Publication No. WO 00/03651). In the case of any acidic compounds, it is beneficial to fully contain the compounds infused within the treatment site, and to expeditiously remove and aspirate the dissolved material.
- various treatment modalities such as saline, contrast, pharmacologic agents such as tPA, ReoPro, IIB3A inhibitors and the like, or chemical ablation agents or acid solutions such as those listed above regarding FIGS. 22 and 23, and/or those described in
- the treatment catheter 130 and specifically the mechanical pump ( 141 and 141 ′) is used to remove some or all remaining occlusive material OM, including thrombus, plaque, fibrin, clot and the like, while still protecting the vessel wall.
- Fluid may optionally be circulated by, for example, infusion via lumen 115 while aspirating via a lumen 163 of shaft 113 , the aspiration often being assisted by rotation of the Archimedes screw pump 141 ′ within the aspiration lumen as described above.
- a vacuum source may be applied to the aspiration lumen via the proximal housing or only a proximal pump may be included, and some embodiments of the occlusion removal and access catheters described herein may not include an integral mechanical pump disposed in a distal lumen of the catheter system.
- the catheter is then removed and the vessel may then be further treated with a liner, stent, coated stent, stent-graft, or the like, as is taught by the prior art and is known to those skilled in the art.
- a positioning cage 110 is located on the distal portion of a treatment catheter 120 a.
- Treatment catheter 120 a may include an axially moveable driveshaft 165 , the cutters 122 may be axially affixed in a distally exposed configuration, or a distal cover may be removed in situ from cutters 122 of the morcellator.
- the driveshaft 165 can be advanced into the occlusion TO while the driveshaft and (and the cutters carried thereon) rotate to create the desired pilot hole, propagation plane or passage for a guidewire or other guide device.
- the inner or outer cage may be translated distally and/or in tension to distally expose a morcellator that drills similarly into and/or through the total occlusion TO.
- a morcellator formed of helical cutters extending distally from within a lumen
- the penetrator may comprise a blunt disection tool distally extending from a fixed outer or rotating inner cage, a cutter in the form of a spinning burr or screw extending distally from a rotating inner cage, or the like.
- the isolation balloon or distal protection device may be used in conjunction with the positioning cage catheter 120 , and well as through and in conjunction with treatment catheter 130 .
- the terms pilot hole and propagation plane are used to refer to any path that is created through a occlusion (TO), either through the center of the vessel lumen, or to one side or the other around the circumference of the vessel lumen.
- TO occlusion
Abstract
Description
- This application is a division of, and claims the benefit of priority from U.S. Ser. No. 09/820,301 (Attorney Docket No. 19744P-001010US), which claims the benefit of priority from Provisional Application No. 60/193,539 filed Mar. 31, 2000 (Attorney Docket No. 19744P-001000US), and from Provisional Application No. 60/260,170 filed Jan. 4, 2001 (Attorney Docket No. 19744P-001200), the full disclosures of which are incorporated herein by reference.
- Not Applicable
- Not Applicable
- 1. Field of the Invention
- The present invention relates generally to medical devices and methods. In one embodiment, the present invention relates to devices and methods for disrupting, collecting, and removing thrombus and/or other occlusive material from blood vessels and other body lumens. In other embodiments, the present invention relates to devices and methods for placement of guidewires, often for subsequent removal of unwanted tissue, thrombus, atheroma, fluid, polyps, cysts or other obstructive matter from natural and artificial body lumens such as blood vessels, grafts, implanted stenosed stents, ureters, bile ducts or fallopian tubes.
- Thrombosis and atherosclerosis are common ailments which occur in humans and which result from the deposition of thrombus and clot on the walls of blood vessels. When hardened, such deposits are commonly referred to as plaque. Such deposits are most common in the peripheral blood vessels that feed the limbs of the human body and the coronary arteries which feed the heart. Stasis, incompetent valves, and trauma in the venous circulation cause thrombosis, particularly occurring as a deep vein thrombosis in the peripheral vasculature. When such deposits build-up in localized regions of the blood vessel, they can restrict blood flow and cause a serious health risk.
- In addition to forming in the natural vasculature, thrombosis is a serious problem in “artificial” blood vessels, particularly in peripheral femoral-popliteal and coronary bypass grafts and dialysis access grafts and fistulas. The creation of such artificial blood vessels generally involves anastomotic attachment at at least one, and usually at at least two, locations in the vasculature. Such sites of an anastomotic attachment are particularly susceptible to thrombus formation due to narrowing caused by intimal hyperplasia, and thrombus formation at these sites is a frequent cause of failure of the implanted graft or fistula. The arteriovenous grafts and fistulas which are used for dialysis access are significantly compromised by thrombosis at the sites of anastomotic attachment and elsewhere. Thrombosis often occurs to such an extent that the graft needs to be replaced within a few years or, in the worst cases, a few months.
- A variety of methods have been developed for treating thrombosis and atherosclerosis in the coronary and peripheral vasculature as well as in implanted grafts and fistulas. Such techniques include surgical procedures, such as coronary artery bypass grafting, and minimally invasive procedures, such as angioplasty, atherectomy, transmyocardial revasculaturization, and the like. In many of the surgical clinical approaches to removing unwanted material, the treatment site is accessed directly through a surgical incision. Of particular interest of the present invention, a variety of techniques generally described as “thrombectomy” have been developed. Thrombectomy generally refers to procedures for the removal of relatively soft thrombus and clot from the vasculature. Removal is usually achieved by mechanically disrupting the clot, optionally with the introduction of thrombolytic agents. The disrupted thrombus or clot is then withdrawn through a catheter, typically with a vacuum or mechanical transport device.
- Thrombectomy generally differs from angioplasty and atherectomy in the type of occlusive material which is being treated and in the desire to avoid damage to the blood vessel wall. The material removed in most thrombectomy procedures is relatively soft, such as the clot formed in deep vein thrombosis, and is usually not hardened plaque of the type treated by angioplasty in the coronary vasculature. Moreover, it is usually an objective of thrombectomy procedures to have minimum or no deleterious interaction with the blood vessel wall. Ideally, the clot will be disrupted and pulled away from the blood vessel wall with no harmful effect on the wall itself.
- While successful thrombectomy procedures have been achieved, most have required comprise between complete removal of the thrombosis and minimum injury to the blood vessel wall. While more aggressive thrombectomy procedures employing rotating blades can be very effective at thrombus removal, they can present a significant risk of injury to the blood vessel wall. Alternatively, those which rely primarily on vacuum extraction together with minimum disruption of the thrombus, often fail to achieve sufficient thrombus removal.
- In work related to the present invention, an expansible macerator for safely breaking up or disrupting thrombus and other occlusive materials has been proposed. U.S. patent application Ser. No. 09/454,517 filed on Dec. 6, 1999 and entitled “Systems and Methods for Clot Disruption and Retrieval,” describes a catheter having an expansible positioning cage and a helical macerator positioned within the cage. The macerator can be separated from the surrounding cage so as to maintain separation between the macerator and a surrounding wall of the body lumen. This caged macerator represents a significant advancement in the art, as it allows disruption of soft clot while inhibiting trauma to blood vessels of varying diameters. However, as with all advances, still further improvements would be desirable. In particular, it may be beneficial to provide more aggressive and more rapid removal of clot material. It would also be helpful to allow the physician to selectively and controllably remove plaque or other more solid occlusive material during a thrombectomy, preferably using the thrombectomy catheter. It may also be beneficial to more uniformly urge the severed debris toward an aspiration port of the thrombectomy catheter. Finally, it may also be beneficial to find additional beneficial uses for similar and/or related catheter structures.
- As mentioned, atherectomy has been proposed for treatment of the hardened plaque of atherosclerosis. Atherectomy may also remove occlusive tissues proliferating from the vessel wall. While a variety of atherectomy structures and devices have been proposed, and although a variety of atherectomy structures have been made commercially available on the market, the efficacy and use of atherectomy has remained somewhat limited, particularly when compared to alternative treatments for stenotic disease.
- Many of the vascular catheter devices recently developed for fragmentation and removal of plaque and/or thrombus, and for other intraluminal and intravascular procedures, are inserted percutaneously through a puncture in the skin. For example, a catheter device may be inserted into a blood vessel at some distance away from the intended treatment site, and can then be advanced through the vessel lumen until the selected location is reached. In most instances this approach is performed “over the wire,” a technique in which the physician first places a guidewire device into the vessel lumen, so that the larger treatment catheter device can be tracked over the guidewire. In many cases the vessel to be treated is effectively blocked by an occlusive lesion (sometimes referred to as a “total occlusion,” the occlusive lesion usually comprising, thrombus, soft plaque, and/or calcified plaque) so that advancing a guidewire to and/or beyond the lesion is challenging and/or impossible.
- Several techniques and devices can assist in problematic intraluminal procedures, including guided or steerable guidewires and catheters, blunt-ended catheters, and the like. Once a guidewire or guiding catheter is placed, various techniques can be employed to fragment the unwanted plaque or tissue from blood vessels, including rotating abrasion structures or impellers, cutters, high pressure fluid infusion to create a Venturi effect, and the like. Other devices such as atherectomy cutters may also be employed. These known catheters and techniques for accessing and treating luminal lesions have had varying degrees of success. Unfortunately, total occlusions can impede access to the treatment site, making it challenging and/or impossible to place a guide structure for most of these subsequent treatments.
- In light of the above, it would be beneficial to provide improved devices, systems, methods, methods for manufacture, and kits for removing occlusive material from the vasculature and other body lumens. It would be particularly desirable to provide improved techniques for advancing a guidewire or guide catheter, positioning a treatment catheter across the blocking occlusion, isolating the treatment site, and further treating the occlusion while minimizing or eliminating any distal emboli. An improved procedure would also benefit from having a device that can rapidly aspirate the occlusive material from the body lumen. Optionally, these improved devices and methods might be used to treat a total occlusion as the treatment device is being advanced through the occlusion, facilitating placement of a wire across the occlusion so that further treatment can be easily commenced. Device and methods which allow creation of a channel through a total occlusion for placement of a guidewire would also be advantageous, as would improved debulking of stenotic tissues.
- Some or all of these objectives may be met by the device and methods of the present invention.
- 2. Description of the Background Art
- As mentioned above, systems and methods for clot disruption and removal related to the present invention are described in U.S. patent application Ser. No. 09/454,517. A related mechanical pump for removal of fragmented matter and methods was described in U.S. patent application Ser. No. 09/590915, filed on Jun. 9, 2000. A further related method and system for reinfusing filtered body aspirates is described in U.S. Provisional Patent No. 60/174,108, filed on Dec. 31, 1999.
- A cutting stent with a flexible tissue extractor is described in U.S. Pat. No. 6,036,708. A compressible/expandable atherectomy cutter is described in U.S. Pat. No. 5,224,945. Unitary removal of plaque is described in U.S. Pat. No. 5,665,098. A method for performing a partial atherectomy is described in U.S. Pat. No. 5,282,484, while an atherectomy device having a helical blade and a blade guide is described in U.S. Pat. No. 5,569,277. A catheter arthrotome is described in U.S. Pat. No. 5,178,625. A surgical apparatus for transurethral resection is described in U.S. Pat. No. 3,320,957. A vessel deposit sharing apparatus is described in U.S. Pat. No. 5,527,326.
- A coiled stent with locking ends is described in U.S. Pat. No. 5,725,549. A medical instrument with a slotted memory metal tube is described in U.S. Pat. No. 5,885,258. A method for manufacturing a tubular medical device is described in U.S. Pat. No. 6,027,863. The following U.S. Pat. Nos. may also be relevant: 6,010,449; 5,968,064; 5,741,270; 5,766,191; 5,569,275; 5,501,694; 5,795,322; 5,904,968; 5,224,945; 5,312,425; 5,330,484; and 6,022,336.
- All of the above references, and any and all other references cited in this application, are incorporated herein by reference in their entirety for all purposes.
- The present invention provides improved devices, methods, kits, methods for fabrication, and the like, for removing thrombus and/or other obstructive material from the vasculature and other body lumens. The invention generally makes use of cooperating radially expansible shearing members, each shearing members often being in the form of an expansible basket. The exemplary baskets comprise helically oriented struts, with the struts of each shearing member extending with a uniform circumferential direction. The struts will often be independently flexible between proximal and distal portions of the shearing members, which can allow the shearing the members to flex axially to follow axially curving body lumens. The inner basket may be rotatably driven within the outer basket, and may optionally be coupled to an axial pump extending proximally from the shearing members. The outer basket may be coupled to a catheter body to avoid excessive tissue trauma to the body lumen, and the helical struts of the shearing members can by helically counterwound, so that the inner struts may slide substantially continuously across the outer struts. The inner and outer baskets may both radially expand selectively, independently and/or with a single actuator. The resulting shearing action is sufficiently aggressive for highly effective thrombectomy, while use of a rotationally static and axially flexible outer basket may provide a safe, limited, and controllable atherectomy treatment.
- Improved methods and apparatus are also provided for treating total occlusions in natural and artificial lumens of the body such as the vasculature (including the coronary, peripheral, neurovascular circulation, grafts, and implanted stents). In particular, the present invention provides methods and devices for positioning a catheter or guidewire at the proximal side of a total occlusion and crossing that occlusion with a guidewire, and often with another catheter to enable further treatment. The present invention further provides a treatment device that enables crossing of the lesion, and optionally isolating the treatment site (for purposes of embolic protection or for infusing a therapeutic agent to assist in debulking the occlusion), flushing debris, treatment of the occlusion, and maceration and removal of the debris. These techniques may include flushing the vessel or treatment site with fluid (saline, for example) or pharmacologic agents to assist in breaking up the clot or tissue into a particle size that can then be aspirated through a lumen of a treatment device, or of a secondary catheter coupled with a source of vacuum/suction. Due to this fragmentation process, it may also be desirable to occlude or filter the lumen of the vessel proximally and/or distally of the treatment site to inhibit clot, plaque or tissue from embolizing and creating complications for the patient such as stroke, myocardial infarction, limb thrombosis, or limb ischemia, optionally using a non-integral embolic protection device, one or more balloons or expandable structures mounted to the treatment catheter, guidewire, a proximal sheath over the treatment catheter, or the like.
- In a first aspect, the invention provides a vascular obstruction removal catheter comprising a flexible tubular body having a proximal end and a distal end. An outer shearing member is attached near the distal end, the outer member having a perforate inner surface. An inner shearing member is rotatably disposed within the outer member, the inner member having a proximal portion, a distal portion, and a circumferential series of struts extending therebetween. The struts can flex to slide across the inner surface of the outer shearing member when the inner shearing member rotates.
- Optionally, the inner member may rotate about an axis, and the inner and outer shearing bodies may be sufficiently flexible to deflect the axis laterally when the outer shearing member is expanded to engage a surrounding vessel and the inner member rotates therein. The struts may uniformly coil helically in a first circumferential orientation so that rotation of the inner shearing member toward the first circumferential orientation consistently urges sheared occlusive material proximally. The inner shearing member may comprise tube material, the struts being separated by cut surfaces between adjacent tube material portions. The outer shearing member may comprise outer tube material having a proximal outer portion, a distal outer portion and a circumferential series of outer struts extending helically therebetween, with the struts being separated by cut outer surfaces between outer adjacent tube material portions. The struts may be affixed together at the proximal portion and at the distal portion, and may flex independently therebetween.
- The struts may be helically oriented with a local pitch of the struts varying axially along the struts. The local pitch can increase toward the proximal and distal portions sufficiently to inhibit excessive separation between adjacent struts when the outer shearing member flexes axially. The struts may have protrusions which inhibit sliding of obstructive material axially between cooperating edges of the inner and outer shearing bodies. At least one expansion actuator may extend proximally from the shearing members so that the inner and outer shearing members can be radially expanded in situ. Axial translation of an expansion actuator may selectively radially expand the inner and outer shearing members concurrently.
- A distally oriented occlusion penetrator may be disposed adjacent the distal end of the shearing members. The occlusion penetrator may comprise one or more end cutters that rotate with the inner shearing member and are exposed distally of the outer shearing member to help advance the shearing members distally through occlusive material and within a body lumen. Alternative occlusion penetrators include a shaft extendable distally of the shearing members, the shaft axially oscillating through occlusive material without penetrating through a vessel wall. An intravascular ultrasound sensor can be used to measure vascular obstructions for removal and/or identify partial or total occlusion that may impede access to the target region.
- It may also be desirable to attach a porous or non-porous coverings or coatings to at least one shearing member, particularly to the outer shearing member. Such a covering or coating may extend between the struts of a shearing member or positioning cage when the shearing member or positioning cage expands, and can be made from PTFE woven material, filter material (metallic or polymeric), braid material (metallic or polymeric), mesh, polymeric coatings, and the like. The coatings can be applied to the outer basket through a dipping process. Alternatively, the coverings may be applied to the outer basket using cyanoacrylate or other adhesives, thread or suturing, welding or bonding, or the like. Such coatings may be disposed along a distal and/or proximal region of the expandable perforate shearing member or positioning cage, and may inhibit embolization of fragmented occlusive material, constrain a treatment fluid or fluid stream, and the like.
- In another aspect, the invention provides a vascular obstruction removal catheter comprising a flexible tubular body having a proximal end and a distal end. A flexible drive shaft is rotatably disposed within the tubular body. An outer shearing member attached near the distal end of the tubular body has a circumferential series of independently flexible outer struts with inner surfaces. An inner shearing member is rotationally driven by the drive shaft within the outer member, the inner member having a circumferential series of independently flexible inner struts, the inner struts having outer surfaces which slide across the inner surfaces of the outer struts when the inner shearing member rotates, at least one member of the group comprising the inner struts and the outer struts being helically oriented.
- Optionally, the inner and outer shearing members can each have proximal portions and distal portions, the struts of each shearing member affixed together at the proximal and distal portions and extending independently therebetween so that the shearing members flex axially primarily along the struts. A proximal housing may be coupled to the tubular body, the housing having a motor drivingly engaging the drive shaft. The drive shaft may engage the distal portion of the inner shearing member and be axially translatable relative to the outer tubular member from adjacent the proximal housing. An axial bearing surfaces of the outer and inner shearing members can cooperate to effect concurrent radial expansion of the inner and outer shearing members when the drive shave translates axially.
- In another aspect, the invention also provides a method for forming a vascular obstruction removal catheter. The method comprises providing a first tube having a proximal end and a distal end with a central region therebetween, the tube comprising a tube material. The central region of the first tube is cut axially so as to define a circumferential series of independent deformable struts, the struts comprising the tube material. The first cage can be positioned coaxially with a second resiliently deformable cage, and a drive can be attached for rotating at least one of the cages within a blood vessel for shearing of obstructive material between the cages.
- In another aspect, the invention comprises a method for removing obstructive material from a blood vessel of a patient. The method comprises introducing a distal portion of a catheter into the blood vessel. The distal portion of the catheter is positioned adjacent the obstructive material from outside the patient by manipulating a flexible body of the catheter. Inner and outer shearing members of the catheter are radially expanded within the blood vessel, the inner shearing member is rotated within the outer shearing member to shear the occlusive material therebetween.
- In yet another aspect, the invention provides a component for use in a catheter device for removal of obstructive material from the lumen of a body conduit. The component comprises first and second end portions having a longitudinal axis there between. A middle portion has one or more struts around the circumference of said longitudinal axis and extending between (but not along) said first end portion and said second end portion. Said middle portion and said end portions are formed from a continuous tube.
- The struts may comprise a helix about said longitudinal axis. Alternatively, the struts may be formed in a straight configuration along said longitudinal axis and between said first and second end portions. The struts may have a width and a thickness, wherein said width is greater than said thickness. The width of the struts may vary along the length of the struts, and may form at least one serration or pocket. The thickness of the struts may be varied along the length of said strut, optionally so as to form a cutting edge. A cross section of the middle portion may be greater than cross sections of said end first and second end portions. The struts may be formed by laser cutting, by photoetching, by EDM, or by water jet abrasion. The first and second end portions can be formed in a zigzag configuration, and may have a longitudinal length that is less than that of the length of said middle portion. The component can comprise a shape memory alloy (such as a nickel titanium alloy, Elgiloy®, or the like), stainless steel, a formable polymer, a composite material, or the like.
- In yet another aspect, the invention may comprise a component for use in a catheter device for removal of obstructive material from the lumen of a body conduit. The component comprises first and second end portions having a first cross sectional diameter and a longitudinal axis therebetween. A middle portion extends between but does not include the end portions, and has at least one second cross sectional diameter and a plurality of struts forming a helix around the circumference of said longitudinal axis. The middle portion and said end portions are formed from a continuous tube.
- In some embodiments, the struts are axially connected to the adjacent strut by an expandable connector element, with the expandable connector element optionally having a serpentine configuration, defining a zigzag, or the like.
- In yet another aspect, the invention provides a device for treating a total occlusion in a vessel having a vessel wall. The device comprises a catheter body having a proximal end, a distal end and a lumen. A radially expansible positioning cage is disposed near the distal end of the catheter body. A shaft is disposed in the catheter body lumen, the shaft advanceable into the total occlusion without penetrating through the vessel wall when the positioning cage is radially expanded.
- Optionally, the shaft may comprises a dottering member extendable beyond the catheter body distal end. The dottering member by cycle axially and/or rotationally to facilitate advancing the dottering member into the total occlusion, the dottering member making a “pilot hole” into the occlusive material without penetrating through the vessel wall. A mechanical pump may be received within the catheter body lumen, and/or a macerator may extend at least partially along the length of said lumen, particularly adjacent the distal end. Distally exposed rotating cutters may be particularly beneficial for advancing the catheter into the total occlusion.
- In another method aspect, the invention provides a method of removing a total occlusion from the vessel of a patient. The method comprises introducing a positioning cage catheter system into a vessel of a patient and advancing the catheter system to the site of the occlusion to be treated. A positioning cage of the catheter system is radially expanded within the vessel to position a lumen of the catheter system. An occlusion penetrator of the catheter system is advanced within the positioned lumen and into the occlusion along a luminal length of the occlusion. The catheter system is manipulated to advance a guidewire or guide catheter distally of the occlusion.
- FIG. 1 is a perspective view of inclusive material removal catheter having a rotationally driven inner basket which cooperates with a outer basket to shear occlusive material therebetween.
- FIG. 2 is a perspective view of the distal portion of the catheter of FIG. 1.
- FIG. 3A-3C is a perspective view showing the inner and outer baskets of the catheter of FIG. 1. 3B and 3C show how the outer basket may have a coating or covering for embolic capture.
- FIG. 4 is a perspective view of an outer basket or shearing member of the catheter of FIG. 1.
- FIG. 5 is a perspective view of a tube cut so as to form the inner or outer basket of the catheter of FIG. 1.
- FIG. 6 illustrates a flat pattern of the basket of FIG. 5, showing variable pitch of the helical struts.
- FIG. 7 is a perspective view of an alternative basket having protrusions and/or circumferential indentations to inhibit axial sliding of occlusive material during shearing.
- FIG. 8 is a perspective view of yet another alternative basket having circumferential proximal and/or distal web members between struts to inhibit severing of valves and other structures disposed axially of the shearing baskets.
- FIG. 9 is a cross-sectional view of the connection between the proximal end of the shearing baskets and the distal end of the catheter body.
- FIG. 10 is a simplified cross-sectional view of the proximal end of the shearing baskets and the distal end of the catheter.
- FIG. 11 is a cross-sectional view showing attachment of the inner shearing basket to a drive shaft.
- FIG. 12 is a perspective view of a proximal housing of the catheter of FIG. 1.
- FIG. 13 is a perspective view of the housing of FIG. 12 with a portion of the cover removed to show the drive system and other internal components.
- FIGS.14-17 schematically illustrate the use of the occlusive material removal catheter of FIG. 1.
- FIGS. 18A and 18B illustrate alternative embodiments of the positioning cage catheter device of the present invention.
- FIGS.18C-18F illustrate radially expandable positioning and shearing structures having an occlusive material penetrator in the form of a distally exposed morcellator for forming a passage through a total occlusion.
- FIG. 19 illustrates the positioning cage catheter device of the present invention being used to initiate the crossing of a total occlusion.
- FIG. 20 illustrates an alternative embodiment of the present invention wherein a positioning cage and a treatment device are formed integrally and placed over a guidewire.
- FIG. 21 illustrates details of the distal end of the integral positioning cage and treatment device of FIG. 20.
- FIGS. 22, 23, and24A-24B illustrates steps in methods for use of the system of FIG. 20 for accessing a treatment site of an occlusion which is challenging and/or impossible to traverse with a standard guidewire.
- FIG. 25A-25C illustrates method of treating luminal occlusions in which a treatment region of the lumen is at least partially isolated.
- FIG. 26 illustrates an alternative embodiment of the present invention wherein a drive shaft is advanced to gain access through the total occlusion.
- Referring now to FIG. 1, a vascular
obstruction removal catheter 10 generally includes an elongateflexible catheter body 12 having aproximal end 14 and adistal end 16. Cooperating inner andouter shearing baskets distal end 16 ofcatheter body 12, while aproximal housing 22 is disposed nearproximal end 14 of the catheter body. More specifically,outer basket 20 will typically be affixed atdistal end 16 ofcatheter body 12, while a drive shaft drivingly couplesinner basket 18 to a drive motor ofproximal housing 22. - The inner and
outer baskets Outer basket 20 is shown withoutinner basket 18 in FIG. 4. - Each of the
baskets proximal portion 24, adistal portion 26, and anintermediate portion 28.Intermediate portion 28 includes a circumferential series of helical struts 30.Struts 30 are affixed together atproximal portion 24 anddistal portion 26, but generally extend independently therebetween. This allows struts 30 to flex individually, and allows the overall axis of eachbasket 18, 20 (as well as shearing means 19) to deflect laterally so as to accommodate axial curvature of the vasculature. -
Baskets Baskets baskets - The baskets may also be biased toward a profile which is smaller than a fully radially expanded configuration, so that radially and/or axial restraints are used to actively expand the diameter of shearing means19. In other words, by decreasing the length of
baskets outer baskets axial actuator 34 of proximal housing 22 (see FIG. 1) is actuated from outside the patient body, as will be described hereinbelow. Hence, struts 30 may optionally be biased toward the radially expanded configuration, a low-profile configuration, or some configuration therebetween. Advantageously, the profile of shearing means 19 can be selected from a plurality and/or continuous range of expanded sizes, and can be varied during treatment. -
Outer basket 20 may be rotationally coupled tocatheter body 12. Thus, movement of the outer basket within the vasculature can be substantially limited to, for example, axial positioning and advancement of the shearing means for treatment, thereby inhibiting excessive trauma to the surrounding vessel wall. Optionally, additional manipulation ofcatheter body 12 may be used to abraid the vessel wall with direct engagement between the outer basket and the endothelium. -
Struts 30 ofouter basket 20 have continuousinner surfaces 36 betweenproximal portion 24 anddistal portion 26. Similarly, struts 30 ofinner basket 18 may have continuousouter surfaces 38 between the proximal and distal portions. By rotationally drivinginner basket 18 withinouter basket 20 usingdrive shaft 32,outer surfaces 38 slide acrossinner surfaces 36 so as to shear occlusive material within the vasculature therebetween. In some cases, direct engagement between the inner basket and the surrounding tissues between the struts of the outer basket may also provide some shearing and/or abrasion of occlusive mater. - The drive shaft may be axially coupled to both the inner and outer baskets at
distal portions 26. This allows concurrent and coordinated radial expansion of the inner and outer baskets so as to maintain sufficient proximity between theinner surface 36 and theouter surface 38 to provide the desired shearing effect. In the exemplary embodiment, driveshaft 32 comprises a tube having aguide wire lumen 40 and an outerhelical pumping element 42. As described in detail in U.S. patent application Ser. No. 09/590,915, previously incorporated herein by reference, rotation of such a helical pumping element within anaspiration lumen 44 ofcatheter body 12 can draw and/or pump severed fragments of occlusive material, debris, and fluid proximally into and/or through the catheter body. This actively pumped aspiration may draw fluid proximally from withinproximal portions 24 ofbaskets more aspiration windows 46 aboutcatheter body 12. - In some embodiments, at least one of the inner and
outer baskets struts 30 which extend, at least in part, substantially axially. Preferably, at least one of the baskets will havestruts 30, which wind primarily toward a firstcircumferential orientation 50 as the struts proceed distally, as can be understood with reference to FIG. 4. Such a consistent winding direction can be used to consistently urge sheared materials proximally, as can be understood with reference to the arrows illustrated in FIG. 3A. As inner andouter surfaces - FIGS. 3B and 3C illustrate a catheter having a shearing means similar to that of FIG. 3A, and also having an expansible distal covering31 (FIG. 3B) or an expansible proximal covering 33 (FIG. 3C).
Coverings baskets Coatings Coverings - Referring now to FIGS. 5 and 6, an alternative basket structure is illustrated in a perspective view and as a flat pattern, respectively. The flat pattern of FIG. 6 graphically illustrates the configuration of the
struts 30 as ifbasket 50 were cut along one side and unrolled. Such flat patterns are useful for fabrication and understanding the strut configuration. - As is clearly seen in FIGS. 5 and 6, a local helical wind angle defined between
struts 30 and anaxis 52 ofbasket 50 can vary along the axis. Preferably, ahelical angle 54 along a central portion ofstruts 30 is significantly greater than ahelical angle 56 near proximal anddistal portions struts 30 may vary locally along the axis ofbasket 50, with the pitch generally being greater adjacent the proximal anddistal portions struts 30 whenaxis 52 is deflected laterally, so that uneven separation between the struts during axial bending is inhibited. - Referring now to FIG. 7, at least one of inner and
outer baskets struts 30 having one or morecircumferential protrusions 62.Struts 30 ofbasket 60 can define pockets which effectively capture occlusive material against the struts of the cooperating basket. This can help avoid excessively axial sliding of material for which shearing is desired, as the material will be caught at a pocket or protrusion between the cooperating shearing struts. This can be understood by imagining a pencil which is to be sheared between the cooperating surfaces of a pair of scissors. The pencil may slide along straight cooperating shearing surfaces. Such sliding may be inhibited by forming a protrusion and/or pocket to capture the pencil along an edge of one or both shearing members. - A still further
alternative basket 70 is illustrated in FIG. 8. In this embodiment, one or morecircumferential members 72 extend betweenadjacent struts 30 adjacent proximal and/ordistal portions Circumferential member 72 can allow some expansion at the ends, and can help inhibit entraining structures which are disposed axially of the shearing baskets. For example,circumferential member 72 may help avoid severing valves within blood vessels. A variety of alternative circumferential members might be used, including expandable and/or elastomeric webs, braided meshes, or the like. - The shearing baskets may be formed of a metal, optionally comprising a superelastic metal, such as Nitinol®, Elgiloy®, or the like. Alternative basket materials may include stainless steel or other high strength metals, and the baskets may comprise a polymer in some embodiments. Optionally, struts30 may comprise wire with wire struts often being affixed at the proximal and
distal portions proximal portion 24, along struts 30, and alongdistal portion 26. The struts may have a circumferential width in a range from about 0.004″ to about 0.100″, preferably having a width from about 0.006″ to about 0.025″. The radial thickness of the struts will typically be in a range from about 0.001″ to 0.050″, preferably being in a range from about 0.003″ to about 0.025″. The baskets may be formed by selectively cutting a tube so as to define the struts, often by use of photoetch processing, laser cutting, water jet abrasion, or EDM techniques. - Referring now to FIGS.9-11, coupling of
drive shaft 32 andcatheter body 12 to inner andouter shearing baskets proximal end 24,catheter 12 is axially and rotationally affixed toouter basket 20, as illustrated in FIGS. 9 and 10. Driveshaft 32 rotates withinaspiration lumen 44 ofcatheter body 12, and the drive shaft may have ahelical pumping member 42. Pumpingmember 42 acts as an Archimedes screw, urging fluid and debris withinproximal portion 24 ofinner basket 18 proximally, and/or entraining fluid radially throughaspiration windows 46. -
Inner cutter 18 is rotationally affixed to driveshaft 32adjacent portion 26, as illustrated in FIG. 11.Inner basket 18 is rotatable withinproximal portion 24 ofouter basket 20, and axial movement of the inner basket within the outer basket is limited by proximal cooperating thrust bearing surfaces 80, as seen in FIGS. 9 and 10. Similarly,distal portion 26 ofouter basket 20 is axially coupled to driveshaft 32 andinner basket 18 by distal thrust bearing surfaces 82, as illustrated in FIG. 11. Anose cone 84 presents an atraumatic distal tip adjacent the distal port ofguidewire lumen 40. - As can now be understood with reference to FIGS.9-11, rotation of
drive shaft 40 results in rotation ofinner basket 18 withinouter basket 20. Translatingdrive shaft 40 proximally withincatheter 12 can result in radial expansion of the shearing baskets, as the cooperating distal thrust bearing surfaces 82 decrease the overall length of the shearing baskets. Separate thrust bearing surfaces might be coupled to independently axially movable structures so as to effect independent radial expansion of the baskets - The structure and use of
proximal housing 22 can be more clearly understood with reference to FIGS. 12 and 13.Housing 22 contains a motor drivingly engagingdrive shaft 32 withincatheter body 12. The motor may be actuated by adrive actuator 88, with the drive actuator optionally effecting shearing motion of the inner basket and urging the sheared debris proximally when the actuator is moved in a first direction. When drive actuator is moved in a second direction, driveshaft 32 may rotate in an alternative direction, which may help free a jammed inner cutting member, or the like. Anaspiration port 90 may be coupled to a vacuum source, such as a lockable syringe, a vacuum pump, or the like. Avacuum actuator 92 may provide momentary aspiration. Linear actuation of thedrive shaft 32 may be provided by a linear actuator 34 (See FIG. 1)coupled to the drive shaft using thrust bearings and axially slidable engagement of drive splines, or the like. - Referring now to FIGS.14-17,
catheter 10 will generally be introduced into a blood vessel B over a guidewire GW using a conventional percutaneous or cut-down technique. Optionally, a portion of the blood vessel encompassing the target occlusive material may be isolated from surrounding blood flow. Such isolation may be provided by using a balloon guidewire and/or a sheath disposed aroundcatheter body 12, with the sheath having an expandable member such as an annular balloon. Hence, isolation may be provided proximally and/or distally of an occlusive material O within a blood vessel wall W. Inner andouter baskets - As illustrated in FIG. 15, once
catheter 10 has been appropriately positioned, driveshaft 32 may be translated proximally relative tocatheter body 12 so as to radially expand inner andouter baskets shaft 32 may be released to allow the baskets to expand. Where the baskets are biased to a configuration smaller than the desired deployed configuration, the drive shaft may be urged proximally relative tocatheter body 12 so as to overcome the resilience of the basket structures. Advantageously, the overall size of the cooperating shearing members may be selected by selectively axially positioning the drive shaft relative to the surrounding catheter body. This helps provide accurate control over the depth of material sheared from wall W. - Once the positioned catheter is properly expanded to the desired size, rotation of the
inner basket 18 is initiated by actuation ofdrive actuator 88 of theproximal housing 22. This results in both shearing of occlusive material O from wall W, and in urging of the severed debris in a proximal direction (effected both by the crossing angle of thestruts 30 and pumping of the helical member ofdrive shaft 32. An aspiration pressure differential may also be applied viaproximal housing 22 as described above so as to avoid release of debris within the blood vessel. - As illustrated in FIG. 16,
catheter 10 may advanced distally over guidewire GW within the vessel wall W during rotation ofinner basket 18.Outer basket 20 slides distally against the vessel wall substantially without rotating, thereby providing an incremental and controlled shearing action which can follow axial bends of the natural or artificial blood vessel B. The amount of occlusive material O removed form vessel wall W at a particular location may depend on the expanded size of the cooperating shearing baskets at that location, on the speed of rotation of the inner basket, on the speed of axial translation of the shearing means, and on the total time and number of rotations of the inner basket at that location. - For relative soft occlusive material O, such as clot material, the proximal shearing action of the struts may, at least in part, draw the occlusive material proximally from along the vessel wall into the interior of the baskets, as can be understood with reference to FIG. 17. Similarly, rotation of the
helical struts 30 ofinner basket 18 may help drawcatheter 10 distally within blood vessel B. - As can be understood with reference to FIG. 17, serrated
circumferential surfaces 94 may improve shearing efficiency by limiting sliding of occlusive material O. Regardless, as the strut ofinner basket 18 rotates relative to the struts ofouter basket 20, occlusive material O protruding into an interior of the baskets from wall W is both severed and/or urged proximally. - A variety of adaptations and modifications on the structures and methods described herein may be provided. For example, a kit may include some or all of the components of
catheter 10 together with instructions for their use according to one or more of the methods described herein. Proximal end ordistal portions catheter 10. It may be advantageous to at least slightly bias struts 30 radially outwardly so as to facilitate initial axial compression of the baskets. While the present invention has been described with reference to removal of clot, plaque, hyperplasia, or other occlusive material of a blood vessel, the structures and methods of the present invention may find applications for removing occlusive material from a wide variety of alternative body structures and lumens, including the fallopian tubes, genitourinary tract (for example, for treatment of benign prostatic hyperplasia, and the like), gastrointestinal tract, and the like. - A
positioning cage catheter 120 which is particularly beneficial for treatment of blood vessels having a total occlusion (when it is difficult or impossible to access the entire treatment site with a standard guidewire) is illustrated in FIGS. 18A and 18B. Many of known intraluminal therapies require that (or are facilitated when) the lumen has a significant open cross section, without an excessively tortuous luminal path, to allow the guide structure to be placed across the occlusion. - It should be noted that the term total occlusion may refer to any substance or anatomic morphology that acts to severely occlude a body conduit such that it is difficult to pass a wire from proximal end of the occlusion to the distal end. Depending on the type of material occluding the body conduit (soft plaque, calcified plaque, thrombus, fibrin, clot, intimal hyperplasia, in-stent restenosis, fatty tissue etc.) some occlusions may be more severe than others but all are included in the scope of the present invention when there may be some difficulty passing a guidewire therethrough.
-
Cage 110 may be formed of multiple straight wires or struts 111, or multiple curved wires or struts 112 formed into a helix as depicted in FIG. 18B. It is noted that a double wire (not shown) may also be employed to form the cage structure. These cage structures are fixedly attached to acatheter body 113, having adistal tip 114 accommodating passage of a guidewire throughlumen 115. - In an exemplary embodiment,
catheter system 120 comprises a positioning cage such as described one of those described above, or such as those in related U.S. patent application Ser. No. 09/388,294, incorporated herein by reference. A guidewire such as the described in U.S. patent application Ser. No. 09/491,401 (vibrating guidewire) or U.S. patent application Ser. No. 09/005,217 incorporated herein by reference, or in some cases such as those readily available from various manufacturers (TERUMO, CORP./BOSTON SCIENTIFIC, Natick, Mass., GUIDANT, CORP., Indianapolis, Ind., or PERCUSURGE, Sunnyvale, Calif.) may be used withincatheter system 120, as will be understood from the following description. Optionally, the positioning cage and the treatment catheter may be employed as an integral unit to both place the guidewire, and to perform the subsequent treatment. In such embodiments a device such as those described in U.S. patent application Ser. Nos. 09/491,401 and 09/388,294 previously incorporated herein by reference, may be employed. - In use, the total occlusion access devices of the present invention may be inserted into a body conduit and advanced to the proximal side of the occlusion, either over a guidewire, or by just advancing the positioning cage to the treatment site, depending on the body lumen to be treated. Once at the treatment site, the positioning cage can be pushed against the occlusion. As will be described below, a guidewire or dottering device may be advanced from the cage through a lumen coaxial with the cage (and hence, substantially coaxial with the body lumen when the cage is expanded therein ) to penetrate and/or pierce the occlusion. The combination action of the positioning cage asserting forces against the vessel wall and the occlusive material (optionally by rotating the cage or expanding the against the vessel wall), and the guidewire or dottering device probing against the occlusion, may work to tunnel the devices through the occlusion to the distalmost portion and beyond. The positioning cage may help to center the action of the dottering member and inhibit perforations through the vessel wall or other vessel wall damage.
- The positioning cage may be part of a treatment catheter and therefore, once the guidewire is in place, the treatment catheter may be advanced to initiate removal of the occlusion. Depending on the occlusion to be treated, a distal protection device, such as a balloon fixed to a guidewire, a filter affixed to a guidewire, or the like, may be employed distal of the occlusion and expanded to minimize any embolization of clot or other material. In addition, an occlusion balloon or filter may be deployed proximal of the occlusion to isolate the lesion and allow the treatment device (or a separate structure) to infuse saline, contrast, pharmacologic agents such as tPA, ReoPro, IIB3A inhibitors and the like, or chemical ablation agents or acid solutions such as those described in PCT Application No. PCT/US99/15918 (WO 00/03651). The occlusive debris can be removed by activating the shearing, macerating, and aspirating function of the device of the present invention as described above, and in U.S. patent application Ser. No. 09/388,294 and U.S. Provisional Patent Application No. 60/154,752.
- Referring now to FIGS.18C-F, the structure of an exemplary positioning
cage catheter system 120 a adjacentdistal tip 114 is illustrated in more detail.Catheter system 120 a includes inner and outer shearing members in the form ofbaskets - To facilitate advancement of
catheter system 120 a distally for treatment of a total occlusion, a total occlusion penetrator is providedadjacent tip 114. In the embodiment of FIGS. 18C-F, the penetrator is in the form of a distally exposedmorcellator 122.Morcellator 122 comprises a circumferential series of helical cutters which may be rotationally coupled toinner shearing member 18 or may rotate independently of the shearing member. The cutters ofmorcellator 122 may extend distally of the distal portion of theouter shearing member 20 and/or distally of the inner tubular body which defines theguidewire lumen 115 sufficiently to allow the rotating cutters to advance into the occlusive material of a total occlusion when the morcellator rotates. Expansion of the shearing member can maintain separation between the advancing morcellator and the vascular walls, so that the expanded shearing member acts as a positioning cage. As described above, use of a morcellator in the form of one or more helical structures within a lumen (the lumen here defined by the distal portion of outer shearing member 20) can act as a pump or Archimedes screw to urge the occlusive material proximally. - In use (as illustrated in FIG. 19), the
positioning catheter 120 is inserted into a vessel BV and advanced to the treatment site just proximal of total occlusion TO.Cage 110 may actually engage the occlusion TO and begin loosening the plaque or other material making up the occlusion. Furthermore cage may be manually rotated to further engage the occlusion. Once at the treatment site, guidewire GW may be optionally advanced out of the distal tip of the positioning catheter to contact and help fragment the occlusion TO, the guidewire optionally being adapted for use as an occlusion penetrator, as will be described below. As described above regarding FIGS. 18C-E, amorcellator 122 may also be used as an occlusive material penetrator by rotating the distally exposed morcellator and advancing the catheter system to engage the rotating morcellator against the total occlusion TO.Catheter 120, guidewire GW, and/ormorcellator 122 may be used in combination or in an alternating motions or cycles to create a pilot hole through the occlusion TO such that the guidewire GW may be placed through the occlusion and advanced distally therebeyond. - An alternative positioning cage catheter system is schematically depicted in FIG. 20.
Treatment catheter 130 comprises a proximal end having ahandle 131 with anactuator knob 132 and aY connection 133 to allow infusion and/or aspiration. Acatheter shaft 113 extends distally fromhandle 131 toward a distal workingend 134. FIG. 21 depicts the distal working end oftreatment catheter 130, showing apositioning cage 110 attached at its proximal end tocatheter shaft 113, and on its distal end todistal tip 114. Distal workingend 134 further comprises adrive shaft 141 with an optional coiledmechanical pump 141′ and amacerator 142 coiled therearound. A more detailed description oftreatment catheter 130 may be found in related case U.S. patent application Ser. No. 09/388,294 as previously incorporated by reference. - In use, as illustrated in FIG. 22,
treatment catheter 130 is inserted into the lumen of a vessel BV and advanced to the proximal portion of the treatment site. At this point the lesion can either be crossed mechanically (as described above regarding FIG. 19) and/or saline or other therapeutic agents may be infused (optionally viaguidewire lumen 115, as shown in FIGS. 18) to assist in dissolving, softening, and/or fragmenting the occlusive material. In some embodiments, such agent flow from the catheter system alone may be sufficient to allow a standard guidewire to be advanced through the occlusion. The remaining components of the catheter system may then be advanced over the guidewire and remove some or all of the occlusive material, as described above. - A standard or modified guidewire may be used to help form a pilot hole or passage for placement of a guide structure. In the exemplary embodiment, a dottering tool or
dottering guidewire 151 can be centered within the lumen of the blood vessel BV by expandingcage 110. Thecentered dottering tool 151 may then be used as an occlusive material penetrator by advancing the dottering tool in a linear translating and/or cycling motion to begin formation of a pilot hole or pathway through the total occlusion. Although dottering guidewire 151 may have a structure similar to a standard guidewire, the dottering tool will optionally have a more rigid construction than a standard guidewire adjacent the distal end, and the distal portion of the dottering tool may also be able to assume a straight configuration with sufficient axial column strength for advancement of an atraumatic tip distally from the guidewire lumen of the catheter system and into the occlusive material. Oncedottering tool 151 has formed apassage 153 through the total occlusion, other devices (such as standard guidewires, a balloon guidewire or other distal protection devices to inhibit embolisms and/or release of therapeutic agents distally of the total occlusion, and the like) may be advanced through the passage, or the dottering wire may be used as a guide structure. - Referring now to FIGS. 22 and 23, centering cage or
basket 110 can provide centering ofguidewire lumen 115. Centering of this coaxial lumen can help protect the vessel wall from mechanical injury imposed bydottering device 151.Dottering device 151 may be cycled axially mechanically or using an axial drive motor, and may also be rotated manually or by drive motor. The centered guidewire lumen, which should be substantially coaxial with the vessel, may also be used for infusion of any of a variety of fluids. It may be advantageous to locally deliver (viaguidewire lumen 115 or via some other infusion pathway) a thrombolytic agent having an enzymatic action with breads down fibrin clot matrix (such as Alteplase, tPA, Activase, Tenecteplase, TNK, and TNKase from Genentech, Inc.; Anistrpelase a-SK, and Eminase from Roberts Pharmaceuticals; Reteplase, r-PA, and Retavase from Centocor, Inc.; Streptokinase, SK, and Streptase from AstraZeneca, Inc.; and/or Abbokinase, from Abbott, Inc. In some embodiments, a GP IIb/IIIa inhibitor, which inhibits the fibrogen binding site of platelet membrane, may be locally delivered. Suitable GP IIb/IIIa inhibitors may include Abciximab and ReoPro from Centocor, Inc.; Tirofiban and Aggrastat from Merck, Inc.; Eptifibatide and Integrelin from Cor Therapeutics, Inc.; Bitistatin, Kistrin, and Aspirin. Still further active agents might be used, including anti-thrombin agents and agents directed toward prevention of restenosis (to inhibit coagulation and/or decreasing smooth muscle proliferation and migration), such as Heparin, LMW, enoxaparine or Lovenox, dalteparin or Fragmin, ardeparin or Normoflo, Hirudin, Argatroban, PPACK, radioactive agents, nitrate, HA 1077, calcium antagonists, angiotensin converting enzyme inhibitor, anti-inflammatory agents, steroidal agents, anti-mitotic agents, HMG CoA reductase inhibitors, colchicine, angiopeptin, cytoclasin B, and the like. Gene therapy agents might also be locally delivered to inhibit restenosis and/or promote angiogenesis, with suitable agents optionally being delivered via plasmid vectors or by viral vectors, and suitable agents including genes relating to VEGF, C-myb, FGF, transforming growth factor b. endothelial growth factor, protooncogenes such as C-myc, C-myg, CDC-2, PCNA, and the like. Local delivery of chemotherapeutic agents (which are used to treat malignancies) may be employed, such as adriamycin or Doxorubicin. Imaging Media such as contrast media, radioactively labeled agents, or the like may be locally delivered, as might other agents such as plasminogen addative as an adjunct to thrombolytic therapy, immunosuppressive agents, Corazo'n material, lytics, saline, or the like. - As seen in FIG. 23,
positioning cage 110 anddottering device 151 may be advanced simultaneously or in alternating partial steps into and through the total occlusion. Alternatively,dottering device 151 may be advanced through the total occlusion while the expanded positioning cage remains at a fixed location. Regardless, some penetrator structure of the catheter system will preferably advance until apassage 153 is formed through the total occlusion. Once an opening, propagation plane, or pathway has been formed through the occlusion TO, a guide structure may be passed distally alongpassage 153 beyond the total occlusion. - In addition to use of
cage 110 to protect the vessel wall W from harm by positioning of the penetrator, the cage may be advanced against the proximal portion of the occlusion TO as shown in FIG. 24A (in whichcage 110 is shown in a partially expandedconfiguration 110 a) and then expanded (to a more fully expandedconfiguration 110 b) to assist in propagating a passage, plane, or pathway through the occlusion, as shown in FIG. 24B. In other words, expansion ofcage 110 may open up or propagate a cleavage plane to facilitate passing a guidewire or dottering device 51 using a wedge effect. This wedge effect may, of course, be combined with axial cycling of dottering device 51, rotation and advancement of a cutter, occlusive material agent dissolution, and any of the other mechanisms described herein. Similarly, the various occlusion treatment methods and structures described herein will generally be compatible for use in combination. - FIGS.25A-25B illustrate further steps in treatment of the occlusion (TO) once a guidewire has been passed distally. As illustrated, a
distal protection member 155 is inserted over the guidewire (or is attached to the guidewire itself) throughpassage 153 and expanded distally of the occlusion.Distal protection member 155 inhibits distal flow beyond the occlusion and can help decrease or prevent embolization of material downstream of the treatment site.Distal member 155 may comprise an annular balloon fixed on a catheter or guidewire, a radially expandable filter, or any of a wide variety of flow and/or embolization inhibiting intraluminal structures. Optionally, an intravascular ultrasound (IVUS)sensor 157 may be carried by at least one of the components of the catheter system, optionally in a component which will traverse the occlusion such as the guidewire or dottering device 151 (or other penetrator), a shaft axially coupled todistal protection member 155, or the like. Alternatively, IVUS capabilities may be incorporated in one or more of the other catheter system components, or may be provided by a dedicated structure that can be advanced through a lumen of the catheter system or independent thereof. Such IVUS capabilities may be useful for planning an occlusion therapy, for monitoring progress of the therapy, and/or for verifying the effectiveness of the therapy. - Once flow distal of the occlusive material OM is inhibited, treatment of the lesion can continue using any of a wide variety of modalities of treatment such as atherectomy, endarterectomy, infusion of occlusive material removal flow or active agents, and the like. Alternatively, as shown in FIG. 25B, a proximal occluding
member 159 may also be inflated or expanded to isolate the treatment site. Proximal occluding member may again comprise a balloon or embolic filter carried on the outer surface ofshaft 113 or on anouter sheath 161, with occlusion and fluid isolation allowing the infusion of various treatment modalities such as saline, contrast, pharmacologic agents such as tPA, ReoPro, IIB3A inhibitors and the like, or chemical ablation agents or acid solutions such as those listed above regarding FIGS. 22 and 23, and/or those described in PCT Application No. PCT/US99/15918 (Publication No. WO 00/03651). In the case of any acidic compounds, it is beneficial to fully contain the compounds infused within the treatment site, and to expeditiously remove and aspirate the dissolved material. - In FIGS. 25B and C, the
treatment catheter 130, and specifically the mechanical pump (141 and 141′) is used to remove some or all remaining occlusive material OM, including thrombus, plaque, fibrin, clot and the like, while still protecting the vessel wall. Fluid may optionally be circulated by, for example, infusion vialumen 115 while aspirating via alumen 163 ofshaft 113, the aspiration often being assisted by rotation of theArchimedes screw pump 141′ within the aspiration lumen as described above. A vacuum source may be applied to the aspiration lumen via the proximal housing or only a proximal pump may be included, and some embodiments of the occlusion removal and access catheters described herein may not include an integral mechanical pump disposed in a distal lumen of the catheter system. The catheter is then removed and the vessel may then be further treated with a liner, stent, coated stent, stent-graft, or the like, as is taught by the prior art and is known to those skilled in the art. - The use of the occlusive material removing catheter system embodiment of FIGS.18C-E can be understood with reference to FIG. 26. Once again, a
positioning cage 110 is located on the distal portion of atreatment catheter 120 a.Treatment catheter 120 a may include an axiallymoveable driveshaft 165, thecutters 122 may be axially affixed in a distally exposed configuration, or a distal cover may be removed in situ fromcutters 122 of the morcellator. Regardless, thedriveshaft 165 can be advanced into the occlusion TO while the driveshaft and (and the cutters carried thereon) rotate to create the desired pilot hole, propagation plane or passage for a guidewire or other guide device. Alternatively, the inner or outer cage may be translated distally and/or in tension to distally expose a morcellator that drills similarly into and/or through the total occlusion TO. Hence, a variety of related embodiments will be clear to those of skill in the art in light of the disclosure herein. For example, rather than a morcellator formed of helical cutters extending distally from within a lumen, the penetrator may comprise a blunt disection tool distally extending from a fixed outer or rotating inner cage, a cutter in the form of a spinning burr or screw extending distally from a rotating inner cage, or the like. - It should be noted that any of the method steps or devices used in one method description may be interchanged with method steps of another description and still be in the scope of the present invention. For example, the isolation balloon or distal protection device may be used in conjunction with the
positioning cage catheter 120, and well as through and in conjunction withtreatment catheter 130. Furthermore, the terms pilot hole and propagation plane are used to refer to any path that is created through a occlusion (TO), either through the center of the vessel lumen, or to one side or the other around the circumference of the vessel lumen. - While the exemplary embodiments have been described in some detail, by way of example and for clarity of understanding, a variety of adaptations, changes, and modifications will be obvious to those of skill in the art. Hence, the scope of the present invention is limited solely by the appended claims.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/285,843 US20030055445A1 (en) | 2000-03-31 | 2002-10-31 | Expansible shearing catheters for thrombus and occlusive material removal |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19353900P | 2000-03-31 | 2000-03-31 | |
US26017001P | 2001-01-04 | 2001-01-04 | |
US09/820,301 US20010031981A1 (en) | 2000-03-31 | 2001-03-27 | Method and device for locating guidewire and treating chronic total occlusions |
US10/285,843 US20030055445A1 (en) | 2000-03-31 | 2002-10-31 | Expansible shearing catheters for thrombus and occlusive material removal |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/820,301 Division US20010031981A1 (en) | 2000-03-31 | 2001-03-27 | Method and device for locating guidewire and treating chronic total occlusions |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030055445A1 true US20030055445A1 (en) | 2003-03-20 |
Family
ID=27393213
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/820,301 Abandoned US20010031981A1 (en) | 2000-03-31 | 2001-03-27 | Method and device for locating guidewire and treating chronic total occlusions |
US09/823,652 Expired - Lifetime US6652548B2 (en) | 2000-03-31 | 2001-03-30 | Expansible shearing catheters for thrombus removal |
US10/285,843 Abandoned US20030055445A1 (en) | 2000-03-31 | 2002-10-31 | Expansible shearing catheters for thrombus and occlusive material removal |
US10/285,727 Abandoned US20030055444A1 (en) | 2000-03-31 | 2002-10-31 | Expansible shearing catheters for thrombus and occlusive material removal |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/820,301 Abandoned US20010031981A1 (en) | 2000-03-31 | 2001-03-27 | Method and device for locating guidewire and treating chronic total occlusions |
US09/823,652 Expired - Lifetime US6652548B2 (en) | 2000-03-31 | 2001-03-30 | Expansible shearing catheters for thrombus removal |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/285,727 Abandoned US20030055444A1 (en) | 2000-03-31 | 2002-10-31 | Expansible shearing catheters for thrombus and occlusive material removal |
Country Status (8)
Country | Link |
---|---|
US (4) | US20010031981A1 (en) |
EP (1) | EP1272110B1 (en) |
JP (1) | JP2004503265A (en) |
AT (1) | ATE507781T1 (en) |
AU (1) | AU5303501A (en) |
CA (1) | CA2404144C (en) |
DE (1) | DE60144557D1 (en) |
WO (1) | WO2001074255A1 (en) |
Cited By (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1543785A1 (en) * | 2003-12-18 | 2005-06-22 | Asahi Intecc Co., Ltd. | A basket-like medical treating tool for removing occlusive material |
US20050240146A1 (en) * | 2004-04-27 | 2005-10-27 | Nash John E | Thrombectomy and soft debris removal device |
US20070154555A1 (en) * | 2004-12-02 | 2007-07-05 | Strauss Bradley H | Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions |
US20080097499A1 (en) * | 2004-04-27 | 2008-04-24 | Nash John E | Thrombectomy and soft debris removal device |
US20080188864A1 (en) * | 2007-01-12 | 2008-08-07 | Wilson-Cook Medical Inc. | Lithotripsy basket drill |
WO2009003113A1 (en) * | 2007-06-26 | 2008-12-31 | Unique Catheter Designs, Llc | Catheter apparatus and methods for treating vasculatures |
US20090240278A1 (en) * | 2006-02-17 | 2009-09-24 | Deutsch Harvey L | Device for placing an occlusion removing structure in a tubular structure with a substantially closed distal end |
WO2009154441A1 (en) * | 2008-06-19 | 2009-12-23 | Wittens Cornelis Hendrikus Ann | A thrombectomy catheter and a device comprising the same |
US20090318816A1 (en) * | 2003-05-23 | 2009-12-24 | Embro Corporation | Light catheter for illuminating tissue structures |
US20100204672A1 (en) * | 2009-02-12 | 2010-08-12 | Penumra, Inc. | System and method for treating ischemic stroke |
US20110172700A1 (en) * | 2004-09-10 | 2011-07-14 | Penumbra, Inc. | System and method for treating ischemic stroke |
US20120316589A1 (en) * | 2011-06-07 | 2012-12-13 | Cook Medical Technologies Llc | Balloon catheter with raised elements and visual marker |
WO2013052625A1 (en) * | 2011-10-05 | 2013-04-11 | Penumbra, Inc. | System and method for treating ischemic stroke |
US20130103067A1 (en) * | 2011-07-28 | 2013-04-25 | Myra I. L. Fabro | Discectomy devices and related methods |
WO2014169266A1 (en) * | 2013-04-12 | 2014-10-16 | Yu Yongyi Alan | Systems and methods for restoring blood flow to a vessel |
US8961551B2 (en) | 2006-12-22 | 2015-02-24 | The Spectranetics Corporation | Retractable separating systems and methods |
US9028520B2 (en) | 2006-12-22 | 2015-05-12 | The Spectranetics Corporation | Tissue separating systems and methods |
US9126020B2 (en) | 2007-06-26 | 2015-09-08 | Roxwood Medical, Inc. | Catheter apparatus with telescoping lumen catheters and its use in methods for treating vasculatures |
US9125683B2 (en) | 2007-06-26 | 2015-09-08 | Roxwood Medical Inc. | Method and apparatus for placing a catheter within a vasculature |
US20160058458A1 (en) * | 2014-09-02 | 2016-03-03 | Cook Medical Technologies Llc | Clot retrieval catheter |
US9283040B2 (en) | 2013-03-13 | 2016-03-15 | The Spectranetics Corporation | Device and method of ablative cutting with helical tip |
US9291663B2 (en) | 2013-03-13 | 2016-03-22 | The Spectranetics Corporation | Alarm for lead insulation abnormality |
US9358037B2 (en) | 2007-06-26 | 2016-06-07 | Roxwood Medical, Inc. | Method and apparatus for centering a microcatheter within a vasculature |
US9413896B2 (en) | 2012-09-14 | 2016-08-09 | The Spectranetics Corporation | Tissue slitting methods and systems |
USD765243S1 (en) | 2015-02-20 | 2016-08-30 | The Spectranetics Corporation | Medical device handle |
US9456872B2 (en) | 2013-03-13 | 2016-10-04 | The Spectranetics Corporation | Laser ablation catheter |
USD770616S1 (en) | 2015-02-20 | 2016-11-01 | The Spectranetics Corporation | Medical device handle |
US9603618B2 (en) | 2013-03-15 | 2017-03-28 | The Spectranetics Corporation | Medical device for removing an implanted object |
US9668765B2 (en) | 2013-03-15 | 2017-06-06 | The Spectranetics Corporation | Retractable blade for lead removal device |
WO2017165842A1 (en) * | 2016-03-24 | 2017-09-28 | Edwards Lifesciences Corporation | Delivery system for prosthetic heart valve |
US9877742B2 (en) | 2013-11-14 | 2018-01-30 | Cook Medical Technologies Llc | Thrombectomy catheter with flow directing mechanism |
US9883885B2 (en) | 2013-03-13 | 2018-02-06 | The Spectranetics Corporation | System and method of ablative cutting and pulsed vacuum aspiration |
US9925366B2 (en) | 2013-03-15 | 2018-03-27 | The Spectranetics Corporation | Surgical instrument for removing an implanted object |
US9956384B2 (en) | 2014-01-24 | 2018-05-01 | Cook Medical Technologies Llc | Articulating balloon catheter and method for using the same |
US9980743B2 (en) | 2013-03-15 | 2018-05-29 | The Spectranetics Corporation | Medical device for removing an implanted object using laser cut hypotubes |
US10039900B2 (en) | 2010-09-07 | 2018-08-07 | Angiodynamics, Inc. | Fluid delivery and treatment device and method of use |
US10136913B2 (en) | 2013-03-15 | 2018-11-27 | The Spectranetics Corporation | Multiple configuration surgical cutting device |
US20180344970A1 (en) * | 2011-05-23 | 2018-12-06 | Nitiloop Ltd. | Deployment mechanism for body vessel insertion devices |
US10286190B2 (en) | 2013-12-11 | 2019-05-14 | Cook Medical Technologies Llc | Balloon catheter with dynamic vessel engaging member |
CN110090063A (en) * | 2018-01-30 | 2019-08-06 | 上海沃比医疗科技有限公司 | Thrombus capture device and its method |
US10383691B2 (en) | 2013-03-13 | 2019-08-20 | The Spectranetics Corporation | Last catheter with helical internal lumen |
US10405924B2 (en) | 2014-05-30 | 2019-09-10 | The Spectranetics Corporation | System and method of ablative cutting and vacuum aspiration through primary orifice and auxiliary side port |
US10426510B2 (en) | 2012-10-22 | 2019-10-01 | Roxwood Medical, Inc. | Method and apparatus for centering a microcatheter within a vasculature |
US10448999B2 (en) | 2013-03-15 | 2019-10-22 | The Spectranetics Corporation | Surgical instrument for removing an implanted object |
US10596354B2 (en) | 2015-09-25 | 2020-03-24 | Mark Taber | Guide wires, catheters, and guide wire catheter systems and methods |
WO2020160179A1 (en) * | 2019-01-31 | 2020-08-06 | Merit Medical Systems, Inc. | Thrombosis macerating devices for blood vessels |
US10743907B2 (en) | 2014-11-07 | 2020-08-18 | National University Of Ireland, Galway | Thrombectomy device |
US10779852B2 (en) | 2013-03-15 | 2020-09-22 | National University Of Ireland, Galway | Device suitable for removing matter from inside the lumen and the wall of a body lumen |
US10835279B2 (en) | 2013-03-14 | 2020-11-17 | Spectranetics Llc | Distal end supported tissue slitting apparatus |
US10842532B2 (en) | 2013-03-15 | 2020-11-24 | Spectranetics Llc | Medical device for removing an implanted object |
WO2021260715A1 (en) * | 2020-06-25 | 2021-12-30 | Meril Life Sciences Pvt Ltd | Clot retrieval device |
US11304713B2 (en) | 2018-09-07 | 2022-04-19 | Merit Medical Systems, Inc. | Thrombosis macerating and aspiration devices for blood vessels |
US11464537B2 (en) | 2011-03-15 | 2022-10-11 | Angiodynamics, Inc. | Device and method for removing material from a hollow anatomical structure |
US11589880B2 (en) | 2007-12-20 | 2023-02-28 | Angiodynamics, Inc. | System and methods for removing undesirable material within a circulatory system utilizing during a surgical procedure |
US11648020B2 (en) | 2020-02-07 | 2023-05-16 | Angiodynamics, Inc. | Device and method for manual aspiration and removal of an undesirable material |
WO2024003912A1 (en) * | 2022-06-28 | 2024-01-04 | Shabat Matan | Tissue ablation device and system |
US11896246B2 (en) | 2007-12-20 | 2024-02-13 | Angiodynamics, Inc. | Systems and methods for removing undesirable material within a circulatory system utilizing a balloon catheter |
Families Citing this family (545)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7992572B2 (en) | 1998-06-10 | 2011-08-09 | Asthmatx, Inc. | Methods of evaluating individuals having reversible obstructive pulmonary disease |
US6634363B1 (en) | 1997-04-07 | 2003-10-21 | Broncus Technologies, Inc. | Methods of treating lungs having reversible obstructive pulmonary disease |
US7027869B2 (en) | 1998-01-07 | 2006-04-11 | Asthmatx, Inc. | Method for treating an asthma attack |
US7037316B2 (en) * | 1997-07-24 | 2006-05-02 | Mcguckin Jr James F | Rotational thrombectomy device |
US6461370B1 (en) * | 1998-11-03 | 2002-10-08 | C. R. Bard, Inc. | Temporary vascular filter guide wire |
US7921855B2 (en) | 1998-01-07 | 2011-04-12 | Asthmatx, Inc. | Method for treating an asthma attack |
US9586023B2 (en) | 1998-02-06 | 2017-03-07 | Boston Scientific Limited | Direct stream hydrodynamic catheter system |
US8181656B2 (en) | 1998-06-10 | 2012-05-22 | Asthmatx, Inc. | Methods for treating airways |
US7198635B2 (en) | 2000-10-17 | 2007-04-03 | Asthmatx, Inc. | Modification of airways by application of energy |
CA2261192A1 (en) * | 1999-02-16 | 2000-08-16 | Rd-Chus Inc. | Surgical extractor |
US6709465B2 (en) | 1999-03-18 | 2004-03-23 | Fossa Medical, Inc. | Radially expanding ureteral device |
US7214229B2 (en) * | 1999-03-18 | 2007-05-08 | Fossa Medical, Inc. | Radially expanding stents |
US6893450B2 (en) * | 1999-03-26 | 2005-05-17 | Cook Urological Incorporated | Minimally-invasive medical retrieval device |
US6702811B2 (en) | 1999-04-05 | 2004-03-09 | Medtronic, Inc. | Ablation catheter assembly with radially decreasing helix and method of use |
US6299622B1 (en) | 1999-08-19 | 2001-10-09 | Fox Hollow Technologies, Inc. | Atherectomy catheter with aligned imager |
US7713279B2 (en) | 2000-12-20 | 2010-05-11 | Fox Hollow Technologies, Inc. | Method and devices for cutting tissue |
US7708749B2 (en) | 2000-12-20 | 2010-05-04 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
US8328829B2 (en) | 1999-08-19 | 2012-12-11 | Covidien Lp | High capacity debulking catheter with razor edge cutting window |
US8414543B2 (en) | 1999-10-22 | 2013-04-09 | Rex Medical, L.P. | Rotational thrombectomy wire with blocking device |
AU2614901A (en) | 1999-10-22 | 2001-04-30 | Boston Scientific Corporation | Double balloon thrombectomy catheter |
US8251070B2 (en) | 2000-03-27 | 2012-08-28 | Asthmatx, Inc. | Methods for treating airways |
US6818001B2 (en) * | 2000-04-05 | 2004-11-16 | Pathway Medical Technologies, Inc. | Intralumenal material removal systems and methods |
US6569129B1 (en) * | 2000-09-13 | 2003-05-27 | Mayo Foundation For Medical Education And Research | Biological revascularization |
DE10049865B8 (en) * | 2000-10-09 | 2008-10-30 | Universitätsklinikum Freiburg | Device for removing an aortic valve on the human heart by means of a minimally invasive surgical procedure |
US7104987B2 (en) | 2000-10-17 | 2006-09-12 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
ES2436668T3 (en) | 2000-12-20 | 2014-01-03 | Covidien Lp | Catheter to remove atheromatous or thrombotic occlusive material |
US6500186B2 (en) * | 2001-04-17 | 2002-12-31 | Scimed Life Systems, Inc. | In-stent ablative tool |
US6878153B2 (en) * | 2001-07-02 | 2005-04-12 | Rubicon Medical, Inc. | Methods, systems, and devices for providing embolic protection and removing embolic material |
US6962598B2 (en) * | 2001-07-02 | 2005-11-08 | Rubicon Medical, Inc. | Methods, systems, and devices for providing embolic protection |
US6997939B2 (en) * | 2001-07-02 | 2006-02-14 | Rubicon Medical, Inc. | Methods, systems, and devices for deploying an embolic protection filter |
DE60212006T2 (en) * | 2001-07-13 | 2007-04-19 | B. Braun Medical Sas | Vascular protection system and angioplasty device |
US7025734B1 (en) * | 2001-09-28 | 2006-04-11 | Advanced Cardiovascular Systmes, Inc. | Guidewire with chemical sensing capabilities |
US8262689B2 (en) * | 2001-09-28 | 2012-09-11 | Advanced Cardiovascular Systems, Inc. | Embolic filtering devices |
US20040138692A1 (en) * | 2003-01-13 | 2004-07-15 | Scimed Life Systems, Inc. | Embolus extractor |
US7749243B2 (en) * | 2001-10-19 | 2010-07-06 | Boston Scientific Scimed, Inc. | Embolus extractor |
WO2003041760A2 (en) | 2001-11-09 | 2003-05-22 | Novoste Corporation | Baloon catheter with non-deployable stent |
US20040111108A1 (en) | 2001-11-09 | 2004-06-10 | Farnan Robert C. | Balloon catheter with non-deployable stent |
BR0215098A (en) * | 2001-11-26 | 2004-12-14 | Genentech Inc | Useful composition for removing blood clots, method for removing blood clots, catheter and multi-compartment packaging. |
DE60209799T2 (en) | 2001-12-03 | 2007-01-25 | Ekos Corp., Bothell | CATHETER WITH SEVERAL ULTRASOUND EMITTING PARTS |
US10098640B2 (en) * | 2001-12-04 | 2018-10-16 | Atricure, Inc. | Left atrial appendage devices and methods |
US6741878B2 (en) | 2001-12-14 | 2004-05-25 | Biosense Webster, Inc. | Basket catheter with improved expansion mechanism |
US7241304B2 (en) * | 2001-12-21 | 2007-07-10 | Advanced Cardiovascular Systems, Inc. | Flexible and conformable embolic filtering devices |
DE10203265A1 (en) * | 2002-01-29 | 2003-07-31 | Ina Schaeffler Kg | Thrust washer of a planetary gear |
US20030187495A1 (en) | 2002-04-01 | 2003-10-02 | Cully Edward H. | Endoluminal devices, embolic filters, methods of manufacture and use |
US6855136B2 (en) * | 2002-04-03 | 2005-02-15 | Gore Enterprise Holdings, Inc. | Infusion catheter having an atraumatic tip |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US20140018880A1 (en) | 2002-04-08 | 2014-01-16 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
DE10233085B4 (en) | 2002-07-19 | 2014-02-20 | Dendron Gmbh | Stent with guide wire |
US8425549B2 (en) | 2002-07-23 | 2013-04-23 | Reverse Medical Corporation | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US20040034376A1 (en) * | 2002-08-15 | 2004-02-19 | Mark Wildes | Vasovasostomy stent |
US20040093012A1 (en) | 2002-10-17 | 2004-05-13 | Cully Edward H. | Embolic filter frame having looped support strut elements |
US20070014779A1 (en) * | 2002-11-14 | 2007-01-18 | Genentech, Inc. | Plasminogen activator variant formulations |
US7004971B2 (en) * | 2002-12-31 | 2006-02-28 | Depuy Acromed, Inc. | Annular nucleus pulposus replacement |
US7686824B2 (en) * | 2003-01-21 | 2010-03-30 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
US20050021070A1 (en) * | 2003-01-21 | 2005-01-27 | Angioscore, Inc. | Methods and apparatus for manipulating vascular prostheses |
US8080026B2 (en) | 2003-01-21 | 2011-12-20 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
JP2004249093A (en) * | 2003-01-31 | 2004-09-09 | Olympus Corp | Basket forceps |
US20060052788A1 (en) * | 2003-02-04 | 2006-03-09 | Thelen Sarah L | Expandable fixation devices for minimally invasive surgery |
US7131981B2 (en) * | 2003-03-25 | 2006-11-07 | Angiodynamics, Inc. | Device and method for converting a balloon catheter into a cutting balloon catheter |
US20040199201A1 (en) * | 2003-04-02 | 2004-10-07 | Scimed Life Systems, Inc. | Embolectomy devices |
US8246640B2 (en) | 2003-04-22 | 2012-08-21 | Tyco Healthcare Group Lp | Methods and devices for cutting tissue at a vascular location |
WO2004100772A2 (en) * | 2003-05-12 | 2004-11-25 | University Of Florida | Devices and methods for disruption and removal of luninal occlusions |
US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
US8393328B2 (en) | 2003-08-22 | 2013-03-12 | BiO2 Medical, Inc. | Airway assembly and methods of using an airway assembly |
US7699865B2 (en) | 2003-09-12 | 2010-04-20 | Rubicon Medical, Inc. | Actuating constraining mechanism |
US8535344B2 (en) | 2003-09-12 | 2013-09-17 | Rubicon Medical, Inc. | Methods, systems, and devices for providing embolic protection and removing embolic material |
DE202004021944U1 (en) | 2003-09-12 | 2013-07-16 | Vessix Vascular, Inc. | Selectable eccentric remodeling and / or ablation of atherosclerotic material |
US20050113836A1 (en) * | 2003-11-25 | 2005-05-26 | Lozier Antony J. | Expandable reamer |
CA2553165A1 (en) * | 2004-01-29 | 2005-08-11 | Ekos Corporation | Method and apparatus for detecting vascular conditions with a catheter |
WO2005084562A2 (en) | 2004-03-04 | 2005-09-15 | Straub Medical Ag | Catheter for sucking, fragmenting removing material extractable from blood vessels |
US8313505B2 (en) | 2004-03-19 | 2012-11-20 | Aga Medical Corporation | Device for occluding vascular defects |
US8398670B2 (en) * | 2004-03-19 | 2013-03-19 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
US9039724B2 (en) | 2004-03-19 | 2015-05-26 | Aga Medical Corporation | Device for occluding vascular defects |
US8747453B2 (en) | 2008-02-18 | 2014-06-10 | Aga Medical Corporation | Stent/stent graft for reinforcement of vascular abnormalities and associated method |
US8777974B2 (en) * | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US20050228434A1 (en) * | 2004-03-19 | 2005-10-13 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US7686825B2 (en) | 2004-03-25 | 2010-03-30 | Hauser David L | Vascular filter device |
US8007495B2 (en) | 2004-03-31 | 2011-08-30 | Biosense Webster, Inc. | Catheter for circumferential ablation at or near a pulmonary vein |
JP2005323702A (en) * | 2004-05-13 | 2005-11-24 | Asahi Intecc Co Ltd | Medical treatment instrument |
US7976557B2 (en) | 2004-06-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Cutting balloon and process |
DE102004040868A1 (en) * | 2004-08-23 | 2006-03-09 | Miloslavski, Elina | Device for removing thrombi |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US7393181B2 (en) | 2004-09-17 | 2008-07-01 | The Penn State Research Foundation | Expandable impeller pump |
CN101031254B (en) * | 2004-09-27 | 2010-10-27 | 库克公司 | Removable vena cava filter comprising struts having axial beds |
US8795315B2 (en) | 2004-10-06 | 2014-08-05 | Cook Medical Technologies Llc | Emboli capturing device having a coil and method for capturing emboli |
WO2006052940A2 (en) | 2004-11-05 | 2006-05-18 | Asthmatx, Inc. | Medical device with procedure improvement features |
US7949407B2 (en) | 2004-11-05 | 2011-05-24 | Asthmatx, Inc. | Energy delivery devices and methods |
US20070093802A1 (en) * | 2005-10-21 | 2007-04-26 | Danek Christopher J | Energy delivery devices and methods |
US7819887B2 (en) * | 2004-11-17 | 2010-10-26 | Rex Medical, L.P. | Rotational thrombectomy wire |
WO2006063199A2 (en) * | 2004-12-09 | 2006-06-15 | The Foundry, Inc. | Aortic valve repair |
US8109941B2 (en) * | 2005-02-28 | 2012-02-07 | Boston Scientific Scimed, Inc. | Distal release retrieval assembly and related methods of use |
US8945169B2 (en) | 2005-03-15 | 2015-02-03 | Cook Medical Technologies Llc | Embolic protection device |
US8221446B2 (en) | 2005-03-15 | 2012-07-17 | Cook Medical Technologies | Embolic protection device |
US8475487B2 (en) * | 2005-04-07 | 2013-07-02 | Medrad, Inc. | Cross stream thrombectomy catheter with flexible and expandable cage |
US7645290B2 (en) * | 2005-05-05 | 2010-01-12 | Lucas Paul R | Multi-functional thrombectomy device |
US10076641B2 (en) | 2005-05-11 | 2018-09-18 | The Spectranetics Corporation | Methods and systems for delivering substances into luminal walls |
US7850708B2 (en) | 2005-06-20 | 2010-12-14 | Cook Incorporated | Embolic protection device having a reticulated body with staggered struts |
US8109962B2 (en) | 2005-06-20 | 2012-02-07 | Cook Medical Technologies Llc | Retrievable device having a reticulation portion with staggered struts |
US7766934B2 (en) | 2005-07-12 | 2010-08-03 | Cook Incorporated | Embolic protection device with an integral basket and bag |
US7771452B2 (en) | 2005-07-12 | 2010-08-10 | Cook Incorporated | Embolic protection device with a filter bag that disengages from a basket |
US8187298B2 (en) | 2005-08-04 | 2012-05-29 | Cook Medical Technologies Llc | Embolic protection device having inflatable frame |
US8632560B2 (en) * | 2005-08-11 | 2014-01-21 | Cook Medical Technologies Llc | System for breaking up thrombi and plaque in the vasculature |
US8998923B2 (en) | 2005-08-31 | 2015-04-07 | Spinealign Medical, Inc. | Threaded bone filling material plunger |
US8377092B2 (en) | 2005-09-16 | 2013-02-19 | Cook Medical Technologies Llc | Embolic protection device |
EP1937348A2 (en) * | 2005-09-20 | 2008-07-02 | Emerge Medsystems, LLC | Embolic filter device and related systems and methods |
WO2007034820A1 (en) * | 2005-09-22 | 2007-03-29 | Nipro Corporation | Filter of catheter for capturing thrombi and method of producing the same |
US8632562B2 (en) | 2005-10-03 | 2014-01-21 | Cook Medical Technologies Llc | Embolic protection device |
US8182508B2 (en) * | 2005-10-04 | 2012-05-22 | Cook Medical Technologies Llc | Embolic protection device |
US8252017B2 (en) | 2005-10-18 | 2012-08-28 | Cook Medical Technologies Llc | Invertible filter for embolic protection |
US8216269B2 (en) | 2005-11-02 | 2012-07-10 | Cook Medical Technologies Llc | Embolic protection device having reduced profile |
US8152831B2 (en) | 2005-11-17 | 2012-04-10 | Cook Medical Technologies Llc | Foam embolic protection device |
US8162878B2 (en) | 2005-12-05 | 2012-04-24 | Medrad, Inc. | Exhaust-pressure-operated balloon catheter system |
US8137256B2 (en) | 2005-12-16 | 2012-03-20 | Portola Medical, Inc. | Brachytherapy apparatus |
US20070270627A1 (en) * | 2005-12-16 | 2007-11-22 | North American Scientific | Brachytherapy apparatus for asymmetrical body cavities |
WO2007089897A2 (en) * | 2006-02-01 | 2007-08-09 | The Cleveland Clinic Foundation | Inflatable-deflatable passive exercise unit |
EP1986568B1 (en) | 2006-02-03 | 2017-04-05 | Covidien LP | Methods and devices for restoring blood flow within blocked vasculature |
JP4932854B2 (en) * | 2006-02-13 | 2012-05-16 | レトロ・ヴァスキュラー・インコーポレーテッド | Catheter system |
JP4493608B2 (en) * | 2006-03-06 | 2010-06-30 | テルモ株式会社 | Atherectomy catheter |
EP1832240B1 (en) | 2006-03-06 | 2009-12-23 | Terumo Kabushiki Kaisha | Atherectomy catheter |
EP3115070B8 (en) | 2006-03-23 | 2019-05-08 | The Penn State Research Foundation | Heart assist device with expandable impeller pump |
US20070276419A1 (en) | 2006-05-26 | 2007-11-29 | Fox Hollow Technologies, Inc. | Methods and devices for rotating an active element and an energy emitter on a catheter |
EP2068727A4 (en) * | 2006-06-20 | 2012-12-19 | Aortx Inc | Prosthetic valve implant site preparation techniques |
KR20090049051A (en) | 2006-06-30 | 2009-05-15 | 아테로메드, 아이엔씨. | Atherectomy devices and methods |
US20080004645A1 (en) | 2006-06-30 | 2008-01-03 | Atheromed, Inc. | Atherectomy devices and methods |
US8361094B2 (en) | 2006-06-30 | 2013-01-29 | Atheromed, Inc. | Atherectomy devices and methods |
US8007506B2 (en) | 2006-06-30 | 2011-08-30 | Atheromed, Inc. | Atherectomy devices and methods |
US9314263B2 (en) | 2006-06-30 | 2016-04-19 | Atheromed, Inc. | Atherectomy devices, systems, and methods |
US20090018566A1 (en) | 2006-06-30 | 2009-01-15 | Artheromed, Inc. | Atherectomy devices, systems, and methods |
US9492192B2 (en) | 2006-06-30 | 2016-11-15 | Atheromed, Inc. | Atherectomy devices, systems, and methods |
US8628549B2 (en) | 2006-06-30 | 2014-01-14 | Atheromed, Inc. | Atherectomy devices, systems, and methods |
US20080045986A1 (en) | 2006-06-30 | 2008-02-21 | Atheromed, Inc. | Atherectomy devices and methods |
US7655013B2 (en) * | 2006-07-06 | 2010-02-02 | Bruce Kirke Bieneman | Snare retrieval device |
GB0616411D0 (en) | 2006-08-18 | 2006-09-27 | Renishaw Plc | Neurosurgical instruments |
US20080281364A1 (en) * | 2007-05-08 | 2008-11-13 | Spineworks Medical, Inc. | Systems, devices and methods for stabilizing bone |
US20090012564A1 (en) * | 2007-03-07 | 2009-01-08 | Spineworks Medical, Inc. | Transdiscal interbody fusion device and method |
US8876754B2 (en) * | 2006-08-31 | 2014-11-04 | Bayer Medical Care Inc. | Catheter with filtering and sensing elements |
US8361084B2 (en) * | 2006-09-01 | 2013-01-29 | Boston Scientific Scimed, Inc. | Medical retrieval baskets |
US20080071307A1 (en) | 2006-09-19 | 2008-03-20 | Cook Incorporated | Apparatus and methods for in situ embolic protection |
US9149609B2 (en) * | 2006-10-16 | 2015-10-06 | Embolitech, Llc | Catheter for removal of an organized embolic thrombus |
CA2666663C (en) | 2006-10-18 | 2016-02-09 | Minnow Medical, Inc. | System for inducing desirable temperature effects on body tissue |
US7931647B2 (en) | 2006-10-20 | 2011-04-26 | Asthmatx, Inc. | Method of delivering energy to a lung airway using markers |
US20080269774A1 (en) | 2006-10-26 | 2008-10-30 | Chestnut Medical Technologies, Inc. | Intracorporeal Grasping Device |
WO2008058089A2 (en) | 2006-11-03 | 2008-05-15 | North American Scientific, Inc. | Brachytherapy device having seed tubes with individually-settable tissue spacings |
US7357770B1 (en) * | 2006-11-03 | 2008-04-15 | North American Scientific, Inc. | Expandable brachytherapy device with constant radiation source spacing |
WO2008070353A2 (en) | 2006-11-07 | 2008-06-12 | Genentech, Inc. | Tissue plasminogen activator variant uses |
US8246641B2 (en) * | 2006-11-08 | 2012-08-21 | Cook Medical Technolgies, LLC | Thrombus removal device |
DE102006054218A1 (en) * | 2006-11-15 | 2008-05-21 | Karl Storz Medizinische Nähsysteme GmbH & Co. KG | Surgical instrument e.g. endoscope, for occluding incision into human body, has occluder that is moved for occluding incision using guidance wire from guidance channel, which is work channel of endoscope |
US10182833B2 (en) | 2007-01-08 | 2019-01-22 | Ekos Corporation | Power parameters for ultrasonic catheter |
CA2677343C (en) | 2007-02-05 | 2016-06-21 | Boston Scientific Limited | Thrombectomy apparatus and method |
US9901434B2 (en) | 2007-02-27 | 2018-02-27 | Cook Medical Technologies Llc | Embolic protection device including a Z-stent waist band |
EP2129329A2 (en) * | 2007-03-07 | 2009-12-09 | Spinealign Medical, Inc. | Systems, methods, and devices for soft tissue attachment to bone |
US8535334B2 (en) | 2007-04-17 | 2013-09-17 | Lazarus Effect, Inc. | Complex wire formed devices |
US11202646B2 (en) | 2007-04-17 | 2021-12-21 | Covidien Lp | Articulating retrieval devices |
US10076346B2 (en) | 2007-04-17 | 2018-09-18 | Covidien Lp | Complex wire formed devices |
US10064635B2 (en) | 2007-04-17 | 2018-09-04 | Covidien Lp | Articulating retrieval devices |
WO2008136005A2 (en) * | 2007-05-07 | 2008-11-13 | Medi-Tate | Device for dilating the urethra of the body of a patient and device for removing prostate tissue |
US20110022149A1 (en) | 2007-06-04 | 2011-01-27 | Cox Brian J | Methods and devices for treatment of vascular defects |
US8974418B2 (en) * | 2007-06-12 | 2015-03-10 | Boston Scientific Limited | Forwardly directed fluid jet crossing catheter |
US20080319386A1 (en) * | 2007-06-20 | 2008-12-25 | Possis Medical, Inc. | Forwardly directable fluid jet crossing catheter |
US9044568B2 (en) | 2007-06-22 | 2015-06-02 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
EP2164409B1 (en) * | 2007-06-29 | 2018-08-08 | Atheromed, Inc. | Atherectomy system |
ATE525972T1 (en) * | 2007-06-29 | 2011-10-15 | Spinealign Medical Inc | COMPATIBLE BONE STABILIZING DEVICES FOR USE WITH BONE SCREWS |
US8235983B2 (en) | 2007-07-12 | 2012-08-07 | Asthmatx, Inc. | Systems and methods for delivering energy to passageways in a patient |
US10376685B2 (en) | 2007-08-31 | 2019-08-13 | Mermaid Medical Vascular Aps | Thrombus detection device and method |
US9039728B2 (en) | 2007-08-31 | 2015-05-26 | BiO2 Medical, Inc. | IVC filter catheter with imaging modality |
US8613753B2 (en) | 2007-08-31 | 2013-12-24 | BiO2 Medical, Inc. | Multi-lumen central access vena cava filter apparatus and method of using same |
US8668712B2 (en) | 2007-08-31 | 2014-03-11 | BiO2 Medical, Inc. | Multi-lumen central access vena cava filter apparatus and method of using same |
US9687333B2 (en) | 2007-08-31 | 2017-06-27 | BiO2 Medical, Inc. | Reduced profile central venous access catheter with vena cava filter and method |
US8252018B2 (en) | 2007-09-14 | 2012-08-28 | Cook Medical Technologies Llc | Helical embolic protection device |
US9138307B2 (en) | 2007-09-14 | 2015-09-22 | Cook Medical Technologies Llc | Expandable device for treatment of a stricture in a body vessel |
US8419748B2 (en) | 2007-09-14 | 2013-04-16 | Cook Medical Technologies Llc | Helical thrombus removal device |
US9034007B2 (en) * | 2007-09-21 | 2015-05-19 | Insera Therapeutics, Inc. | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
US20090105687A1 (en) * | 2007-10-05 | 2009-04-23 | Angioscore, Inc. | Scoring catheter with drug delivery membrane |
DE502007005973D1 (en) * | 2007-10-08 | 2011-01-27 | Ais Gmbh Aachen Innovative Solutions | Catheter device |
US8439859B2 (en) | 2007-10-08 | 2013-05-14 | Ais Gmbh Aachen Innovative Solutions | Catheter device |
US9220522B2 (en) | 2007-10-17 | 2015-12-29 | Covidien Lp | Embolus removal systems with baskets |
US10123803B2 (en) | 2007-10-17 | 2018-11-13 | Covidien Lp | Methods of managing neurovascular obstructions |
US8585713B2 (en) | 2007-10-17 | 2013-11-19 | Covidien Lp | Expandable tip assembly for thrombus management |
US20100256600A1 (en) * | 2009-04-04 | 2010-10-07 | Ferrera David A | Neurovascular otw pta balloon catheter and delivery system |
US8088140B2 (en) | 2008-05-19 | 2012-01-03 | Mindframe, Inc. | Blood flow restorative and embolus removal methods |
US8066757B2 (en) | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
US11337714B2 (en) | 2007-10-17 | 2022-05-24 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
US8926680B2 (en) | 2007-11-12 | 2015-01-06 | Covidien Lp | Aneurysm neck bridging processes with revascularization systems methods and products thereby |
US9198687B2 (en) | 2007-10-17 | 2015-12-01 | Covidien Lp | Acute stroke revascularization/recanalization systems processes and products thereby |
US20100174309A1 (en) * | 2008-05-19 | 2010-07-08 | Mindframe, Inc. | Recanalization/revascularization and embolus addressing systems including expandable tip neuro-microcatheter |
US8070762B2 (en) | 2007-10-22 | 2011-12-06 | Atheromed Inc. | Atherectomy devices and methods |
CN101896125A (en) * | 2007-10-25 | 2010-11-24 | 康奈尔大学 | Tissue retrieval bags |
WO2009055782A1 (en) | 2007-10-26 | 2009-04-30 | Possis Medical, Inc. | Intravascular guidewire filter system for pulmonary embolism protection and embolism removal or maceration |
US8157751B2 (en) * | 2007-12-13 | 2012-04-17 | Boston Scientific Scimed, Inc. | Coil member for a medical device |
WO2009079539A1 (en) | 2007-12-17 | 2009-06-25 | Medrad, Inc. | Rheolytic thrombectomy catheter with self-inflation distal balloon |
US20090287120A1 (en) | 2007-12-18 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US9672471B2 (en) | 2007-12-18 | 2017-06-06 | Gearbox Llc | Systems, devices, and methods for detecting occlusions in a biological subject including spectral learning |
US9717896B2 (en) | 2007-12-18 | 2017-08-01 | Gearbox, Llc | Treatment indications informed by a priori implant information |
US20090163851A1 (en) * | 2007-12-19 | 2009-06-25 | Holloway Kenneth A | Occlusive material removal device having selectively variable stiffness |
WO2009082669A1 (en) | 2007-12-26 | 2009-07-02 | Medrad, Inc. | Rheolytic thrombectomy catheter with self-inflating proximal balloon with drug infusion capabilities |
US8545526B2 (en) | 2007-12-26 | 2013-10-01 | Lazarus Effect, Inc. | Retrieval systems and methods for use thereof |
US20090171386A1 (en) * | 2007-12-28 | 2009-07-02 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US20090177206A1 (en) * | 2008-01-08 | 2009-07-09 | Zimmer Spine, Inc. | Instruments, implants, and methods for fixation of vertebral compression fractures |
GB0800981D0 (en) * | 2008-01-18 | 2008-02-27 | Plaque Attack Ltd | Catheter |
US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
WO2009103125A1 (en) * | 2008-02-20 | 2009-08-27 | Neustent Pty Ltd | A stent |
AU2009217354B2 (en) | 2008-02-22 | 2013-10-10 | Covidien Lp | Methods and apparatus for flow restoration |
US8784440B2 (en) | 2008-02-25 | 2014-07-22 | Covidien Lp | Methods and devices for cutting tissue |
US10159472B2 (en) * | 2008-03-02 | 2018-12-25 | V.V.T. Med Ltd. | Method and device for vein ablation |
DE112009000700T5 (en) | 2008-03-20 | 2011-02-10 | Medrad, Inc. | Hydrodynamic direct current catheter system |
CN101977650A (en) | 2008-04-11 | 2011-02-16 | 曼德弗雷姆公司 | Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby |
US20090264859A1 (en) * | 2008-04-21 | 2009-10-22 | Medtronic Vascular, Inc. | Catheter Having a Selectively Expandable Distal Tip |
CA3048277C (en) | 2008-05-02 | 2022-06-21 | Sequent Medical Inc. | Filamentary devices for treatment of vascular defects |
JP2011519699A (en) | 2008-05-09 | 2011-07-14 | インノブアトイブエ プルモナルイ ソルウトイオンス,インコーポレイティッド | Systems, assemblies and methods for treatment of bronchial trees |
US20090292323A1 (en) * | 2008-05-20 | 2009-11-26 | Chirico Paul E | Systems, devices and methods for posterior lumbar interbody fusion |
CA2726585A1 (en) * | 2008-06-02 | 2009-12-10 | Spinealign Medical, Inc. | Controlled deployment handles for bone stabilization devices |
US8192451B2 (en) * | 2008-06-05 | 2012-06-05 | Cardiovascular Systems, Inc. | Cutting and coring atherectomy device and method |
US8939991B2 (en) | 2008-06-08 | 2015-01-27 | Hotspur Technologies, Inc. | Apparatus and methods for removing obstructive material from body lumens |
WO2009150920A1 (en) * | 2008-06-09 | 2009-12-17 | 株式会社パイオラックスメディカルデバイス | Medical treatment tool for tubular organs |
WO2009150099A1 (en) * | 2008-06-10 | 2009-12-17 | Bavaria Medizin Technologie Gmbh | Scoring catheter for treating diseased heart valves |
US8945160B2 (en) | 2008-07-03 | 2015-02-03 | Hotspur Technologies, Inc. | Apparatus and methods for treating obstructions within body lumens |
US9101382B2 (en) | 2009-02-18 | 2015-08-11 | Hotspur Technologies, Inc. | Apparatus and methods for treating obstructions within body lumens |
EP2902070B1 (en) | 2008-07-03 | 2016-10-05 | Hotspur Technologies, Inc | Apparatus for treating obstructions within body lumens |
MX2011002670A (en) * | 2008-09-17 | 2011-04-12 | Bayer Oy | An inserter. |
FI20080523A0 (en) | 2008-09-17 | 2008-09-17 | Bayer Schering Pharma Oy | An inserter |
FI20080524A0 (en) | 2008-09-17 | 2008-09-17 | Bayer Schering Pharma Oy | An inserter |
EP2344051B1 (en) | 2008-09-22 | 2016-11-09 | Hotspur Technologies, Inc | Flow restoration systems |
US8057496B2 (en) * | 2008-10-06 | 2011-11-15 | Cook Medical Technologies Llc | Mechanical thrombectomy device |
US9149377B2 (en) * | 2008-10-10 | 2015-10-06 | Veryan Medical Ltd. | Stent suitable for deployment in a blood vessel |
KR101645754B1 (en) | 2008-10-13 | 2016-08-04 | 코비디엔 엘피 | Devices and methods for manipulating a catheter shaft |
US8771305B2 (en) * | 2008-11-11 | 2014-07-08 | Edgar Louis Shriver | Lateral intravascular excision/incision devices |
CH699981A2 (en) | 2008-11-27 | 2010-05-31 | Straub Medical Ag | Catheter for aspirating, fragmenting and out transport of removable material from blood vessels. |
EP2194278A1 (en) | 2008-12-05 | 2010-06-09 | ECP Entwicklungsgesellschaft mbH | Fluid pump with a rotor |
US8470043B2 (en) * | 2008-12-23 | 2013-06-25 | Benvenue Medical, Inc. | Tissue removal tools and methods of use |
US8388644B2 (en) | 2008-12-29 | 2013-03-05 | Cook Medical Technologies Llc | Embolic protection device and method of use |
IT1394691B1 (en) * | 2008-12-30 | 2012-07-13 | Invatec Spa | TRUMPET REMOVAL DEVICE |
US8641753B2 (en) | 2009-01-31 | 2014-02-04 | Cook Medical Technologies Llc | Preform for and an endoluminal prosthesis |
EP2216059A1 (en) | 2009-02-04 | 2010-08-11 | ECP Entwicklungsgesellschaft mbH | Catheter device with a catheter and an actuation device |
US8361095B2 (en) * | 2009-02-17 | 2013-01-29 | Cook Medical Technologies Llc | Loop thrombectomy device |
US8758847B2 (en) | 2009-02-18 | 2014-06-24 | AUST Development, LLC | Apparatus and methods for making coated liners and tubular devices including such liners |
US20120109057A1 (en) | 2009-02-18 | 2012-05-03 | Hotspur Technologies, Inc. | Apparatus and methods for treating obstructions within body lumens |
US9339630B2 (en) * | 2009-02-19 | 2016-05-17 | Medtronic Vascular, Inc. | Retractable drug delivery system and method |
EP2403583B1 (en) | 2009-03-06 | 2016-10-19 | Lazarus Effect, Inc. | Retrieval systems |
EP2229965A1 (en) * | 2009-03-18 | 2010-09-22 | ECP Entwicklungsgesellschaft mbH | Fluid pump with particular form of a rotor blade |
WO2010126882A1 (en) | 2009-04-29 | 2010-11-04 | Fox Hollow Technologies, Inc. | Methods and devices for cutting and abrading tissue |
EP2246078A1 (en) | 2009-04-29 | 2010-11-03 | ECP Entwicklungsgesellschaft mbH | Shaft assembly with a shaft which moves within a fluid-filled casing |
EP2248544A1 (en) | 2009-05-05 | 2010-11-10 | ECP Entwicklungsgesellschaft mbH | Fluid pump with variable circumference, particularly for medical use |
US20100286593A1 (en) * | 2009-05-11 | 2010-11-11 | Hotspur Technologies, Inc. | Balloon catheter with cutting features and methods for use |
RU2509538C2 (en) | 2009-05-14 | 2014-03-20 | ТАЙКО ХЕЛСКЕА ГРУП эЛПи | Cleanable atherectomy catheters and methods for using them |
US9510855B2 (en) * | 2009-06-15 | 2016-12-06 | Perflow Medical Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
EP2266640A1 (en) | 2009-06-25 | 2010-12-29 | ECP Entwicklungsgesellschaft mbH | Compressible and expandable turbine blade for a fluid pump |
EP2282070B1 (en) | 2009-08-06 | 2012-10-17 | ECP Entwicklungsgesellschaft mbH | Catheter device with a coupling device for a drive device |
CH701695A1 (en) | 2009-08-27 | 2011-02-28 | Straub Medical Ag | Catheter with protection system for aspirating, fragmenting and out pumping of removable material from hollow bodies or vessels, in particular of the human or animal body. |
AU2015264848B2 (en) * | 2009-08-31 | 2018-01-18 | Applied Medical Resources Corporation | Multifunctional surgical access system |
WO2011028203A1 (en) | 2009-09-02 | 2011-03-10 | Reflow Medical Inc. | Systems, methods and devices for ablation, crossing, and cutting of occlusions |
EP2298373A1 (en) | 2009-09-22 | 2011-03-23 | ECP Entwicklungsgesellschaft mbH | Fluid pump with at least one turbine blade and a seating device |
EP3441616B1 (en) | 2009-09-22 | 2023-04-19 | ECP Entwicklungsgesellschaft mbH | Compressible rotor for a fluid pump |
EP2298372A1 (en) | 2009-09-22 | 2011-03-23 | ECP Entwicklungsgesellschaft mbH | Rotor for an axial pump for transporting a fluid |
EP2298371A1 (en) | 2009-09-22 | 2011-03-23 | ECP Entwicklungsgesellschaft mbH | Function element, in particular fluid pump with a housing and a transport element |
EP2314330A1 (en) | 2009-10-23 | 2011-04-27 | ECP Entwicklungsgesellschaft mbH | Flexible shaft arrangement |
EP2314331B1 (en) | 2009-10-23 | 2013-12-11 | ECP Entwicklungsgesellschaft mbH | Catheter pump arrangement and flexible shaft arrangement with a cable core |
KR101722290B1 (en) | 2009-10-27 | 2017-03-31 | 호라이라 인코포레이티드 | Delivery devices with coolable energy emitting assemblies |
US20110152993A1 (en) | 2009-11-05 | 2011-06-23 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
DE102009052002B4 (en) * | 2009-11-05 | 2012-09-27 | Acandis Gmbh & Co. Kg | A medical device for recanalizing body cavities and set comprising such device |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
CN102711645B (en) | 2009-11-11 | 2016-12-28 | 赫莱拉公司 | For processing tissue and controlling narrow system and device |
WO2011068932A1 (en) | 2009-12-02 | 2011-06-09 | Fox Hollow Technologies, Inc. | Methods and devices for cutting tissue |
JP5511107B2 (en) | 2009-12-11 | 2014-06-04 | コヴィディエン リミテッド パートナーシップ | Substance removal device and method with improved substance capture efficiency |
US8771289B2 (en) * | 2009-12-21 | 2014-07-08 | Acist Medical Systems, Inc. | Thrombus removal device and system |
EP2338539A1 (en) | 2009-12-23 | 2011-06-29 | ECP Entwicklungsgesellschaft mbH | Pump device with a detection device |
EP2338540A1 (en) | 2009-12-23 | 2011-06-29 | ECP Entwicklungsgesellschaft mbH | Delivery blade for a compressible rotor |
EP2338541A1 (en) | 2009-12-23 | 2011-06-29 | ECP Entwicklungsgesellschaft mbH | Radial compressible and expandable rotor for a fluid pump |
US9925031B2 (en) | 2009-12-28 | 2018-03-27 | Cook Medical Technologies Llc | Endoluminal device with kink-resistant regions |
US8801748B2 (en) | 2010-01-22 | 2014-08-12 | Lazarus Effect, Inc. | Retrieval systems and methods for use thereof |
EP2347778A1 (en) | 2010-01-25 | 2011-07-27 | ECP Entwicklungsgesellschaft mbH | Fluid pump with a radially compressible rotor |
DE102010025661A1 (en) * | 2010-02-05 | 2011-08-11 | Acandis GmbH & Co. KG, 76327 | Medical device for the release of concrements, method for producing such a device, treatment system with such a device and method for producing a treatment system |
EP2539012B1 (en) | 2010-02-23 | 2018-01-24 | Covidien LP | Devices for vascular recanalization |
DE102010009723A1 (en) * | 2010-03-01 | 2011-09-01 | Andramed Gmbh | Guidewire / catheter guided valvulotome |
WO2011109570A2 (en) * | 2010-03-04 | 2011-09-09 | Talecris Biotherapeutics, Inc. | Therapeutic delivery devices, systems, and methods |
EP2363157A1 (en) | 2010-03-05 | 2011-09-07 | ECP Entwicklungsgesellschaft mbH | Device for exerting mechanical force on a medium, in particular fluid pump |
US9199066B2 (en) | 2010-03-12 | 2015-12-01 | Quattro Vascular Pte Ltd. | Device and method for compartmental vessel treatment |
EP2380604A1 (en) | 2010-04-19 | 2011-10-26 | InnoRa Gmbh | Improved coating formulations for scoring or cutting balloon catheters |
US9023070B2 (en) | 2010-05-13 | 2015-05-05 | Rex Medical, L.P. | Rotational thrombectomy wire coupler |
US9795406B2 (en) | 2010-05-13 | 2017-10-24 | Rex Medical, L.P. | Rotational thrombectomy wire |
US8764779B2 (en) | 2010-05-13 | 2014-07-01 | Rex Medical, L.P. | Rotational thrombectomy wire |
US8663259B2 (en) | 2010-05-13 | 2014-03-04 | Rex Medical L.P. | Rotational thrombectomy wire |
EP2388029A1 (en) | 2010-05-17 | 2011-11-23 | ECP Entwicklungsgesellschaft mbH | Pump array |
KR101493138B1 (en) | 2010-06-14 | 2015-02-12 | 코비디엔 엘피 | Material removal device |
EP2399639A1 (en) | 2010-06-25 | 2011-12-28 | ECP Entwicklungsgesellschaft mbH | System for introducing a pump |
US9247942B2 (en) | 2010-06-29 | 2016-02-02 | Artventive Medical Group, Inc. | Reversible tubal contraceptive device |
WO2012002944A1 (en) | 2010-06-29 | 2012-01-05 | Artventive Medical Group, Inc. | Reducing flow through a tubular structure |
EP2407187A3 (en) | 2010-07-15 | 2012-06-20 | ECP Entwicklungsgesellschaft mbH | Blood pump for invasive application within the body of a patient |
EP2407185A1 (en) | 2010-07-15 | 2012-01-18 | ECP Entwicklungsgesellschaft mbH | Radial compressible and expandable rotor for a pump with a turbine blade |
WO2012009675A2 (en) | 2010-07-15 | 2012-01-19 | Lazarus Effect, Inc. | Retrieval systems and methods for use thereof |
EP2407186A1 (en) | 2010-07-15 | 2012-01-18 | ECP Entwicklungsgesellschaft mbH | Rotor for a pump, produced with an initial elastic material |
US9943668B2 (en) | 2010-07-16 | 2018-04-17 | Sub3 Vascular, Llc | Guidewire and catheter system and method for treating a blood clot |
EP2422735A1 (en) | 2010-08-27 | 2012-02-29 | ECP Entwicklungsgesellschaft mbH | Implantable blood transportation device, manipulation device and coupling device |
US8632559B2 (en) | 2010-09-21 | 2014-01-21 | Angioscore, Inc. | Method and system for treating valve stenosis |
US9039749B2 (en) | 2010-10-01 | 2015-05-26 | Covidien Lp | Methods and apparatuses for flow restoration and implanting members in the human body |
US9282991B2 (en) | 2010-10-06 | 2016-03-15 | Rex Medical, L.P. | Cutting wire assembly with coating for use with a catheter |
US8685050B2 (en) | 2010-10-06 | 2014-04-01 | Rex Medical L.P. | Cutting wire assembly for use with a catheter |
US8685049B2 (en) | 2010-11-18 | 2014-04-01 | Rex Medical L.P. | Cutting wire assembly for use with a catheter |
US9149277B2 (en) | 2010-10-18 | 2015-10-06 | Artventive Medical Group, Inc. | Expandable device delivery |
MX2013004235A (en) | 2010-10-25 | 2013-05-30 | Medtronic Ardian Luxembourg | Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods. |
EP2632352B1 (en) | 2010-10-28 | 2017-04-12 | Covidien LP | Material removal device |
CA2817213C (en) | 2010-11-11 | 2016-06-14 | Covidien Lp | Flexible debulking catheters with imaging and methods of use and manufacture |
US8702736B2 (en) | 2010-11-22 | 2014-04-22 | Rex Medical L.P. | Cutting wire assembly for use with a catheter |
RU2492824C2 (en) * | 2010-11-30 | 2013-09-20 | Компания с ограниченной ответственностью Глобитек 2000 | Trawl device for extraction of foreign bodies from tubular organs |
US9066685B2 (en) * | 2010-12-31 | 2015-06-30 | Volcano Corporation | Multiple sclerosis therapeutic methods using therapeutic delivery devices and systems |
WO2012094641A2 (en) | 2011-01-06 | 2012-07-12 | Thoratec Corporation | Percutaneous heart pump |
KR101858780B1 (en) * | 2011-01-24 | 2018-05-16 | 닐스 비. 에이디 | Devices, systems, and methods for extracting a material from a material sample |
EP2497521A1 (en) | 2011-03-10 | 2012-09-12 | ECP Entwicklungsgesellschaft mbH | Push device for axial insertion of a string-shaped, flexible body |
WO2012161875A1 (en) | 2011-04-08 | 2012-11-29 | Tyco Healthcare Group Lp | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
CN102743207B (en) * | 2011-04-20 | 2014-12-24 | 首都医科大学宣武医院 | Thrombus breaking and thrombus taking device |
WO2012145072A1 (en) | 2011-04-22 | 2012-10-26 | Topera, Inc. | Basket style cardiac mapping catheter having a flexible electrode assembly for detection of cardiac rhythm disorders |
BR112013030183A2 (en) | 2011-05-23 | 2017-12-05 | Lazarus Effect Inc | interventional medical device for recovering and securing an obstruction within a vessel lumen, method of securing an obstruction within a vessel, method of preparing a retrieval device, medical device retrieval system, for securing an obstruction within a lumen and for use with a catheter configured to be navigated through the vasculature, interventional medical device to secure a retrieval device having one or more obstructions located therein for removal of a body and stent retrieval device to expand against one or more occlusive bodies in a vasculature |
AU2012203620B9 (en) | 2011-06-24 | 2014-10-02 | Cook Medical Technologies Llc | Helical Stent |
US9095370B2 (en) | 2011-06-29 | 2015-08-04 | Cordis Corporation | System and method for dilating and adjusting flexibility in a guiding device |
US8956376B2 (en) | 2011-06-30 | 2015-02-17 | The Spectranetics Corporation | Reentry catheter and method thereof |
US8998936B2 (en) | 2011-06-30 | 2015-04-07 | The Spectranetics Corporation | Reentry catheter and method thereof |
US9814862B2 (en) | 2011-06-30 | 2017-11-14 | The Spectranetics Corporation | Reentry catheter and method thereof |
US20130018384A1 (en) * | 2011-07-15 | 2013-01-17 | Gary Kappel | Medical Retrieval and Capture Device and Related Methods of Use |
WO2013033426A2 (en) | 2011-09-01 | 2013-03-07 | Covidien Lp | Catheter with helical drive shaft and methods of manufacture |
EP2564771A1 (en) | 2011-09-05 | 2013-03-06 | ECP Entwicklungsgesellschaft mbH | Medicinal product with a functional element for invasive use in the body of a patient |
US9554904B2 (en) | 2011-09-28 | 2017-01-31 | Medtronic CV Luxembourg S.a.r.l. | Distal tip assembly for a heart valve delivery catheter |
US10149697B2 (en) | 2011-10-04 | 2018-12-11 | Angioworks Medical, B.V. | Devices and methods for percutaneous tissue removal |
US8926492B2 (en) | 2011-10-11 | 2015-01-06 | Ecp Entwicklungsgesellschaft Mbh | Housing for a functional element |
CN103957825B (en) | 2011-10-13 | 2018-12-07 | 阿瑟罗迈德公司 | Atherectomy device, system and method |
US8758389B2 (en) * | 2011-11-18 | 2014-06-24 | Aga Medical Corporation | Devices and methods for occluding abnormal openings in a patient's vasculature |
WO2013114201A1 (en) | 2012-02-01 | 2013-08-08 | Tanhum Feld | Device for compartmental dilatation of blood vessels |
SG11201403915XA (en) | 2012-02-08 | 2014-08-28 | Quattro Vascular Pte Ltd | Constraining structure with non-linear axial struts |
US9216033B2 (en) | 2012-02-08 | 2015-12-22 | Quattro Vascular Pte Ltd. | System and method for treating biological vessels |
JP2015128457A (en) * | 2012-04-27 | 2015-07-16 | テルモ株式会社 | embolus discharge catheter |
US9126013B2 (en) | 2012-04-27 | 2015-09-08 | Teleflex Medical Incorporated | Catheter with adjustable guidewire exit position |
US9848881B2 (en) | 2012-05-09 | 2017-12-26 | Fusion Medical, Inc. | Clot removal device for deep vein thrombosis |
US10448969B2 (en) | 2012-05-09 | 2019-10-22 | Fusion Medical, Inc. | Clot removal device for blood vessels |
ES2614272T3 (en) | 2012-05-11 | 2017-05-30 | Medtronic Ardian Luxembourg S.à.r.l. | Multiple electrode catheter assemblies for renal neuromodulation and associated systems and methods |
US9446179B2 (en) | 2012-05-14 | 2016-09-20 | Thoratec Corporation | Distal bearing support |
US9872947B2 (en) | 2012-05-14 | 2018-01-23 | Tc1 Llc | Sheath system for catheter pump |
US9327067B2 (en) | 2012-05-14 | 2016-05-03 | Thoratec Corporation | Impeller for catheter pump |
US8721517B2 (en) | 2012-05-14 | 2014-05-13 | Thoratec Corporation | Impeller for catheter pump |
GB2504176A (en) | 2012-05-14 | 2014-01-22 | Thoratec Corp | Collapsible impeller for catheter pump |
EP3868321B1 (en) | 2012-06-04 | 2022-11-16 | Boston Scientific Scimed, Inc. | Systems for treating tissue of a passageway within a body |
US9211132B2 (en) | 2012-06-27 | 2015-12-15 | MicoVention, Inc. | Obstruction removal system |
EP4186557A1 (en) | 2012-07-03 | 2023-05-31 | Tc1 Llc | Motor assembly for catheter pump |
US9358329B2 (en) | 2012-07-03 | 2016-06-07 | Thoratec Corporation | Catheter pump |
US9421311B2 (en) | 2012-07-03 | 2016-08-23 | Thoratec Corporation | Motor assembly for catheter pump |
US9592086B2 (en) | 2012-07-24 | 2017-03-14 | Boston Scientific Scimed, Inc. | Electrodes for tissue treatment |
ES2949296T3 (en) | 2012-07-24 | 2023-09-27 | Renishaw Plc | Neurosurgical device |
DK2879598T3 (en) | 2012-07-29 | 2019-02-11 | Vvt Medical Ltd | ABLATION CATS FOR BLOOD CARBATION AND PROCEDURES TO USE THEREOF |
US9308007B2 (en) | 2012-08-14 | 2016-04-12 | W. L. Gore & Associates, Inc. | Devices and systems for thrombus treatment |
US9532844B2 (en) | 2012-09-13 | 2017-01-03 | Covidien Lp | Cleaning device for medical instrument and method of use |
US9272132B2 (en) | 2012-11-02 | 2016-03-01 | Boston Scientific Scimed, Inc. | Medical device for treating airways and related methods of use |
WO2014071372A1 (en) | 2012-11-05 | 2014-05-08 | Boston Scientific Scimed, Inc. | Devices for delivering energy to body lumens |
US9943329B2 (en) | 2012-11-08 | 2018-04-17 | Covidien Lp | Tissue-removing catheter with rotatable cutter |
EP3967266B1 (en) * | 2012-11-15 | 2023-07-12 | Nfinium Vascular Technologies, LLC | Temporary vascular scaffold and scoring device |
US8784434B2 (en) * | 2012-11-20 | 2014-07-22 | Inceptus Medical, Inc. | Methods and apparatus for treating embolism |
JP6382214B2 (en) * | 2012-12-05 | 2018-08-29 | ラピッド メディカル リミテッド | Device for assisting medical treatment |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
ES2755651T3 (en) | 2013-01-07 | 2020-04-23 | Taryag Medical Ltd | Expandable Atherectomy Device |
US9358021B2 (en) | 2013-01-09 | 2016-06-07 | Covidien Lp | Connection of an endovascular intervention device to a manipulation member |
US8984733B2 (en) | 2013-02-05 | 2015-03-24 | Artventive Medical Group, Inc. | Bodily lumen occlusion |
US9095344B2 (en) | 2013-02-05 | 2015-08-04 | Artventive Medical Group, Inc. | Methods and apparatuses for blood vessel occlusion |
US11077294B2 (en) | 2013-03-13 | 2021-08-03 | Tc1 Llc | Sheath assembly for catheter pump |
US11033728B2 (en) | 2013-03-13 | 2021-06-15 | Tc1 Llc | Fluid handling system |
EP4122520A1 (en) | 2013-03-13 | 2023-01-25 | Tc1 Llc | Fluid handling system |
US20140316447A1 (en) * | 2013-03-14 | 2014-10-23 | Cardiovascular Systems, Inc. | Devices, systems and methods for a piloting tip bushing for rotational atherectomy |
US9308302B2 (en) | 2013-03-15 | 2016-04-12 | Thoratec Corporation | Catheter pump assembly including a stator |
US8679150B1 (en) | 2013-03-15 | 2014-03-25 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy methods |
US9179974B2 (en) | 2013-03-15 | 2015-11-10 | Medtronic Ardian Luxembourg S.A.R.L. | Helical push wire electrode |
WO2014150288A2 (en) | 2013-03-15 | 2014-09-25 | Insera Therapeutics, Inc. | Vascular treatment devices and methods |
EP3797810A1 (en) | 2013-03-15 | 2021-03-31 | Tc1 Llc | Catheter pump assembly including a stator |
US20140309672A1 (en) * | 2013-03-15 | 2014-10-16 | Cook Medical Technologies Llc | Clot buster aspiration catheter |
US8715315B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment systems |
US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
US10231751B2 (en) * | 2013-05-29 | 2019-03-19 | Thomas A. Sos | Thrombus removal and intravascular distal embolic protection device |
US9814618B2 (en) | 2013-06-06 | 2017-11-14 | Boston Scientific Scimed, Inc. | Devices for delivering energy and related methods of use |
US10149968B2 (en) | 2013-06-14 | 2018-12-11 | Artventive Medical Group, Inc. | Catheter-assisted tumor treatment |
US9737308B2 (en) | 2013-06-14 | 2017-08-22 | Artventive Medical Group, Inc. | Catheter-assisted tumor treatment |
US9737306B2 (en) | 2013-06-14 | 2017-08-22 | Artventive Medical Group, Inc. | Implantable luminal devices |
US9636116B2 (en) | 2013-06-14 | 2017-05-02 | Artventive Medical Group, Inc. | Implantable luminal devices |
CN110547865B (en) | 2013-08-09 | 2022-10-04 | 波士顿科学国际有限公司 | Expandable catheter and related methods of manufacture and use |
US9078658B2 (en) | 2013-08-16 | 2015-07-14 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9955976B2 (en) | 2013-08-16 | 2018-05-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US20150073515A1 (en) | 2013-09-09 | 2015-03-12 | Medtronic Ardian Luxembourg S.a.r.I. | Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods |
US10076399B2 (en) | 2013-09-13 | 2018-09-18 | Covidien Lp | Endovascular device engagement |
US10117668B2 (en) | 2013-10-08 | 2018-11-06 | The Spectranetics Corporation | Balloon catheter with non-deployable stent having improved stability |
PL3055050T3 (en) | 2013-10-13 | 2021-01-11 | V.V.T. Med Ltd. | Foam formation device and method |
EP3054856B1 (en) | 2013-10-13 | 2020-12-09 | V.V.T. Med Ltd. | Device for synchronized injection and aspiration |
CA2963890C (en) * | 2013-10-13 | 2022-05-10 | V.V.T. Med Ltd. | Vein ablation device and method |
EP3057517B1 (en) | 2013-10-15 | 2020-04-08 | Stryker Corporation | Device for creating a void space in a living tissue, the device including a handle with a control knob that can be set regardless of the orientation of the handle |
US10238406B2 (en) | 2013-10-21 | 2019-03-26 | Inari Medical, Inc. | Methods and apparatus for treating embolism |
US9808271B2 (en) | 2014-01-03 | 2017-11-07 | Legacy Ventures LLC | Clot retrieval system |
JP6841659B2 (en) | 2014-01-14 | 2021-03-10 | ボルケーノ コーポレイション | Devices and methods for forming vascular access |
WO2015108957A1 (en) | 2014-01-14 | 2015-07-23 | Volcano Corporation | Systems for improving an av access site |
US10874409B2 (en) | 2014-01-14 | 2020-12-29 | Philips Image Guided Therapy Corporation | Methods and systems for clearing thrombus from a vascular access site |
WO2015108928A1 (en) | 2014-01-14 | 2015-07-23 | Volcano Corporation | Systems and methods for evaluating hemodialysis arteriovenous fistula maturation |
US11027106B2 (en) | 2014-01-26 | 2021-06-08 | Butterfly Medical Ltd. | Dilating device and method for prostatic urethra |
US9855071B2 (en) | 2014-02-03 | 2018-01-02 | Covidien Lp | Thrombectomy catheter system with reference member |
US9579149B2 (en) | 2014-03-13 | 2017-02-28 | Medtronic Ardian Luxembourg S.A.R.L. | Low profile catheter assemblies and associated systems and methods |
WO2015153502A1 (en) * | 2014-03-31 | 2015-10-08 | Spiration, Inc. | Endoluminal sizing device |
US9629635B2 (en) | 2014-04-14 | 2017-04-25 | Sequent Medical, Inc. | Devices for therapeutic vascular procedures |
US10029037B2 (en) | 2014-04-15 | 2018-07-24 | Tc1 Llc | Sensors for catheter pumps |
EP3131599B1 (en) | 2014-04-15 | 2019-02-20 | Tc1 Llc | Catheter pump with access ports |
US10105475B2 (en) | 2014-04-15 | 2018-10-23 | Tc1 Llc | Catheter pump introducer systems and methods |
US10583232B2 (en) | 2014-04-15 | 2020-03-10 | Tc1 Llc | Catheter pump with off-set motor position |
US9801651B2 (en) | 2014-04-23 | 2017-10-31 | Boston Scientific Scimed, Inc. | Tissue extraction devices and related methods |
CN106232043B (en) | 2014-04-24 | 2019-07-23 | 美敦力阿迪安卢森堡有限公司 | Nerve modulation conduit and relevant system and method with braiding axle |
US10363043B2 (en) | 2014-05-01 | 2019-07-30 | Artventive Medical Group, Inc. | Treatment of incompetent vessels |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
WO2015190576A1 (en) * | 2014-06-13 | 2015-12-17 | テルモ株式会社 | Medical device |
WO2015200702A1 (en) | 2014-06-27 | 2015-12-30 | Covidien Lp | Cleaning device for catheter and catheter including the same |
US10314605B2 (en) | 2014-07-08 | 2019-06-11 | Benvenue Medical, Inc. | Apparatus and methods for disrupting intervertebral disc tissue |
WO2016028644A1 (en) | 2014-08-18 | 2016-02-25 | Thoratec Corporation | Guide features for percutaneous catheter pump |
US10456159B2 (en) * | 2014-10-17 | 2019-10-29 | Transmed7, Llc | Thrombo-embolic protection and embolectomy/thrombectomy devices and methods |
US11096715B2 (en) * | 2014-11-04 | 2021-08-24 | Terumo Kabushiki Kaisha | Medical device and treatment method |
WO2016072107A1 (en) * | 2014-11-04 | 2016-05-12 | テルモ株式会社 | Medical device |
DE102014222600A1 (en) * | 2014-11-05 | 2016-05-12 | Epflex Feinwerktechnik Gmbh | Medical safety wire instrument |
US10232148B2 (en) | 2014-11-17 | 2019-03-19 | TriReme Medical, LLC | Balloon catheter system and method of using same |
EP3247420B1 (en) | 2015-01-22 | 2019-10-02 | Tc1 Llc | Reduced rotational mass motor assembly for catheter pump |
WO2016118784A1 (en) | 2015-01-22 | 2016-07-28 | Thoratec Corporation | Attachment mechanisms for motor of catheter pump |
EP3598986B1 (en) | 2015-01-22 | 2021-02-17 | Tc1 Llc | Motor assembly with heat exchanger for catheter pump |
US10022243B2 (en) | 2015-02-06 | 2018-07-17 | Benvenue Medical, Inc. | Graft material injector system and method |
EP3256200A1 (en) | 2015-02-11 | 2017-12-20 | Covidien LP | Expandable tip medical devices and methods |
WO2016152548A1 (en) * | 2015-03-20 | 2016-09-29 | テルモ株式会社 | Catheter system and treating method |
US10314667B2 (en) | 2015-03-25 | 2019-06-11 | Covidien Lp | Cleaning device for cleaning medical instrument |
US10441311B2 (en) | 2015-04-02 | 2019-10-15 | Boston Scientific Scimed, Inc. | Atherectomy medical device |
US9907890B2 (en) | 2015-04-16 | 2018-03-06 | Tc1 Llc | Catheter pump with positioning brace |
US10314602B2 (en) | 2015-04-16 | 2019-06-11 | Stryker Corporation | Embolectomy devices and methods |
CN107835705B (en) | 2015-05-12 | 2022-05-13 | 爱尔兰国立高威大学 | Devices for therapeutic nasal neuromodulation and associated methods and systems |
EP3302312B1 (en) | 2015-05-27 | 2019-08-28 | Angioworks Medical B.V. | Devices for minimally invasive tissue removal |
JP2016221081A (en) * | 2015-06-02 | 2016-12-28 | テルモ株式会社 | Medical device |
WO2016201136A1 (en) | 2015-06-10 | 2016-12-15 | Ekos Corporation | Ultrasound catheter |
JP2018126173A (en) * | 2015-06-16 | 2018-08-16 | テルモ株式会社 | Medical device and treatment method |
US10357275B2 (en) * | 2015-06-26 | 2019-07-23 | CARDINAL HEALTH SWITZERLAND 515 GmbH | Dual-basket self-centering rotational device for treatment of arterial occlusive disease with infinitely adjustable cutting size |
EP3622907B1 (en) | 2015-07-16 | 2021-11-17 | Perflow Medical Ltd. | Apparatus for vessel occlusion removal |
US10292721B2 (en) | 2015-07-20 | 2019-05-21 | Covidien Lp | Tissue-removing catheter including movable distal tip |
US11103263B2 (en) | 2015-07-24 | 2021-08-31 | Ichor Vascular Inc. | Embolectomy system and methods of making and using same |
US10507122B2 (en) * | 2015-07-29 | 2019-12-17 | Butterfly Medical Ltd. | Retracting or/and supporting periurethral tissue |
US10463386B2 (en) * | 2015-09-01 | 2019-11-05 | Mivi Neuroscience, Inc. | Thrombectomy devices and treatment of acute ischemic stroke with thrombus engagement |
US10561440B2 (en) | 2015-09-03 | 2020-02-18 | Vesatek, Llc | Systems and methods for manipulating medical devices |
CN108024821B (en) | 2015-09-21 | 2020-10-30 | 斯瑞克公司 | Embolectomy device |
JP6591664B2 (en) | 2015-09-21 | 2019-10-16 | ストライカー コーポレイションStryker Corporation | Embolization removal device |
US10478194B2 (en) * | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
US10314664B2 (en) | 2015-10-07 | 2019-06-11 | Covidien Lp | Tissue-removing catheter and tissue-removing element with depth stop |
JP6368291B2 (en) * | 2015-10-20 | 2018-08-01 | 朝日インテック株式会社 | catheter |
DK3364891T3 (en) | 2015-10-23 | 2023-10-02 | Inari Medical Inc | Device for intravascular treatment of vascular occlusion |
WO2017074530A1 (en) * | 2015-10-26 | 2017-05-04 | Sos Thomas A | Thrombus removal and intravascular distal embolic protection device |
US10898221B2 (en) * | 2015-10-30 | 2021-01-26 | Terumo Kabushiki Kaisha | Device handle for a medical device |
US10869688B2 (en) * | 2015-10-30 | 2020-12-22 | Terumo Kabushiki Kaisha | Device handle for a medical device |
US10226263B2 (en) | 2015-12-23 | 2019-03-12 | Incuvate, Llc | Aspiration monitoring system and method |
CN108463879A (en) * | 2016-01-14 | 2018-08-28 | 三菱电机株式会社 | The manufacturing method of heat dissipation sheet structure, semiconductor device and the sheet structure that radiates |
WO2017132521A1 (en) * | 2016-01-27 | 2017-08-03 | Fusion Medical, Inc. | Clot removal device for blood vessels |
CA3013626A1 (en) * | 2016-02-08 | 2017-08-17 | Teleflex Medical Incorporated | Rotational mechanical thrombectomy device |
JP2019508201A (en) | 2016-02-16 | 2019-03-28 | インセラ セラピューティクス,インク. | Suction device and fixed blood flow bypass device |
CN113350658B (en) | 2016-02-24 | 2024-03-29 | 禾木(中国)生物工程有限公司 | Nerve vascular catheter with enhanced flexibility |
US10813644B2 (en) | 2016-04-01 | 2020-10-27 | Artventive Medical Group, Inc. | Occlusive implant and delivery system |
JP7092680B2 (en) | 2016-04-15 | 2022-06-28 | テンプル・ユニバーシティ-オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション | Infusion catheter and how to use |
US10905457B2 (en) * | 2016-06-06 | 2021-02-02 | Terumo Kabushiki Kaisha | Device handle for a medical device |
US10966749B2 (en) * | 2016-06-13 | 2021-04-06 | Terumo Kabushiki Kaisha | Medical device and treatment method |
US10980555B2 (en) * | 2016-07-12 | 2021-04-20 | Cardioprolific Inc. | Methods and devices for clots and tissue removal |
EP3487549B1 (en) | 2016-07-21 | 2021-02-24 | Tc1 Llc | Fluid seals for catheter pump motor assembly |
WO2018017683A1 (en) | 2016-07-21 | 2018-01-25 | Thoratec Corporation | Gas-filled chamber for catheter pump motor assembly |
EP3528717A4 (en) | 2016-10-24 | 2020-09-02 | Inari Medical, Inc. | Devices and methods for treating vascular occlusion |
EP3565511B1 (en) * | 2017-01-06 | 2023-10-18 | Incept, LLC | Thromboresistant coatings for aneurysm treatment devices |
US10580131B2 (en) | 2017-02-23 | 2020-03-03 | Zebra Medical Vision Ltd. | Convolutional neural network for segmentation of medical anatomical images |
US11123098B2 (en) * | 2017-02-28 | 2021-09-21 | Angiosafe, Inc. | Device and method for centering and crossing a vascular occlusion |
US10758286B2 (en) | 2017-03-22 | 2020-09-01 | Benvenue Medical, Inc. | Minimal impact access system to disc space |
WO2018185256A1 (en) | 2017-04-05 | 2018-10-11 | National University Of Ireland, Galway | An implantable medical device |
CN110573093B (en) | 2017-04-05 | 2023-06-16 | 爱尔兰国立高威大学 | Implantable medical device |
CN110573098B (en) | 2017-05-03 | 2022-08-23 | 美敦力瓦斯科尔勒公司 | Tissue removal catheter |
US11690645B2 (en) | 2017-05-03 | 2023-07-04 | Medtronic Vascular, Inc. | Tissue-removing catheter |
US11191555B2 (en) | 2017-05-12 | 2021-12-07 | Covidien Lp | Retrieval of material from vessel lumens |
US10722257B2 (en) | 2017-05-12 | 2020-07-28 | Covidien Lp | Retrieval of material from vessel lumens |
US10709464B2 (en) | 2017-05-12 | 2020-07-14 | Covidien Lp | Retrieval of material from vessel lumens |
US11129630B2 (en) | 2017-05-12 | 2021-09-28 | Covidien Lp | Retrieval of material from vessel lumens |
US11298145B2 (en) | 2017-05-12 | 2022-04-12 | Covidien Lp | Retrieval of material from vessel lumens |
CN110831523B (en) | 2017-06-12 | 2022-09-13 | 柯惠有限合伙公司 | Tool for sheathing a treatment device, and associated systems and methods |
US10478322B2 (en) | 2017-06-19 | 2019-11-19 | Covidien Lp | Retractor device for transforming a retrieval device from a deployed position to a delivery position |
US10575864B2 (en) | 2017-06-22 | 2020-03-03 | Covidien Lp | Securing element for resheathing an intravascular device and associated systems and methods |
US20190021749A1 (en) * | 2017-07-19 | 2019-01-24 | Hoya Corporation | Universal retrieval device for removing obstructions from body lumens |
AU2018328011B2 (en) | 2017-09-06 | 2022-09-15 | Inari Medical, Inc. | Hemostasis valves and methods of use |
US10105154B1 (en) | 2017-11-09 | 2018-10-23 | Pebble Hill Partners, Llc | Basket for a catheter device |
CN107898487B (en) * | 2017-11-28 | 2023-11-03 | 郑州大学第一附属医院 | General thrombus crushing and taking device with bionic jellyfish shrinkage and expansion functions |
CA3084506C (en) * | 2017-12-21 | 2022-10-04 | W. L. Gore & Associates, Inc. | Catheter-based occlusion removal systems and methods |
CN107928747A (en) * | 2017-12-29 | 2018-04-20 | 科睿驰(深圳)医疗科技发展有限公司 | A kind of thrombus withdrawing device |
US11490923B2 (en) | 2018-01-05 | 2022-11-08 | Cook Medical Technologies Llc | Device with sharp and blunt regions for removing occlusions |
US11154314B2 (en) | 2018-01-26 | 2021-10-26 | Inari Medical, Inc. | Single insertion delivery system for treating embolism and associated systems and methods |
WO2019148083A1 (en) | 2018-01-29 | 2019-08-01 | Benvenue Medical, Inc. | Minimally invasive interbody fusion |
WO2019178575A1 (en) | 2018-03-16 | 2019-09-19 | Benvenue Medical, Inc. | Articulated instrumentation and methods of using the same |
US11395665B2 (en) | 2018-05-01 | 2022-07-26 | Incept, Llc | Devices and methods for removing obstructive material, from an intravascular site |
CN112203593A (en) | 2018-05-01 | 2021-01-08 | 因赛普特有限责任公司 | Device and method for removing occlusive material from an intravascular site |
JP6563075B2 (en) * | 2018-05-21 | 2019-08-21 | 朝日インテック株式会社 | catheter |
CA3101761A1 (en) * | 2018-06-04 | 2019-12-12 | Pavel V. Efremkin | Devices and methods for intrabody surgery |
US11517335B2 (en) | 2018-07-06 | 2022-12-06 | Incept, Llc | Sealed neurovascular extendable catheter |
US11471582B2 (en) | 2018-07-06 | 2022-10-18 | Incept, Llc | Vacuum transfer tool for extendable catheter |
US11678905B2 (en) | 2018-07-19 | 2023-06-20 | Walk Vascular, Llc | Systems and methods for removal of blood and thrombotic material |
US20210307767A1 (en) * | 2018-08-10 | 2021-10-07 | The Foundry, Llc | Mechanical venous clot retrieval |
CA3114285A1 (en) | 2018-08-13 | 2020-02-20 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
EP3636172A1 (en) | 2018-10-11 | 2020-04-15 | Aurigen Medical Limited | A device for accessing the epicardial space |
EP3636171A1 (en) | 2018-10-11 | 2020-04-15 | National University of Ireland Galway | A device for implantation in a left atrial appendage of the heart |
JP2020062317A (en) * | 2018-10-19 | 2020-04-23 | 朝日インテック株式会社 | catheter |
US11357534B2 (en) | 2018-11-16 | 2022-06-14 | Medtronic Vascular, Inc. | Catheter |
US11666378B2 (en) | 2018-12-11 | 2023-06-06 | Neurent Medical Limited | Systems and methods for therapeutic nasal neuromodulation |
US11291453B2 (en) | 2019-03-15 | 2022-04-05 | Sequent Medical, Inc. | Filamentary devices having a flexible joint for treatment of vascular defects |
WO2020190620A1 (en) | 2019-03-15 | 2020-09-24 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
CN113573765A (en) | 2019-03-15 | 2021-10-29 | 后续医疗股份有限公司 | Silk device for treating vascular defects |
US11766539B2 (en) | 2019-03-29 | 2023-09-26 | Incept, Llc | Enhanced flexibility neurovascular catheter |
WO2020219392A2 (en) | 2019-04-24 | 2020-10-29 | Stryker Corporation | Systems and methods for off-axis augmentation of a vertebral body |
US11819236B2 (en) | 2019-05-17 | 2023-11-21 | Medtronic Vascular, Inc. | Tissue-removing catheter |
WO2021055603A2 (en) * | 2019-09-18 | 2021-03-25 | Merit Medical Systems, Inc. | Torque cable |
US11376034B2 (en) * | 2019-09-19 | 2022-07-05 | Stryker Corporation | Devices for removing obstructing materials from blood vessels |
EP4044906A4 (en) | 2019-10-15 | 2023-05-24 | Imperative Care, Inc. | Systems and methods for multivariate stroke detection |
CA3157521A1 (en) | 2019-10-16 | 2021-04-22 | Inari Medical, Inc. | Systems, devices, and methods for treating vascular occlusions |
US11553935B2 (en) | 2019-12-18 | 2023-01-17 | Imperative Care, Inc. | Sterile field clot capture module for use in thrombectomy system |
WO2021127004A1 (en) | 2019-12-18 | 2021-06-24 | Imperative Care, Inc. | Methods and systems for treating venous thromboembolic disease |
US11457936B2 (en) | 2019-12-18 | 2022-10-04 | Imperative Care, Inc. | Catheter system for treating thromboembolic disease |
WO2021127609A1 (en) * | 2019-12-20 | 2021-06-24 | Surmodics, Inc. | Universal scoring device |
KR102358005B1 (en) * | 2020-01-08 | 2022-02-03 | 경일대학교산학협력단 | Catheter capable of diagnosing and treating vascular diseases |
CN115038491A (en) * | 2020-02-04 | 2022-09-09 | 阿比奥梅德公司 | Intravascular blood pump with access filter |
WO2021183444A1 (en) | 2020-03-10 | 2021-09-16 | Imperative Care, Inc. | Enhanced flexibility neurovascular catheter |
CN113440214B (en) * | 2020-03-24 | 2023-04-14 | 张学民 | Thrombus removing device |
WO2021205230A1 (en) | 2020-04-09 | 2021-10-14 | Neurent Medical Limited | Systems and methods for therapeutic nasal treatment |
WO2021205229A1 (en) | 2020-04-09 | 2021-10-14 | Neurent Medical Limited | Systems and methods for improving sleep with therapeutic nasal treatment |
GB202005439D0 (en) | 2020-04-14 | 2020-05-27 | Aurigen Medical Ltd | A device for occlusion of a left a trial appendage of a heart |
US11738188B2 (en) * | 2020-06-08 | 2023-08-29 | Covidien Lp | Connection of intravascular interventional elements and elongate manipulation members |
CN113796923A (en) * | 2020-06-12 | 2021-12-17 | 苏州天鸿盛捷医疗器械有限公司 | Thrombus treatment platform |
US20210402157A1 (en) * | 2020-06-29 | 2021-12-30 | Neuravi Limited | Intravascular plaque isolation, destabilization, and aspiration |
US20230241358A1 (en) * | 2020-07-02 | 2023-08-03 | Mehmet Hakan Akpinar | A perfusion balloon with an expandable internal lumen |
US11207497B1 (en) | 2020-08-11 | 2021-12-28 | Imperative Care, Inc. | Catheter with enhanced tensile strength |
CN114098915A (en) * | 2020-08-27 | 2022-03-01 | 先健科技(深圳)有限公司 | Medical device and medical system |
CN114098914A (en) * | 2020-08-27 | 2022-03-01 | 先健科技(深圳)有限公司 | Medical device and medical system |
WO2022079235A1 (en) | 2020-10-17 | 2022-04-21 | Aurigen Medical Limited | A device for treatment of the left atrial appendage |
JP2023545853A (en) * | 2020-10-20 | 2023-10-31 | レガシー ベンチャーズ リミテッド ライアビリティ カンパニー | Blood clot collection system |
CA3200204A1 (en) | 2020-12-15 | 2022-06-23 | Tony O'halloran | A device to occlude a body lumen |
US20240090917A1 (en) * | 2020-12-16 | 2024-03-21 | Koninklijke Philips N.V. | Perforation guard |
US11304723B1 (en) | 2020-12-17 | 2022-04-19 | Avantec Vascular Corporation | Atherectomy devices that are self-driving with controlled deflection |
WO2022192897A1 (en) * | 2021-03-10 | 2022-09-15 | Intervene, Inc. | Device for modifying and/or removing obstructive material from a lumen of a blood vessel |
US11696793B2 (en) | 2021-03-19 | 2023-07-11 | Crossfire Medical Inc | Vascular ablation |
EP4079239A1 (en) * | 2021-04-22 | 2022-10-26 | Vetex Medical Ltd. | A thrombectomy device |
EP4119083A1 (en) | 2021-07-13 | 2023-01-18 | Aurigen Medical Limited | A system comprising an elongated catheter and an implant detachably attached to a distal end of the elongated catheter |
EP4119082A1 (en) | 2021-07-13 | 2023-01-18 | Aurigen Medical Limited | A system comprising an elongated catheter and an implant detachably attached to a distal end of the elongated catheter |
CN114469261A (en) * | 2022-02-11 | 2022-05-13 | 科塞尔医疗科技(苏州)有限公司 | Mechanical thrombus suction device |
WO2023186304A1 (en) * | 2022-03-31 | 2023-10-05 | Clearstream Technologies Limited | Vascular device |
WO2023222466A1 (en) * | 2022-05-19 | 2023-11-23 | Koninklijke Philips N.V. | Expandable debulking tool for intravascular procedures |
CN115252055B (en) * | 2022-06-23 | 2023-06-27 | 上海玮琅医疗科技有限公司 | Thrombus capturing bracket assembly and thrombus capturing method |
WO2024010583A1 (en) * | 2022-07-07 | 2024-01-11 | Bard Peripheral Vascular, Inc. | Endovascular apparatus for treating vessel intima and related methods |
US11911581B1 (en) | 2022-11-04 | 2024-02-27 | Controlled Delivery Systems, Inc. | Catheters and related methods for the aspiration controlled delivery of closure agents |
Citations (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3320957A (en) * | 1964-05-21 | 1967-05-23 | Sokolik Edward | Surgical instrument |
US4631052A (en) * | 1984-01-03 | 1986-12-23 | Intravascular Surgical Instruments, Inc. | Method and apparatus for surgically removing remote deposits |
US4857045A (en) * | 1987-04-30 | 1989-08-15 | Schneider (Usa) Inc., A Pfizer Company | Atherectomy catheter |
US4886061A (en) * | 1988-02-09 | 1989-12-12 | Medinnovations, Inc. | Expandable pullback atherectomy catheter system |
US4926858A (en) * | 1984-05-30 | 1990-05-22 | Devices For Vascular Intervention, Inc. | Atherectomy device for severe occlusions |
US5085662A (en) * | 1989-11-13 | 1992-02-04 | Scimed Life Systems, Inc. | Atherectomy catheter and related components |
US5154724A (en) * | 1990-05-14 | 1992-10-13 | Andrews Winston A | Atherectomy catheter |
US5176693A (en) * | 1992-05-11 | 1993-01-05 | Interventional Technologies, Inc. | Balloon expandable atherectomy cutter |
US5178625A (en) * | 1989-12-07 | 1993-01-12 | Evi Corporation | Catheter atherotome |
US5224945A (en) * | 1992-01-13 | 1993-07-06 | Interventional Technologies, Inc. | Compressible/expandable atherectomy cutter |
US5282484A (en) * | 1989-08-18 | 1994-02-01 | Endovascular Instruments, Inc. | Method for performing a partial atherectomy |
US5318576A (en) * | 1992-12-16 | 1994-06-07 | Plassche Jr Walter M | Endovascular surgery systems |
US5462529A (en) * | 1993-09-29 | 1995-10-31 | Technology Development Center | Adjustable treatment chamber catheter |
US5490859A (en) * | 1992-11-13 | 1996-02-13 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5501694A (en) * | 1992-11-13 | 1996-03-26 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5527326A (en) * | 1992-12-29 | 1996-06-18 | Thomas J. Fogarty | Vessel deposit shearing apparatus |
US5540707A (en) * | 1992-11-13 | 1996-07-30 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5569277A (en) * | 1989-09-12 | 1996-10-29 | Devices For Vascular Intervention, Inc. | Atherectomy device having helical blade and blade guide |
US5571122A (en) * | 1992-11-09 | 1996-11-05 | Endovascular Instruments, Inc. | Unitary removal of plaque |
US5653722A (en) * | 1995-01-03 | 1997-08-05 | Kieturakis; Maciej J. | Anterograde/retrograde spiral dissector and method of use in vein grafting |
US5681336A (en) * | 1995-09-07 | 1997-10-28 | Boston Scientific Corporation | Therapeutic device for treating vien graft lesions |
US5725549A (en) * | 1994-03-11 | 1998-03-10 | Advanced Cardiovascular Systems, Inc. | Coiled stent with locking ends |
US5766191A (en) * | 1992-04-07 | 1998-06-16 | Johns Hopkins University | Percutaneous mechanical fragmentation catheter system |
US5836868A (en) * | 1992-11-13 | 1998-11-17 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5879361A (en) * | 1996-07-26 | 1999-03-09 | Kensey Nash Corporation | System and method of use for revascularizing stenotic bypass grafts and other blood vessels |
US5882329A (en) * | 1997-02-12 | 1999-03-16 | Prolifix Medical, Inc. | Apparatus and method for removing stenotic material from stents |
US5885258A (en) * | 1996-02-23 | 1999-03-23 | Memory Medical Systems, Inc. | Medical instrument with slotted memory metal tube |
US5904698A (en) * | 1997-06-10 | 1999-05-18 | Applied Medical Resources Corporation | Surgical shaving device for use within body conduits |
US6027863A (en) * | 1991-09-05 | 2000-02-22 | Intratherapeutics, Inc. | Method for manufacturing a tubular medical device |
US6027514A (en) * | 1997-12-17 | 2000-02-22 | Fox Hollow Technologies, Inc. | Apparatus and method for removing occluding material from body lumens |
US6036708A (en) * | 1998-08-13 | 2000-03-14 | Advanced Cardiovascular Systems, Inc. | Cutting stent with flexible tissue extractor |
US6454775B1 (en) * | 1999-12-06 | 2002-09-24 | Bacchus Vascular Inc. | Systems and methods for clot disruption and retrieval |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8114987A (en) | 1986-11-14 | 1988-05-19 | Heart Technology, Inc. | Clinically practical rotational angioplasty system |
DE4025825A1 (en) | 1990-08-16 | 1992-02-20 | Cook William Europ | DEVICE FOR CRUSHING BLOOD CLOTS |
US5569275A (en) | 1991-06-11 | 1996-10-29 | Microvena Corporation | Mechanical thrombus maceration device |
US5713848A (en) | 1993-05-19 | 1998-02-03 | Dubrul; Will R. | Vibrating catheter |
US5795322A (en) | 1995-04-10 | 1998-08-18 | Cordis Corporation | Catheter with filter and thrombus-discharge device |
US6022336A (en) | 1996-05-20 | 2000-02-08 | Percusurge, Inc. | Catheter system for emboli containment |
US5904968A (en) | 1996-05-24 | 1999-05-18 | Moore Business Forms, Inc. | Method of labeling blow molded articles with linerless labels |
EP1007139A1 (en) | 1997-02-12 | 2000-06-14 | Prolifix Medical, Inc. | Apparatus for removal of material from stents |
US5741270A (en) | 1997-02-28 | 1998-04-21 | Lumend, Inc. | Manual actuator for a catheter system for treating a vascular occlusion |
US6010449A (en) | 1997-02-28 | 2000-01-04 | Lumend, Inc. | Intravascular catheter system for treating a vascular occlusion |
US5968064A (en) | 1997-02-28 | 1999-10-19 | Lumend, Inc. | Catheter system for treating a vascular occlusion |
AU737311B2 (en) * | 1997-10-01 | 2001-08-16 | Boston Scientific Limited | Medical retrieval basket with legs shaped to enhance capture solid matter and reduce trauma |
US6511492B1 (en) * | 1998-05-01 | 2003-01-28 | Microvention, Inc. | Embolectomy catheters and methods for treating stroke and other small vessel thromboembolic disorders |
AU5101699A (en) | 1998-07-15 | 2000-02-07 | Corazon Technologies, Inc. | Methods and devices for reducing the mineral content of vascular calcified lesions |
WO2001015759A1 (en) | 1999-09-01 | 2001-03-08 | Bacchus Vascular, Inc. | Methods and apparatus for accessing and treating body lumens |
US6702830B1 (en) | 1999-09-17 | 2004-03-09 | Bacchus Vascular, Inc. | Mechanical pump for removal of fragmented matter and methods of manufacture and use |
AU2607901A (en) | 1999-12-31 | 2001-07-16 | Bacchus Vascular Inc. | Method and system for re-infusing filtered bodily aspirates |
US6663613B1 (en) | 2000-01-25 | 2003-12-16 | Bacchus Vascular, Inc. | System and methods for clot dissolution |
-
2001
- 2001-03-27 US US09/820,301 patent/US20010031981A1/en not_active Abandoned
- 2001-03-30 AU AU5303501A patent/AU5303501A/en active Pending
- 2001-03-30 US US09/823,652 patent/US6652548B2/en not_active Expired - Lifetime
- 2001-03-30 EP EP01926502A patent/EP1272110B1/en not_active Expired - Lifetime
- 2001-03-30 WO PCT/US2001/010357 patent/WO2001074255A1/en active IP Right Grant
- 2001-03-30 JP JP2001572003A patent/JP2004503265A/en not_active Withdrawn
- 2001-03-30 DE DE60144557T patent/DE60144557D1/en not_active Expired - Lifetime
- 2001-03-30 AT AT01926502T patent/ATE507781T1/en not_active IP Right Cessation
- 2001-03-30 CA CA2404144A patent/CA2404144C/en not_active Expired - Fee Related
-
2002
- 2002-10-31 US US10/285,843 patent/US20030055445A1/en not_active Abandoned
- 2002-10-31 US US10/285,727 patent/US20030055444A1/en not_active Abandoned
Patent Citations (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3320957A (en) * | 1964-05-21 | 1967-05-23 | Sokolik Edward | Surgical instrument |
US4631052A (en) * | 1984-01-03 | 1986-12-23 | Intravascular Surgical Instruments, Inc. | Method and apparatus for surgically removing remote deposits |
US4926858A (en) * | 1984-05-30 | 1990-05-22 | Devices For Vascular Intervention, Inc. | Atherectomy device for severe occlusions |
US4857045A (en) * | 1987-04-30 | 1989-08-15 | Schneider (Usa) Inc., A Pfizer Company | Atherectomy catheter |
US4886061A (en) * | 1988-02-09 | 1989-12-12 | Medinnovations, Inc. | Expandable pullback atherectomy catheter system |
US5282484A (en) * | 1989-08-18 | 1994-02-01 | Endovascular Instruments, Inc. | Method for performing a partial atherectomy |
US5569277A (en) * | 1989-09-12 | 1996-10-29 | Devices For Vascular Intervention, Inc. | Atherectomy device having helical blade and blade guide |
US5085662A (en) * | 1989-11-13 | 1992-02-04 | Scimed Life Systems, Inc. | Atherectomy catheter and related components |
US5178625A (en) * | 1989-12-07 | 1993-01-12 | Evi Corporation | Catheter atherotome |
US5154724A (en) * | 1990-05-14 | 1992-10-13 | Andrews Winston A | Atherectomy catheter |
US6027863A (en) * | 1991-09-05 | 2000-02-22 | Intratherapeutics, Inc. | Method for manufacturing a tubular medical device |
US5224945A (en) * | 1992-01-13 | 1993-07-06 | Interventional Technologies, Inc. | Compressible/expandable atherectomy cutter |
US5766191A (en) * | 1992-04-07 | 1998-06-16 | Johns Hopkins University | Percutaneous mechanical fragmentation catheter system |
US5176693A (en) * | 1992-05-11 | 1993-01-05 | Interventional Technologies, Inc. | Balloon expandable atherectomy cutter |
US5665098A (en) * | 1992-11-09 | 1997-09-09 | Endovascular Instruments, Inc. | Unitary removal of plaque |
US5571122A (en) * | 1992-11-09 | 1996-11-05 | Endovascular Instruments, Inc. | Unitary removal of plaque |
US5540707A (en) * | 1992-11-13 | 1996-07-30 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5501694A (en) * | 1992-11-13 | 1996-03-26 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5490859A (en) * | 1992-11-13 | 1996-02-13 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5836868A (en) * | 1992-11-13 | 1998-11-17 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5318576A (en) * | 1992-12-16 | 1994-06-07 | Plassche Jr Walter M | Endovascular surgery systems |
US5527326A (en) * | 1992-12-29 | 1996-06-18 | Thomas J. Fogarty | Vessel deposit shearing apparatus |
US5462529A (en) * | 1993-09-29 | 1995-10-31 | Technology Development Center | Adjustable treatment chamber catheter |
US5725549A (en) * | 1994-03-11 | 1998-03-10 | Advanced Cardiovascular Systems, Inc. | Coiled stent with locking ends |
US5653722A (en) * | 1995-01-03 | 1997-08-05 | Kieturakis; Maciej J. | Anterograde/retrograde spiral dissector and method of use in vein grafting |
US5681336A (en) * | 1995-09-07 | 1997-10-28 | Boston Scientific Corporation | Therapeutic device for treating vien graft lesions |
US5885258A (en) * | 1996-02-23 | 1999-03-23 | Memory Medical Systems, Inc. | Medical instrument with slotted memory metal tube |
US5879361A (en) * | 1996-07-26 | 1999-03-09 | Kensey Nash Corporation | System and method of use for revascularizing stenotic bypass grafts and other blood vessels |
US5882329A (en) * | 1997-02-12 | 1999-03-16 | Prolifix Medical, Inc. | Apparatus and method for removing stenotic material from stents |
US5904698A (en) * | 1997-06-10 | 1999-05-18 | Applied Medical Resources Corporation | Surgical shaving device for use within body conduits |
US6027514A (en) * | 1997-12-17 | 2000-02-22 | Fox Hollow Technologies, Inc. | Apparatus and method for removing occluding material from body lumens |
US6036708A (en) * | 1998-08-13 | 2000-03-14 | Advanced Cardiovascular Systems, Inc. | Cutting stent with flexible tissue extractor |
US6454775B1 (en) * | 1999-12-06 | 2002-09-24 | Bacchus Vascular Inc. | Systems and methods for clot disruption and retrieval |
Cited By (125)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090318816A1 (en) * | 2003-05-23 | 2009-12-24 | Embro Corporation | Light catheter for illuminating tissue structures |
US20050154400A1 (en) * | 2003-12-18 | 2005-07-14 | Asahi Intecc Co., Ltd | Medical treating tool |
EP1543785A1 (en) * | 2003-12-18 | 2005-06-22 | Asahi Intecc Co., Ltd. | A basket-like medical treating tool for removing occlusive material |
US10517633B2 (en) | 2004-04-27 | 2019-12-31 | The Spectranetics Corporation | Thrombectomy and soft debris removal device |
US7666161B2 (en) | 2004-04-27 | 2010-02-23 | The Spectranetics Corporation | Thrombectomy and soft debris removal device |
US20080097499A1 (en) * | 2004-04-27 | 2008-04-24 | Nash John E | Thrombectomy and soft debris removal device |
US20050240146A1 (en) * | 2004-04-27 | 2005-10-27 | Nash John E | Thrombectomy and soft debris removal device |
US7976528B2 (en) | 2004-04-27 | 2011-07-12 | The Spectranetics, Corp. | Thrombectomy and soft debris removal device |
US20070282303A1 (en) * | 2004-04-27 | 2007-12-06 | Nash John E | Thrombectomy and soft debris removal device |
US9808277B2 (en) | 2004-04-27 | 2017-11-07 | The Spectranetics Corporation | Thrombectomy and soft debris removal device |
US7959608B2 (en) | 2004-04-27 | 2011-06-14 | The Spectranetics Corporation | Thrombectomy and soft debris removal device |
US8920402B2 (en) | 2004-04-27 | 2014-12-30 | The Spectranetics Corporation | Thrombectomy and soft debris removal device |
US20100145259A1 (en) * | 2004-04-27 | 2010-06-10 | The Spectranetics Corporation | Thrombectomy and soft debris removal device |
US8460312B2 (en) | 2004-09-10 | 2013-06-11 | Penumbra, Inc. | System and method for treating ischemic stroke |
US9655633B2 (en) | 2004-09-10 | 2017-05-23 | Penumbra, Inc. | System and method for treating ischemic stroke |
US20110172700A1 (en) * | 2004-09-10 | 2011-07-14 | Penumbra, Inc. | System and method for treating ischemic stroke |
US9119656B2 (en) | 2004-09-10 | 2015-09-01 | Penumbra, Inc. | System and method for treating ischemic stroke |
US20070154555A1 (en) * | 2004-12-02 | 2007-07-05 | Strauss Bradley H | Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions |
US8512311B2 (en) * | 2004-12-02 | 2013-08-20 | Bradley H. Strauss | Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions |
JP2008521523A (en) * | 2004-12-02 | 2008-06-26 | ブラッドリー・エイチ・ストラウス | Enhanced intraluminal microangiogenesis to facilitate and facilitate the passage of guidewires in chronic total occlusions |
US20090240278A1 (en) * | 2006-02-17 | 2009-09-24 | Deutsch Harvey L | Device for placing an occlusion removing structure in a tubular structure with a substantially closed distal end |
US10869687B2 (en) | 2006-12-22 | 2020-12-22 | Spectranetics Llc | Tissue separating systems and methods |
US9289226B2 (en) | 2006-12-22 | 2016-03-22 | The Spectranetics Corporation | Retractable separating systems and methods |
US10537354B2 (en) | 2006-12-22 | 2020-01-21 | The Spectranetics Corporation | Retractable separating systems and methods |
US9808275B2 (en) | 2006-12-22 | 2017-11-07 | The Spectranetics Corporation | Retractable separating systems and methods |
US9801650B2 (en) | 2006-12-22 | 2017-10-31 | The Spectranetics Corporation | Tissue separating systems and methods |
US9028520B2 (en) | 2006-12-22 | 2015-05-12 | The Spectranetics Corporation | Tissue separating systems and methods |
US8961551B2 (en) | 2006-12-22 | 2015-02-24 | The Spectranetics Corporation | Retractable separating systems and methods |
US20080188864A1 (en) * | 2007-01-12 | 2008-08-07 | Wilson-Cook Medical Inc. | Lithotripsy basket drill |
US8764730B2 (en) | 2007-06-26 | 2014-07-01 | Roxwood Medical, Inc. | Catheter apparatus and methods for treating vasculatures |
US10471234B2 (en) | 2007-06-26 | 2019-11-12 | Roxwood Medical, Inc. | Catheter apparatus and methods for treating vasculatures |
WO2009003113A1 (en) * | 2007-06-26 | 2008-12-31 | Unique Catheter Designs, Llc | Catheter apparatus and methods for treating vasculatures |
US9126020B2 (en) | 2007-06-26 | 2015-09-08 | Roxwood Medical, Inc. | Catheter apparatus with telescoping lumen catheters and its use in methods for treating vasculatures |
US9125683B2 (en) | 2007-06-26 | 2015-09-08 | Roxwood Medical Inc. | Method and apparatus for placing a catheter within a vasculature |
US11065028B2 (en) | 2007-06-26 | 2021-07-20 | Roxwood Medical Inc. | Method and apparatus for placing a catheter within a vasculature |
US7988646B2 (en) | 2007-06-26 | 2011-08-02 | Mark Taber | Catheter apparatus and methods for treating vasculatures |
US10130795B2 (en) | 2007-06-26 | 2018-11-20 | Roxwood Medical Inc. | Catheter apparatus with telescoping lumen catheters and its use in methods for treating vasculatures |
US9358037B2 (en) | 2007-06-26 | 2016-06-07 | Roxwood Medical, Inc. | Method and apparatus for centering a microcatheter within a vasculature |
US10130385B2 (en) | 2007-06-26 | 2018-11-20 | Roxwood Medical Inc. | Method and apparatus for placing a catheter within a vasculature |
WO2009097008A1 (en) * | 2007-10-12 | 2009-08-06 | The Spectranetics Corporation | Thrombectomy and soft debris removal device |
US11589880B2 (en) | 2007-12-20 | 2023-02-28 | Angiodynamics, Inc. | System and methods for removing undesirable material within a circulatory system utilizing during a surgical procedure |
US11896246B2 (en) | 2007-12-20 | 2024-02-13 | Angiodynamics, Inc. | Systems and methods for removing undesirable material within a circulatory system utilizing a balloon catheter |
WO2009154441A1 (en) * | 2008-06-19 | 2009-12-23 | Wittens Cornelis Hendrikus Ann | A thrombectomy catheter and a device comprising the same |
US20110190806A1 (en) * | 2008-06-19 | 2011-08-04 | Angiodynamics, Inc. | Thrombectomy catheter and a device comprising the same |
US20100204672A1 (en) * | 2009-02-12 | 2010-08-12 | Penumra, Inc. | System and method for treating ischemic stroke |
US10039900B2 (en) | 2010-09-07 | 2018-08-07 | Angiodynamics, Inc. | Fluid delivery and treatment device and method of use |
US11464537B2 (en) | 2011-03-15 | 2022-10-11 | Angiodynamics, Inc. | Device and method for removing material from a hollow anatomical structure |
US20180344970A1 (en) * | 2011-05-23 | 2018-12-06 | Nitiloop Ltd. | Deployment mechanism for body vessel insertion devices |
US10773052B2 (en) * | 2011-05-23 | 2020-09-15 | Nitiloop Ltd. | Deployment mechanism for body vessel insertion devices |
US20120316589A1 (en) * | 2011-06-07 | 2012-12-13 | Cook Medical Technologies Llc | Balloon catheter with raised elements and visual marker |
US20130103067A1 (en) * | 2011-07-28 | 2013-04-25 | Myra I. L. Fabro | Discectomy devices and related methods |
WO2013052625A1 (en) * | 2011-10-05 | 2013-04-11 | Penumbra, Inc. | System and method for treating ischemic stroke |
US10993731B2 (en) | 2011-10-05 | 2021-05-04 | Penumbra, Inc. | System and method for treating ischemic stroke |
CN104053410A (en) * | 2011-10-05 | 2014-09-17 | 半影公司 | System and method for treating ischemic stroke |
US10531891B2 (en) | 2012-09-14 | 2020-01-14 | The Spectranetics Corporation | Tissue slitting methods and systems |
US9949753B2 (en) | 2012-09-14 | 2018-04-24 | The Spectranetics Corporation | Tissue slitting methods and systems |
US10368900B2 (en) | 2012-09-14 | 2019-08-06 | The Spectranetics Corporation | Tissue slitting methods and systems |
US11596435B2 (en) | 2012-09-14 | 2023-03-07 | Specrtranetics Llc | Tissue slitting methods and systems |
US9724122B2 (en) | 2012-09-14 | 2017-08-08 | The Spectranetics Corporation | Expandable lead jacket |
US9763692B2 (en) | 2012-09-14 | 2017-09-19 | The Spectranetics Corporation | Tissue slitting methods and systems |
US9413896B2 (en) | 2012-09-14 | 2016-08-09 | The Spectranetics Corporation | Tissue slitting methods and systems |
US10426510B2 (en) | 2012-10-22 | 2019-10-01 | Roxwood Medical, Inc. | Method and apparatus for centering a microcatheter within a vasculature |
US9937005B2 (en) | 2013-03-13 | 2018-04-10 | The Spectranetics Corporation | Device and method of ablative cutting with helical tip |
US10265520B2 (en) | 2013-03-13 | 2019-04-23 | The Spetranetics Corporation | Alarm for lead insulation abnormality |
US10799293B2 (en) | 2013-03-13 | 2020-10-13 | The Spectranetics Corporation | Laser ablation catheter |
US9925371B2 (en) | 2013-03-13 | 2018-03-27 | The Spectranetics Corporation | Alarm for lead insulation abnormality |
US9456872B2 (en) | 2013-03-13 | 2016-10-04 | The Spectranetics Corporation | Laser ablation catheter |
US10485613B2 (en) | 2013-03-13 | 2019-11-26 | The Spectranetics Corporation | Device and method of ablative cutting with helical tip |
US9291663B2 (en) | 2013-03-13 | 2016-03-22 | The Spectranetics Corporation | Alarm for lead insulation abnormality |
US9883885B2 (en) | 2013-03-13 | 2018-02-06 | The Spectranetics Corporation | System and method of ablative cutting and pulsed vacuum aspiration |
US9283040B2 (en) | 2013-03-13 | 2016-03-15 | The Spectranetics Corporation | Device and method of ablative cutting with helical tip |
US10383691B2 (en) | 2013-03-13 | 2019-08-20 | The Spectranetics Corporation | Last catheter with helical internal lumen |
US10835279B2 (en) | 2013-03-14 | 2020-11-17 | Spectranetics Llc | Distal end supported tissue slitting apparatus |
US11925380B2 (en) | 2013-03-14 | 2024-03-12 | Spectranetics Llc | Distal end supported tissue slitting apparatus |
US10874421B2 (en) * | 2013-03-15 | 2020-12-29 | National University Of Ireland, Galway | Extraction devices |
US11406418B2 (en) | 2013-03-15 | 2022-08-09 | Vetex Medial Limited | Thrombectomy devices with control assemblies |
US10219819B2 (en) | 2013-03-15 | 2019-03-05 | The Spectranetics Corporation | Retractable blade for lead removal device |
US9603618B2 (en) | 2013-03-15 | 2017-03-28 | The Spectranetics Corporation | Medical device for removing an implanted object |
US10842532B2 (en) | 2013-03-15 | 2020-11-24 | Spectranetics Llc | Medical device for removing an implanted object |
US10314615B2 (en) | 2013-03-15 | 2019-06-11 | The Spectranetics Corporation | Medical device for removing an implanted object |
US11925334B2 (en) | 2013-03-15 | 2024-03-12 | Spectranetics Llc | Surgical instrument for removing an implanted object |
US10136913B2 (en) | 2013-03-15 | 2018-11-27 | The Spectranetics Corporation | Multiple configuration surgical cutting device |
US11896257B2 (en) | 2013-03-15 | 2024-02-13 | Vetex Medical Limited | Thrombectomy devices with control assemblies |
US9925366B2 (en) | 2013-03-15 | 2018-03-27 | The Spectranetics Corporation | Surgical instrument for removing an implanted object |
US9668765B2 (en) | 2013-03-15 | 2017-06-06 | The Spectranetics Corporation | Retractable blade for lead removal device |
US10813663B2 (en) | 2013-03-15 | 2020-10-27 | National University Of Ireland, Galway | Device suitable for removing matter from inside the lumen and the wall of a body lumen |
US10052129B2 (en) | 2013-03-15 | 2018-08-21 | The Spectranetics Corporation | Medical device for removing an implanted object |
US10448999B2 (en) | 2013-03-15 | 2019-10-22 | The Spectranetics Corporation | Surgical instrument for removing an implanted object |
US10779852B2 (en) | 2013-03-15 | 2020-09-22 | National University Of Ireland, Galway | Device suitable for removing matter from inside the lumen and the wall of a body lumen |
US10849603B2 (en) | 2013-03-15 | 2020-12-01 | Spectranetics Llc | Surgical instrument for removing an implanted object |
US11317939B2 (en) | 2013-03-15 | 2022-05-03 | Vetex Medical Limited | Thrombectomy devices with maceration |
US10524817B2 (en) | 2013-03-15 | 2020-01-07 | The Spectranetics Corporation | Surgical instrument including an inwardly deflecting cutting tip for removing an implanted object |
US9980743B2 (en) | 2013-03-15 | 2018-05-29 | The Spectranetics Corporation | Medical device for removing an implanted object using laser cut hypotubes |
US11278307B2 (en) | 2013-03-15 | 2022-03-22 | Vetex Medical Limited | Thrombectomy devices with aspiration |
US11160579B2 (en) | 2013-03-15 | 2021-11-02 | Spectranetics Llc | Multiple configuration surgical cutting device |
US9956399B2 (en) | 2013-03-15 | 2018-05-01 | The Spectranetics Corporation | Medical device for removing an implanted object |
US9918737B2 (en) | 2013-03-15 | 2018-03-20 | The Spectranetics Corporation | Medical device for removing an implanted object |
US9393035B2 (en) | 2013-04-12 | 2016-07-19 | Yongyi Alan Yu | Systems and methods for restoring blood flow to a vessel |
EP2983597A4 (en) * | 2013-04-12 | 2016-11-16 | Yongyi Alan Yu | Systems and methods for restoring blood flow to a vessel |
US10194928B2 (en) | 2013-04-12 | 2019-02-05 | Yongyi Alan Yu | Systems and methods for restoring blood flow to a vessel |
CN105377156A (en) * | 2013-04-12 | 2016-03-02 | 余永毅 | Systems and methods for restoring blood flow to a vessel |
WO2014169266A1 (en) * | 2013-04-12 | 2014-10-16 | Yu Yongyi Alan | Systems and methods for restoring blood flow to a vessel |
US9877742B2 (en) | 2013-11-14 | 2018-01-30 | Cook Medical Technologies Llc | Thrombectomy catheter with flow directing mechanism |
US10286190B2 (en) | 2013-12-11 | 2019-05-14 | Cook Medical Technologies Llc | Balloon catheter with dynamic vessel engaging member |
US9956384B2 (en) | 2014-01-24 | 2018-05-01 | Cook Medical Technologies Llc | Articulating balloon catheter and method for using the same |
US10405924B2 (en) | 2014-05-30 | 2019-09-10 | The Spectranetics Corporation | System and method of ablative cutting and vacuum aspiration through primary orifice and auxiliary side port |
US9801643B2 (en) * | 2014-09-02 | 2017-10-31 | Cook Medical Technologies Llc | Clot retrieval catheter |
US10772649B2 (en) * | 2014-09-02 | 2020-09-15 | Cook Medical Technologies Llc | Clot retrieval catheter |
US20160058458A1 (en) * | 2014-09-02 | 2016-03-03 | Cook Medical Technologies Llc | Clot retrieval catheter |
US10743907B2 (en) | 2014-11-07 | 2020-08-18 | National University Of Ireland, Galway | Thrombectomy device |
USD819204S1 (en) | 2015-02-20 | 2018-05-29 | The Spectranetics Corporation | Medical device handle |
USD854682S1 (en) | 2015-02-20 | 2019-07-23 | The Spectranetics Corporation | Medical device handle |
USD806245S1 (en) | 2015-02-20 | 2017-12-26 | The Spectranetics Corporation | Medical device handle |
USD765243S1 (en) | 2015-02-20 | 2016-08-30 | The Spectranetics Corporation | Medical device handle |
USD770616S1 (en) | 2015-02-20 | 2016-11-01 | The Spectranetics Corporation | Medical device handle |
US10596354B2 (en) | 2015-09-25 | 2020-03-24 | Mark Taber | Guide wires, catheters, and guide wire catheter systems and methods |
WO2017165842A1 (en) * | 2016-03-24 | 2017-09-28 | Edwards Lifesciences Corporation | Delivery system for prosthetic heart valve |
EP3745967A4 (en) * | 2018-01-30 | 2022-01-26 | Shanghai Wallaby Medical Technologies Co., Inc. | Devices and methods for treating blocked blood vessels |
WO2019152328A1 (en) | 2018-01-30 | 2019-08-08 | Wallaby Medical, Inc. | Devices and methods for treating blocked blood vessels |
CN110090063A (en) * | 2018-01-30 | 2019-08-06 | 上海沃比医疗科技有限公司 | Thrombus capture device and its method |
US11304713B2 (en) | 2018-09-07 | 2022-04-19 | Merit Medical Systems, Inc. | Thrombosis macerating and aspiration devices for blood vessels |
WO2020160179A1 (en) * | 2019-01-31 | 2020-08-06 | Merit Medical Systems, Inc. | Thrombosis macerating devices for blood vessels |
US11648020B2 (en) | 2020-02-07 | 2023-05-16 | Angiodynamics, Inc. | Device and method for manual aspiration and removal of an undesirable material |
WO2021260715A1 (en) * | 2020-06-25 | 2021-12-30 | Meril Life Sciences Pvt Ltd | Clot retrieval device |
WO2024003912A1 (en) * | 2022-06-28 | 2024-01-04 | Shabat Matan | Tissue ablation device and system |
Also Published As
Publication number | Publication date |
---|---|
US6652548B2 (en) | 2003-11-25 |
US20010031981A1 (en) | 2001-10-18 |
EP1272110A1 (en) | 2003-01-08 |
CA2404144A1 (en) | 2001-10-11 |
EP1272110A4 (en) | 2007-07-18 |
DE60144557D1 (en) | 2011-06-16 |
JP2004503265A (en) | 2004-02-05 |
US20020010487A1 (en) | 2002-01-24 |
US20030055444A1 (en) | 2003-03-20 |
CA2404144C (en) | 2013-02-19 |
EP1272110B1 (en) | 2011-05-04 |
ATE507781T1 (en) | 2011-05-15 |
AU5303501A (en) | 2001-10-15 |
WO2001074255A1 (en) | 2001-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2404144C (en) | Expansible shearing catheters for thrombus and occlusive material removal | |
US11207096B2 (en) | Devices systems and methods for cutting and removing occlusive material from a body lumen | |
US9333007B2 (en) | Atherectomy devices and methods | |
US9675376B2 (en) | Atherectomy devices and methods | |
US10154853B2 (en) | Devices, systems, and methods for cutting and removing occlusive material from a body lumen | |
US7517352B2 (en) | Devices for percutaneous remote endarterectomy | |
EP2211732B1 (en) | Atherectomy devices | |
US8920448B2 (en) | Atherectomy devices and methods | |
US8007506B2 (en) | Atherectomy devices and methods | |
AU2001253035B2 (en) | Expansible shearing catheters for thrombus and occlusive material removal | |
AU2001253035A1 (en) | Expansible shearing catheters for thrombus and occlusive material removal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: BACCHUS VASCULAR, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:EVANS, MICHAEL A.;DEMARAIS, DENISE M.;LEEFLANG, STEPHEN A.;AND OTHERS;SIGNING DATES FROM 20010507 TO 20010511;REEL/FRAME:024645/0211 Owner name: BACCHUS VASCULAR, LLC, MASSACHUSETTS Free format text: MERGER;ASSIGNOR:BACCHUS VASCULAR, INC.;REEL/FRAME:024640/0610 Effective date: 20090326 |
|
AS | Assignment |
Owner name: SHERWOOD MEDICAL COMPANY I, CONNECTICUT Free format text: ASSIGNMENT OF FIFTY ONE PERCENT (51%) OF ASSIGNOR'S ENTIRE RIGHT, TITLE, INTEREST, AND THE GOODWILL;ASSIGNOR:BACCHUS VASCULAR, LLC;REEL/FRAME:024651/0280 Effective date: 20090327 Owner name: VALLEYLAB HOLDING CORPORATION, CONNECTICUT Free format text: ASSIGNMENT OF FORTY NINE PERCENT (49%) OF ASSIGNOR'S ENTIRE RIGHT, TITLE, AND INTEREST;ASSIGNOR:BACCHUS VASCULAR, LLC;REEL/FRAME:024651/0309 Effective date: 20090327 Owner name: TYCO HEALTHCARE GROUP LP, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SHERWOOD MEDICAL COMPANY I;REEL/FRAME:024651/0242 Effective date: 20090327 Owner name: TYCO HEALTHCARE GROUP LP, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VALLEYLAB HOLDING CORPORATION;REEL/FRAME:024651/0256 Effective date: 20090327 |